
<html lang="en"     class="pb-page"  data-request-id="16363d33-2237-4ac0-b5db-f115a38a2864"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b01310"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases" /></meta><meta name="dc.Creator" content="Natalie&#xA;B.  Vinh" /></meta><meta name="dc.Creator" content="Nyssa  Drinkwater" /></meta><meta name="dc.Creator" content="Tess R.  Malcolm" /></meta><meta name="dc.Creator" content="Michael  Kassiou" /></meta><meta name="dc.Creator" content="Leonardo  Lucantoni" /></meta><meta name="dc.Creator" content="Peter M.  Grin" /></meta><meta name="dc.Creator" content="Georgina S.  Butler" /></meta><meta name="dc.Creator" content="Sandra  Duffy" /></meta><meta name="dc.Creator" content="Christopher M.  Overall" /></meta><meta name="dc.Creator" content="Vicky M.  Avery" /></meta><meta name="dc.Creator" content="Peter J.  Scammells" /></meta><meta name="dc.Creator" content="Sheena  McGowan" /></meta><meta name="dc.Description" content="There is an urgent clinical need for antimalarial compounds that target malaria caused by both Plasmodium falciparum and Plasmodium vivax. The M1 and M17 metalloexopeptidases play key roles in Plas..." /></meta><meta name="Description" content="There is an urgent clinical need for antimalarial compounds that target malaria caused by both Plasmodium falciparum and Plasmodium vivax. The M1 and M17 metalloexopeptidases play key roles in Plas..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 11, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01310" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01310" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01310" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01310" /></link>
        
    
    

<title>Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01310" /></meta><meta property="og:title" content="Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0002.jpeg" /></meta><meta property="og:description" content="There is an urgent clinical need for antimalarial compounds that target malaria caused by both Plasmodium falciparum and Plasmodium vivax. The M1 and M17 metalloexopeptidases play key roles in Plasmodium hemoglobin digestion and are validated drug targets. We used a multitarget strategy to rationally design inhibitors capable of potent inhibition of the M1 and M17 aminopeptidases from both P. falciparum (Pf-M1 and Pf-M17) and P. vivax (Pv-M1 and Pv-M17). The novel chemical series contains a hydroxamic acid zinc binding group to coordinate catalytic zinc ion/s, and a variety of hydrophobic groups to probe the S1′ pockets of the four target enzymes. Structural characterization by cocrystallization showed that selected compounds utilize new and unexpected binding modes; most notably, compounds substituted with bulky hydrophobic substituents displace the Pf-M17 catalytic zinc ion. Excitingly, key compounds of the series potently inhibit all four molecular targets and show antimalarial activity comparable to current clinical candidates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01310"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01310">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01310&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01310&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01310&amp;href=/doi/10.1021/acs.jmedchem.8b01310" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 622-640</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01238" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01327" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of <i>Plasmodium</i> M1 and M17 Aminopeptidases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Natalie B. Vinh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natalie B. Vinh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Melbourne, VIC 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natalie%0AB.++Vinh">Natalie B. Vinh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nyssa Drinkwater</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nyssa Drinkwater</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Melbourne, VIC 3800, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nyssa++Drinkwater">Nyssa Drinkwater</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tess R. Malcolm</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tess R. Malcolm</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Melbourne, VIC 3800, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tess+R.++Malcolm">Tess R. Malcolm</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Kassiou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Kassiou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Sydney, Sydney, NSW 2006, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Kassiou">Michael Kassiou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6655-0529" title="Orcid link">http://orcid.org/0000-0002-6655-0529</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leonardo Lucantoni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leonardo Lucantoni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leonardo++Lucantoni">Leonardo Lucantoni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter M. Grin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter M. Grin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Molecular Biology, Centre for Blood Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+M.++Grin">Peter M. Grin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Georgina S. Butler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Georgina S. Butler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Molecular Biology,  Department of Oral Biological and Medical Sciences, Centre for Blood Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Georgina+S.++Butler">Georgina S. Butler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandra Duffy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandra Duffy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Duffy">Sandra Duffy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher M. Overall</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher M. Overall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Molecular Biology,  Department of Oral Biological and Medical Sciences, Centre for Blood Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++Overall">Christopher M. Overall</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5844-2731" title="Orcid link">http://orcid.org/0000-0001-5844-2731</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vicky M. Avery</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vicky M. Avery</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vicky+M.++Avery">Vicky M. Avery</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter J. Scammells</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter J. Scammells</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Melbourne, VIC 3052, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#bfefdacbdacd91ecdcded2d2dad3d3ccffd2d0d1deccd791dadbca"><span class="__cf_email__" data-cfemail="48182d3c2d3a661b2b2925252d24243b08252726293b20662d2c3d">[email protected]</span></a> (P.J.S.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Scammells">Peter J. Scammells</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2930-895X" title="Orcid link">http://orcid.org/0000-0003-2930-895X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sheena McGowan</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sheena McGowan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Melbourne, VIC 3800, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#92c1faf7f7fcf3bcdff1d5fde5f3fcd2fffdfcf3e1fabcf7f6e7"><span class="__cf_email__" data-cfemail="87d4efe2e2e9e6a9cae4c0e8f0e6e9c7eae8e9e6f4efa9e2e3f2">[email protected]</span></a> (S.M.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sheena++McGowan">Sheena McGowan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6863-1106" title="Orcid link">http://orcid.org/0000-0001-6863-1106</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01310&amp;href=/doi/10.1021%2Facs.jmedchem.8b01310" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 622–640</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 11, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 August 2018</li><li><span class="item_label"><b>Published</b> online</span>11 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01310" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01310</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D622%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNatalie%250AB.%2BVinh%252C%2BNyssa%2BDrinkwater%252C%2BTess%2BR.%2BMalcolm%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01310%26title%3DHydroxamic%2BAcid%2BInhibitors%2BProvide%2BCross-Species%2BInhibition%2Bof%2BPlasmodium%2BM1%2Band%2BM17%2BAminopeptidases%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D640%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01310"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1180</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01310" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Natalie\nB.&quot;,&quot;last_name&quot;:&quot;Vinh&quot;},{&quot;first_name&quot;:&quot;Nyssa&quot;,&quot;last_name&quot;:&quot;Drinkwater&quot;},{&quot;first_name&quot;:&quot;Tess&quot;,&quot;last_name&quot;:&quot;R. Malcolm&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Kassiou&quot;},{&quot;first_name&quot;:&quot;Leonardo&quot;,&quot;last_name&quot;:&quot;Lucantoni&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;M. Grin&quot;},{&quot;first_name&quot;:&quot;Georgina&quot;,&quot;last_name&quot;:&quot;S. Butler&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Duffy&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. Overall&quot;},{&quot;first_name&quot;:&quot;Vicky&quot;,&quot;last_name&quot;:&quot;M. Avery&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Scammells&quot;},{&quot;first_name&quot;:&quot;Sheena&quot;,&quot;last_name&quot;:&quot;McGowan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;622-640&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01310&quot;},&quot;abstract&quot;:&quot;There is an urgent clinical need for antimalarial compounds that target malaria caused by both Plasmodium falciparum and Plasmodium vivax. The M1 and M17 metalloexopeptidases play key roles in Plasmodium hemoglobin digestion and are validated drug targets. We used a multitarget strategy to rationally design inhibitors capable of potent inhibition of the M1 and M17 aminopeptidases from both P. falciparum (Pf-M1 and Pf-M17) and P. vivax (Pv-M1 and Pv-M17). The novel chemical series contains a hydroxamic acid zinc binding group to coordinate catalytic zinc ion/s, and a variety of hydrophobic groups to probe the S1′ pockets of the four target enzymes. Structural characterization by cocrystallization showed that selected compounds utilize new and unexpected binding modes; most notably, compounds substituted with bulky hydrophobic substituents displace the Pf-M17 catalytic zinc ion. Excitingly, key compounds of the series potently inhibit all four molecular targets and show antimalarial activity comparable to curre&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01310&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01310" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01310&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01310" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01310&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01310" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01310&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01310&amp;href=/doi/10.1021/acs.jmedchem.8b01310" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01310" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01310" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01310%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DVinh%26date%3D2019%26atitle%3DHydroxamic%2BAcid%2BInhibitors%2BProvide%2BCross-Species%2BInhibition%2Bof%2BPlasmodium%2BM1%2Band%2BM17%2BAminopeptidases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D622%26epage%3D640%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=290966" title="Photovoltaics">Photovoltaics</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There is an urgent clinical need for antimalarial compounds that target malaria caused by both <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i>. The M1 and M17 metalloexopeptidases play key roles in <i>Plasmodium</i> hemoglobin digestion and are validated drug targets. We used a multitarget strategy to rationally design inhibitors capable of potent inhibition of the M1 and M17 aminopeptidases from both <i>P. falciparum</i> (<i>Pf</i>-M1 and <i>Pf</i>-M17) and <i>P. vivax</i> (<i>Pv</i>-M1 and <i>Pv</i>-M17). The novel chemical series contains a hydroxamic acid zinc binding group to coordinate catalytic zinc ion/s, and a variety of hydrophobic groups to probe the S1′ pockets of the four target enzymes. Structural characterization by cocrystallization showed that selected compounds utilize new and unexpected binding modes; most notably, compounds substituted with bulky hydrophobic substituents displace the <i>Pf</i>-M17 catalytic zinc ion. Excitingly, key compounds of the series potently inhibit all four molecular targets and show antimalarial activity comparable to current clinical candidates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria is a widespread parasitic disease; half of the world’s population, approximately 3.2 billion people, is at risk of contracting malaria. In 2016, an estimated 216 million people contracted malaria and 445 000 deaths were reported.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Malaria is caused by five species of the <i>Plasmodium</i> genus: <i>Plasmodium falciparum</i>, <i>Plasmodium malariae</i>, <i>Plasmodium ovale</i>, <i>Plasmodium vivax</i> and <i>Plasmodium knowlesi</i>. <i>P. falciparum</i> is responsible for an estimated 90% of malaria deaths worldwide, making it the most severe and lethal form of the disease;<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> however, <i>P. vivax</i>, which is the predominant parasite causing human malaria outside of Africa, also causes substantial morbidity, primarily due to the difficulty obtaining a complete cure, which results in disease recurrence.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Efforts to control malaria and prevent its spread to new regions have been hindered by the emergence of drug resistance, including to artemisinin, our last line of defense.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Despite the global health toll of malaria, the widespread resistance to commonly used antimalarials, and the alarming development of artemisinin resistance, there are few novel therapeutics in the pipeline. Further, many of the treatments in the Medicine for Malaria Venture pipeline, the major source of new antimalarial therapeutics, still contain artemisinin or its derivatives. Therefore, new therapeutics with novel mechanisms of action and activity against both <i>P. falciparum</i> and <i>P. vivax</i> are urgently required.</div><div class="NLM_p">Hemoglobin digestion is an essential metabolic process in the intraerythrocytic stage of the <i>Plasmodium</i> life cycle. During this process, malaria parasites digest up to 75% of host cell hemoglobin, resulting in the liberation of amino acids required for parasite protein synthesis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Two zinc-dependent metalloaminopeptidases, <i>Pf</i>-M1 and <i>Pf</i>-M17, are involved in the latter stages of hemoglobin degradation (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Figure 1</a>), and are essential for parasite survival.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> In vitro studies have shown that <i>Pf</i>-M1 inhibition kills the parasites by preventing proteolysis of hemoglobin peptides, while <i>Pf-</i>M17 inhibition kills the parasites earlier in their life cycle, suggestive of an additional role for <i>Pf</i>-M17 beyond hemoglobin digestion.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Further, inhibition of both aminopeptidases in vivo reduced parasitemia in <i>Plasmodium chabaudi chabaudi</i> murine models of malaria.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> As such, <i>Pf</i>-M1 and <i>Pf</i>-M17 are validated targets for antimalarial therapy, and have been targeted in a variety of drug discovery programs.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22">(10−22)</a></div><div class="NLM_p">Both <i>Pf</i>-M1 and <i>Pf</i>-M17 use a zinc (Zn<sup>2+</sup>)-dependent mechanism to hydrolyze the scissile peptide bond to catalyze the removal of single amino acids from the N-terminus of short peptides. Despite performing near-identical reactions, albeit with distinct specificities for the amino acid residue they remove (P1 position),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the enzymes themselves are from different enzyme families and possess very different three-dimensional structures.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a><i>Pf</i>-M1 is a monomeric protein of four domains, and has an active site containing a single catalytic Zn<sup>2+</sup> ion buried deep within the catalytic domain.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><i>Pf</i>-M17 is a homohexameric protein, with each subunit composed of two domains. The six active sites of the <i>Pf</i>-M17 hexamer each contain two catalytic Zn<sup>2+</sup> ions and lie on the edge of the catalytic domains, where they are exposed to the large internal cavity of the hexamer.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Despite these differences, the active sites of <i>Pf</i>-M1 and <i>Pf</i>-M17 share a similar structural arrangement; both possess S1 and S1′ pockets (to accommodate substrate P1 and P1′ residues), with bound Zn<sup>2+</sup> ion/s at the junction of the two subsites.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> These common features led us to propose that, through rational drug design, we could develop a single compound capable of potent, dual inhibition of both <i>Pf</i>-M1 and <i>Pf</i>-M17, an attractive strategy for slowing the development of drug-resistant parasites.<a onclick="showRef(event, 'ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref20">(17,20)</a></div><div class="NLM_p last">Research within our group has used rational drug design to optimize arginine mimetics into potent dual <i>Pf</i>-M1 and <i>Pf</i>-M17 inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Figure 2</a>).<a onclick="showRef(event, 'ref15 ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref15 ref17 ref20">(15,17,20)</a><i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)pivalamide (<b>1</b>) coordinates the catalytic Zn<sup>2+</sup> ion/s through a hydroxamic acid moiety and occupies the S1 and S1′ pockets of both enzymes with the trifluorobiphenyl and pivalamide moieties, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Figure 3</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In the S1 pocket of <i>Pf</i>-M1, the fluorine substituents interact through an intricate network of water-mediated hydrogen bonds, while in <i>Pf</i>-M17, the trifluorophenyl ring binds solely through hydrophobic interactions with neighboring Leu492, Phe583, and Met392 residues. Having optimized the binding interactions within the S1 pockets of both enzymes, we sought to improve the pivalamide portion of the molecule, which binds the S1′ pocket. Further, we elected to extend our strategy to target the M1 and M17 homologs in <i>P. vivax</i> (<i>Pv</i>-M1 and <i>Pv</i>-M17) to expand the capacity of our lead compounds and develop cross-species therapeutics.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Multitarget Inhibition Strategy</h3><div class="NLM_p">To achieve effective cross-species activity against <i>P. falciparum</i> and <i>P. vivax</i> by dual inhibition of M1 and M17, compounds capable of potent inhibition of all four molecular targets are required. The challenge this multitarget strategy presents to rational drug design is lessened by the high degree of sequence conservation between the <i>Plasmodium</i> homologs. The M1 homologs of <i>P. falciparum</i> and <i>P. vivax</i> share 72% sequence identity (89% within catalytic domains), while the M17 homologs share 70% identity (92% catalytic domains). Furthermore, the inhibitor binding residues are highly conserved; based on the previously determined crystal structures of <i>Pf</i>-M1 and <i>Pf</i>-M17 in complex with <b>1</b>, the residues lining the active sites and interacting with the inhibitors are 100% conserved between the cross-species homologs. Given this sequence conservation, and the highly conserved reaction mechanisms utilized by the M1 and M17 aminopeptidase families, it is likely that the structure of the active sites is also highly conserved across species. To investigate if these similarities would allow for cross-species inhibition by our inhibitors, we produced recombinant <i>Pv</i>-M1 and <i>Pv</i>-M17. The <i>Pv</i>-M1 (residues 195–1097) and <i>Pv</i>-M17 (residues 203–621) protein constructs were designed and produced in line with methods used for the <i>Pf</i> homologs, and demonstrated comparable kinetic parameters against the reporter substrate, <span class="smallcaps smallerCapital">l</span>-leucine-7-amido-4-methylcoumarin, in our fluorescence-based assay system (complete biochemical characterization of <i>Pv</i>-M1 and <i>Pv</i>-M17 to be reported elsewhere). Interestingly, we found that <b>1</b>, designed to target the <i>Pf</i> enzymes, is actually more potent against the <i>Pv</i> enzymes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This result supports the assertion that the structures of each of the M1 and M17 active sites are highly conserved between <i>Pf</i> and <i>Pv</i>. We therefore elected to perform further rational design of inhibitors targeting the M1 and M17 aminopeptidases from both <i>P. falciparum</i> and <i>P. vivax</i> (four total targets), guided by structural analysis of the <i>Pf</i> enzymes.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of <i>Pf</i>-M1 and <i>Pf</i>-M17 by Hydroxamic Acid Compounds <b>6a</b>–<b>r</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0001.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub>i</sub> values are the mean of three independent experiments.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemical Synthesis of S1′ Exploratory Series</h3><div class="NLM_p">Changes to the amide functionality of <b>1</b> were made to optimize interactions in the S1′ pockets of <i>Pf</i>-M1/<i>Pf</i>-M17, thereby enhancing binding and inhibitory potency. A series of hydroxamic acid analogues containing hydrophobic groups that vary in size and shape were explored to investigate which groups could best satisfy the S1′ pockets of the four target enzymes. Different hydrophobic groups were incorporated into the scaffold using a four-step reaction sequence shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, 2-amino-2-(4-bromophenyl)acetic acid (<b>2</b>) was esterified using standard conditions. The resultant methyl ester <b>3</b> was further functionalized using a Suzuki reaction to append the 3,4,5-trifluorophenyl ring. A mixture of compound <b>3</b>, 3,4,5-trifluorophenylboronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3(aq)</sub>, and tetrahydrofuran (THF) was refluxed for 2 h to give the key amine intermediate <b>4</b> in good yield (65%). The amine <b>4</b> was then elaborated with the desired hydrophobic substituent by treatment with either an acid chloride or an acid in the presence of peptide coupling reagents. These reactions proceeded in moderate yields (28–85%) with the exception of the 2,2,3,3,3-pentafluoropropanamide analogue <b>5e</b>, which was obtained in poor yield (7%) when <i>O</i>-(1<i>H</i>-6-chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HCTU) was used as the coupling reagent. A small improvement in yield (42%) was observed when 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)·HCl was used. Finally, aminolysis of the methyl esters <b>5a</b>–<b>r</b> with hydroxylamine hydrochloride and potassium hydroxide in anhydrous methanol gave the hydroxamic acid analogues (<b>6a</b>–<b>r</b>) in low to good yields (22–75%).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) cat. concd H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux, 30 h; (b) cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 3,4,5-trifluorophenylboronic acid, degassed 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, degassed THF, reflux, 2 h; (c) method A: acid chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 2 h; method B: acid, HCTU, <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), CH<sub>2</sub>Cl<sub>2</sub>, dimethylformamide (DMF), rt, 2 h; method C: acid, EDC·HCl, 4-dimethylaminopyridine (DMAP), CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (d) NH<sub>2</sub>OH·HCl, 5 M KOH/MeOH, dry MeOH, rt, 16 h.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Compound Series Inhibits Multiple Targets</h3><div class="NLM_p">Previous examination of the activity of <i>Pf</i>-M1<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and <i>Pf</i>-M17<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> utilized a fluorescence-based assay system to monitor cleavage of the commercially available reporter substrate <span class="smallcaps smallerCapital">l</span>-leucine-7-amido-4-methylcoumarin. We have previously adapted this system to examine inhibition of both <i>Pf</i>-M1 and <i>Pf</i>-M17 by calculation of compound inhibition constants (<i>K</i><sub>i</sub>) using the Dixon method. During the examination of the current series of compounds, we determined that compounds were inhibiting the enzymes with inhibition constants below the concentration of enzyme in the assay. We therefore restructured our method of compound examination to use a modified Morrison equation for tight-binding inhibitors and performed all assays in biological triplicate.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> This alteration in methodology resulted in a small discrepancy between the <i>K</i><sub>i</sub> values of compound <b>1</b> reported here (<i>K</i><sub>i</sub><i>Pf</i>-M1 = 331 nM, <i>K</i><sub>i</sub><i>Pf</i>-M17 = 147 nM) and that reported previously (<i>K</i><sub>i</sub><i>Pf</i>-M1 = 80 nM, <i>K</i><sub>i</sub><i>Pf</i>-M17 = 60 nM).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The methods utilized herein provide a robust method to evaluate tight-binding inhibitors against four different molecular targets, and we recommend they be used to assess all inhibitors of the <i>Plasmodium</i> aminopeptidases in future studies. We determined the inhibitory activity of <b>6a</b>–<b>r</b> against the M1 and M17 enzymes from both <i>P. falciparum</i> and <i>P. vivax</i>. The binding affinities (<i>K</i><sub>i</sub>) of the synthesized compounds to all four enzymes are described in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The rational design of compound/s capable of potent inhibition of four different enzymes presents a number of logistical difficulties. To simplify, we elected to analyze trends in the binding potencies first between homologous enzyme pairs (<i>Pf</i>- vs <i>Pv</i>-M1 and <i>Pf</i>- vs <i>Pv</i>-M17) and then between enzyme families (M1 vs M17).</div><div class="NLM_p">Overall, the compound series inhibits <i>Pv</i>-M1 with approximately 10-fold greater affinity than <i>Pf</i>-M1, demonstrating that key differences between the M1 homologs exist that have a profound influence on compound binding and inhibition (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Despite the difference in affinities, the trends in potency within the series are largely conserved, i.e., the most potent inhibitors of <i>Pv</i>-M1 are also the most potent <i>Pf</i>-M1 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). Analogues of <b>1</b> that lack one or two methyl groups of the pivalamide (compounds <b>6a</b> and <b>6b</b>, respectively) displayed significantly lower M1 binding affinity. A small series of fluorine-containing <i>tert</i>-butyl isosteres (compounds <b>6c</b>–<b>e</b>) were also evaluated. Of these compounds, only one diastereomer of the 2,3,3,3-tetrafluoropropanamide <b>6d</b> (<b>6d</b>–<b>a</b>) inhibited both the <i>Pf</i>-M1 and <i>Pv</i>-M1 enzymes with comparable potency to <b>1</b>. A series of cycloalkyl carboxamides was also prepared and assessed (compounds <b>6f</b>–<b>k</b>) to further define the steric requirements for optimal <i>Pf</i>-M1 and <i>Pv</i>-M1 activity. The cyclobutyl- and cyclopentylcarboxamides (<b>6g</b> and <b>6h</b>, respectively) proved to be the most potent inhibitors of both enzymes, while analogues of smaller rings (cyclopropyl; <b>6f</b>) or larger rings (cyclohexyl; <b>6i</b>) were significantly less potent inhibitors of both <i>Pf-</i>M1 and <i>Pv</i>-M1. Interestingly, the adamantyl carboxamide <b>6k</b> inhibited <i>Pf</i>-M1 with higher potency (<i>Pf</i>-M1 <i>K</i><sub>i</sub> = 137 nM) than <b>1</b>, but was a much weaker inhibitor (<i>K</i><sub>i</sub> = 122 nM) than <b>1</b> at <i>Pv</i>-M1.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound inhibition trends for (A) <i>Pf</i>- and <i>Pv</i>-M1 enzymes and (B) <i>Pf</i>- and <i>Pv</i>-M17 aminopeptidases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extension of the carboxamide of <b>1</b> by one methylene unit in the 3,3-dimethylbutanamide analogue <b>6l</b> improved potency at both enzymes (cf. <i>Pf</i>-M1 = 269 nM, <i>Pv</i>-M1 = 6.39 nM). On the basis of this promising finding, a series of cycloalkyl acetamides, which possessed an analogous methylene spacer between the amide carbonyl and the cycloalkyl moiety (compounds <b>6m</b>–<b>p</b>), were prepared and evaluated. This series was generally more potent than the corresponding cycloalkyl carboxamides, which lacked the methylene spacer (i.e., compounds <b>6f</b>–<b>i</b>), with the exception of the cyclohexyl analogs <b>6i</b> and <b>6p</b>, which were equipotent. In terms of compounds <b>6m</b>–<b>p</b>, the cyclobutylacetamide <b>6n</b> was the most potent inhibitor of <i>Pf</i>-M1 (<i>K</i><sub>i</sub> = 177 nM), with both the cyclopropyl and cyclopentylacetamides exhibiting slightly lower potency (<b>6m</b>; <i>K</i><sub>i</sub> = 202 nM and <b>6o</b>; <i>K</i><sub>i</sub> = 216 nM, respectively). The same general trend was observed at the <i>Pv</i>-M1 enzyme, where the cyclobutylacetamide <b>6n</b> was once again proved to be the most potent (<i>Pv-</i>M1 <i>K</i><sub>i</sub> = 2.85 nM), with reduced potency observed for the cyclopropyl and cyclopentylacetamides (<b>6m</b>; <i>K</i><sub>i</sub> = 17.9 nM and <b>6o</b>; <i>K</i><sub>i</sub> = 7.58 nM, respectively). To further probe the steric requirements of the S1′-binding pocket, the fused cycloalkyl groups <b>6q</b> and <b>6r</b> were assessed. Both the cubanylacetamide <b>6q</b> and the norbornylacetamide <b>6r</b> exhibited potent inhibitory activity at both <i>Pf</i> and <i>Pv</i>-M1 enzymes, with <b>6q</b> proving to be the most potent M1 inhibitor of all compounds studied (<i>K</i><sub>i</sub><i>Pf</i>-M1 = 88.9 nM, <i>Pv</i>-M1 = 1.73 nM).</div><div class="NLM_p">Determination of the binding potencies of <b>6a</b>–<b>r</b> for <i>Pf</i>- and <i>Pv</i>-M17 shows that, unlike the M1 enzymes, the scale of inhibition of <b>6a</b>–<b>r</b> is largely conserved between the two M17 homologs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Analysis of the trends in inhibition potency across the series highlights some interesting similarities and differences between M17 homologs. The changes to binding potency of the alkyl, fluoroalkyl, and cycloalkyl carboxamides <b>6a</b>–<b>k</b> are conserved between the two M17 enzymes (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Of analogues <b>6a</b>–<b>k</b>, only one produced stronger inhibition of <i>Pf-</i> and <i>Pv-</i>M17 compared to <b>1</b>. Compound <b>6k</b>, containing a bulky hydrophobic adamantyl moiety, showed the most potent inhibition of <i>Pf</i>-M17 observed to date (<i>K</i><sub>i</sub> = 28.9 nM) as well as highly potent <i>Pv</i>-M17 inhibition (<i>K</i><sub>i</sub> = 18.6 nM).</div><div class="NLM_p">Incorporation of a methylene spacer adjacent to the carboxamide resulted in substantial divergence between the <i>Pf</i> and <i>Pv</i> homologs (<b>6l</b>–<b>r</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). There is clearly a difference in the capacity of the S1′ pockets of <i>Pf</i>- and <i>Pv</i>-M17 to accommodate hydrophobic moieties. In general, the derivatives <b>6l</b>–<b>r</b> showed stronger inhibition of the <i>Pv</i>-M17 homolog versus the <i>Pf</i>-M17 homolog with exception of compounds <b>6m</b> and <b>6o</b>. Binding affinity of compounds <b>6l</b>–<b>p</b> to <i>Pf-</i> and <i>Pv-</i>M17 largely improved relative to their analogous compound without the methylene unit (<b>1</b>, <b>6f</b>–<b>i</b>). The 3,3-dimethylbutanamide <b>6l</b> proved to be the most potent inhibitor at both <i>Pf-</i> and <i>Pv-</i>M17 with <i>K</i><sub>i</sub> values of 101 and 3.60 nM, respectively. Interestingly, there was no clear correlation between the size of the carboxamide and inhibitory activity across this series. Of the fused cycloalkyl acetamides <b>6q</b> and <b>6r</b>, norbonylacetamide <b>6r</b> was equivalent in inhibitory potency to both M17 enzymes (<i>K</i><sub>i</sub><i>Pf</i>-M17 = 127 nM, <i>Pv</i>-M17 = 93.1 nM) compared to <b>1</b>.</div><div class="NLM_p last">Overall, both the M1 and M17 enzymes from <i>Pf</i> and <i>Pv</i> were able to accommodate a number of different hydrophobic groups. While the binding capacity of the series showed substantial variation between the four enzymes, the cycloalkyl acetamides (compounds <b>6m</b>–<b>p</b>) were generally the most potent multitarget inhibitors of the series, with all but <b>6p</b>, demonstrating potent inhibition of all four enzymes. These results indicate that it is possible to develop a single compound capable of potent inhibition of both the M1 and M17 aminopeptidases across multiple <i>Plasmodium</i> species.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Binding Mode of Selected Lead Compounds to <i>Pf</i>-M1</h3><div class="NLM_p">To support the structure-activity relationship (SAR) data, and to inform further rational design, we determined the crystal structures of <i>Pf</i>-M1 with selected compounds of the series (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Tables 1 and 2</a>). The eight structures all showed clear compound density for the compounds in the <i>Pf</i>-M1 active site, with all of the compounds coordinating the catalytic Zn<sup>2+</sup> through the hydroxamic acid. Further, the conserved trifluorobiphenyl substituents all adopt identical poses in the S1 site, as was observed on binding of compound <b>1</b> previously.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The overall quaternary structure of <i>Pf</i>-M1 is also largely conserved. Compared to the unliganded <i>Pf</i>-M1 structure, a small shift (0.5 Å) in the backbone of residues 319–Thr321, which sits just behind the S1 site, is observed, with Glu319–Ala320 adopting the cis-configuration in all eight structures described herein.</div><div class="NLM_p">The lack of a distinct inhibition trend across the <i>Pf</i>-M1 series was curious, in that the most potent compounds were substituted with mid-sized (<i>tert</i>-butyl to cyclopentyl) or large (e.g., cubanyl) hydrophobic moieties. We were particularly interested to determine why all three of the compounds substituted with six-membered rings (<b>6i</b>, <b>6j</b>, and <b>6p</b>) were relatively weak inhibitors compared to the closely related five-membered ring analogues (<b>6h</b> and <b>6o</b>). The parent compound <b>1</b> coordinates the catalytic Zn<sup>2+</sup> through the hydroxamic acid, which orients the carboxamide to allow the hydrophobic <i>tert</i>-butyl moiety access to the S1′ site, wherein it forms interactions with the pi electrons of His496 and hydrophobic interactions with Tyr580 and Val493 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Figure 3A</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The carboxamide itself also forms key hydrogen bonds with the backbone amine of Gly460 and Ala461.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The crystal structure of <i>Pf</i>-M1 in complex with <b>6h</b> (1.35 Å) shows that the cyclopentyl moiety of <b>6h</b> largely occupies the same space as the <i>tert</i>-butyl moiety of <b>1</b>, but forms closer interactions with Val493 and the pi cloud of His496 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), which accounts for the modest improvement in inhibitor potency. These interactions are optimized further in the cyclopentylacetamide <b>6o</b>, which combines the cyclopentyl moiety with a methylene spacer. <i>Pf</i>-M1:<b>6o</b> (determined to 1.5 Å) demonstrates that this extension allows the cyclopentane ring deeper access into the S1′ pocket, where it forms hydrophobic interactions of an ideal length with Val493 and Thr492, while also maintaining the interactions with the zinc-binding residue His496 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The improvement in binding of <b>6o</b> compared to <b>6h</b> is only modest (<i>K</i><sub>i</sub> = 216 nM compared to 285 nM), which is likely due to the closer unfavorable contacts with Arg489 formed by <b>6o</b>. Any additional steric bulk in this position would be more unfavorable, which likely indicates why the cyclohexane-substituted analogues are poor inhibitors. To confirm, we determined the structure of <i>Pf</i>-M1 in complex with cyclohexylcarboxamide <b>6i</b> and cyclohexylacetamide <b>6p</b> to 1.65 and 1.50 Å, respectively. The cyclohexyl group of <b>6i</b> sits within the S1′ pocket, as predicted, clashes with Arg489. Additionally, the adopted conformation is of high energy; the substituent is axial and the ring adopts a strained chair conformation with C1–C2–C3 angle of 98°. Together, these observations account for the weak binding of <b>6i</b>. Surprisingly, the added methylene spacer of <b>6p</b> results in a drastically altered <i>Pf</i>-M1 binding conformation. The cyclohexyl substituent has moved out of the S1′ pocket and instead occupies the substrate/product access channel (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). This rearrangement likely occurred to avoid steric clashes of the bulker substituent with the spatially limited S1′ pocket. Unfortunately, the new binding mode places the cyclohexyl substituent within a solvated environment and offers few binding options for a hydrophobic moiety, and as a consequence, reduces binding potency. The ring interacts with the face of Tyr580 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D), but this proximity also results in close contact between the ring of <b>6p</b> and the backbone carbonyl of Tyr575, which results in local small-scale rearrangement of the protein chain similar to that observed on binding of other large inhibitors.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Further, the change in carboxamide geometry required to elicit the new binding mode resulted in a lengthening of the hydrogen bond between carbonyl oxygen and backbone amine of Gly460 and loss of the hydrogen bond to Ala461 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B compared to <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). We also examined the binding of the cyclopropylacetamide <b>6m</b>. Interestingly, the structure of <i>Pf</i>-M1:<b>6m</b> (1.58 Å) showed that the cyclopropane ring of <b>6m</b> also occupies the access channel rather than the S1′ site similar to <b>6p</b>. The contrasting conformational preference of <b>6m</b> compared to <b>6o</b> indicates that both substituent geometry and size influence the <i>Pf</i>-M1 binding mode. Despite occupying the access channel rather than the S1′ subsite, <b>6m</b> does not suffer the same loss of potency as <b>6p</b>. This is likely because the smaller <b>6m</b> does not cause the Tyr575 backbone rearrangement observed on binding <b>6p</b>, nor require the change in geometry of the <i>N</i>-acyl group. Together, these observations account for the loss of potency observed for <b>6p</b> compared to <b>6l</b>–<b>n</b>.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of selected compounds to <i>Pf</i>-M1 (gray cartoon). (A) Overlay of the binding position of <b>1</b> (yellow sticks) and <b>6h</b> (blue sticks) in the <i>Pf</i>-M1 binding pocket (gray sticks). (B) Structure of <b>6o</b> in complex with <i>Pf</i>-M1 (gray sticks). Molecular interactions between <b>6o</b> and the S1′ subsite are indicated by dashed lines. (C) Solvent-accessible surface of <i>Pf</i>-M1 (gray) with the S1 and S1′ subsites as well as the substrate/product access channel are indicated. Stick representation shows the binding positions of <b>6h</b> (purple), <b>6o</b> (pink), and <b>6p</b> (orange). (D) Structure of <b>6p</b> (orange) in complex with <i>Pf</i>-M1 (gray sticks). Molecular interactions between the <i>N</i>-acyl and ethyl-linked cyclohexane moieties of <b>6o</b> are indicated by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having accounted for the loss of potency of compounds substituted with a six-membered ring, we questioned how the larger <b>6k</b>, <b>6q</b>, and <b>6r</b> regained affinity to possess the tightest <i>Pf</i>-M1 inhibition constants of the series. We therefore determined the structure of <i>Pf</i>-M1 in complex with <b>6k</b>. Despite high resolution (1.82 Å), the electron density for the adamantyl moiety was highly disordered. While we were able to model the substituent at partial occupancy (50%) placed mid-way between the S1′ subsite and the access channel, the structure provided limited insight into additional interactions that may be gained by these large hydrophobic groups.</div><div class="NLM_p last">Finally, we sought to investigate the structural mechanism by which <i>Pf</i>-M1 discriminates between the diastereomers, <b>6d</b>–<b>a</b> and <b>6d</b>–<b>b</b>. We therefore determined the crystal structure of <b>6d</b>–<b>a</b>, in complex with <i>Pf</i>-M1 (1.81 Å). Electron density clearly indicated that the inhibitor molecule in complex with the enzyme has the <i>R</i>,<i>R</i>-configuration. This structure showed that the hydroxamic acid zinc binding group and biphenyl system of <b>6d</b>–<b>a</b> bind <i>Pf</i>-M1 comparably to the parent compound <b>1</b>. The interactions of the carboxamides are comparable, as are the interactions with the face of His496 formed by both pivalamide of <b>1</b> and the 2,3,3,3-tetrafluoropropanamide <b>6d</b>–<b>a</b>. Within the S1′ pocket, the dual-natured 2,3,3,3-tetrafluoropropanamide is able to form interactions with the face of His496 and Val493 (similarly to <b>1</b>), as well as additional interactions with Arg489 (unfavorable to <b>1</b>), which likely accounts for the tighter binding of <b>6d</b>–<b>a</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Binding Mode of Selected Lead Compounds to <i>Pf</i>-M17</h3><div class="NLM_p">Inhibition data determined that insertion of a methylene spacer to bulky hydrophobic substituents was generally favorable for binding <i>Pf</i>-M17. We therefore elected to determine the crystal structures of <i>Pf</i>-M17 in complex with <b>6k</b>, the most potent <i>Pf</i>-M17 inhibitor of the series. The first round of crystallization experiments yielded unexpected results; <b>6k</b> uses a novel zinc-binding mode to inhibit <i>Pf</i>-M17 via a previously unobserved mechanism. M17 aminopeptidases possess a conserved binuclear metal center containing “catalytic” and “regulatory” metal-binding sites.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Full activity requires both sites to be occupied; however, the regulatory metal ion is readily lost in crystal structures.<a onclick="showRef(event, 'ref24 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref31">(24,31)</a> Untreated <i>Pf</i>-M17 crystals have only the catalytic Zn<sup>2+</sup> bound (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and require treating with a Zn<sup>2+</sup> soak solution to occupy both sites and achieve the “active” form of the enzyme used for inhibitor design (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Using these methods, we previously determined that the parent compound <b>1</b> binds to <i>Pf</i>-M17 by coordinating both Zn<sup>2+</sup> ions, a conformation that is repeated in all <i>Pf</i>-M17 active sites (two copies of the <i>Pf</i>-M17 hexamer in the asymmetric unit afford 12 total views of the active site) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, use of identical cocrystal growth and Zn<sup>2+</sup> treatment methods to determine <i>Pf</i>-M17:<b>6k</b> yielded an unliganded structure, and increasing the concentration of <b>6k</b> in the Zn<sup>2+</sup> soak solution yielded only very weak density for the compound. Given the potent inhibition of <i>Pf</i>-M17 by <b>6k</b>, the difficulty in obtaining a cocrystal structure was puzzling. We collected a final data set to 2.30 Å from a cocrystal that was not treated with additional Zn<sup>2+</sup>; the structure showed clear electron density for <b>6k</b> and only a single Zn<sup>2+</sup>. Surprisingly, the single Zn<sup>2+</sup> occupies the regulatory site, indicating that the catalytic Zn<sup>2+</sup> site cannot be occupied while <b>6k</b> is bound (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Such an active site arrangement, wherein the catalytic site is unoccupied, has not been observed in any other structure of M17 aminopeptidases. To determine whether Zn<sup>2+</sup> displacement was a consequence of the large hydrophobic substituent on <b>6k</b> or characteristic of other compounds in the series, we also determined the structure of <i>Pf</i>-M17 in complex with <b>6i</b> (2.10 Å), which with a cyclohexane substituted off the <i>N</i>-acyl is intermediate in size between <b>1</b> and <b>6k</b>, and retains tight binding capability. With the exception of the compound identity, the crystal was treated identically to that which yielded <i>Pf</i>-M17:<b>1</b> (including a Zn<sup>2+</sup> soak step). In the <i>Pf</i>-M17:<b>6i</b> structure, clear electron density was observed for the compound; however, the electron density in the catalytic Zn<sup>2+</sup> site was weak and not indicative of a metal ion. Although it is possible that Zn<sup>2+</sup> is at low occupancy, it could not be modeled. It was therefore clear that <b>6i</b> was also in competition with the catalytic Zn<sup>2+</sup>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Arrangement of the binuclear metal site of <i>Pf</i>-M17 (gray sticks and spheres) with S1 and S1′ substrate binding sites and catalytic carbonate ion indicated. (A) Crystal structure of <i>Pf</i>-M17 with only the catalytic metal site occupied (Zn<sup>2+</sup>, site 2).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (B) <i>Pf</i>-M17 crystals treated with a Zn<sup>2+</sup> soak solution yield a structure with both the regulatory site 1 and catalytic site 2 occupied by Zn<sup>2+</sup>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (C) Compound <b>1</b> (yellow) coordinates both Zn<sup>2+</sup> ions through the hydroxamic acid moiety.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (D) Compound <b>6k</b> (teal) displaces the catalytic Zn<sup>2+</sup> from site 2 of <i>Pf</i>-M17.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Beyond the unexpected displacement of the catalytic Zn<sup>2+</sup> ion, the interactions between <i>Pf</i>-M17 and <b>6i</b>/<b>6k</b> were largely as expected. The binding position of the hydroxamic acid has shifted slightly compared to the parent compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). This is likely the result of the bulky substituents occupying the S1′ pocket and the cause of the Zn<sup>2+</sup> displacement. In place of metallo-bonds, the hydroxyls of <b>6i</b> and <b>6k</b> form hydrogen bonds with Glu461, Lys374, and the catalytic carbonate ion (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Despite the large variation in the mechanism of Zn<sup>2+</sup> coordination, the change has little effect on the compound binding position. Similarly to <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Figure 3B</a>), the trifluoro-substituted biphenyl system occupies the S1 pocket (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), where it forms the same hydrophobic interactions. The large S1′ subsite of <i>Pf</i>-M17 was able to accommodate the bulky hydrophobic substituents, wherein they interact with Ala460, Ile547, and the aliphatic chain of Ser554 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Of particular note is that the bulky groups form unfavorably close contacts with Asn457 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), which is spatially restricted and unable to move away from the contact. We predict that these contacts cause the shift in binding position of the <i>N</i>-acyl linker and hydroxamic acid, which results in displacement of the catalytic Zn<sup>2+</sup>. Alternatively, the large hydrophobic substituents may be altering the environment of the pocket to destabilize the charged Zn<sup>2+</sup>; however, it is unknown why the catalytic Zn<sup>2+</sup>, rather than the regulatory Zn<sup>2+</sup>, which is spatially closer to the hydrophobic moiety and previously shown to be readily lost from the active site, would be affected.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of selected compounds to <i>Pf</i>-M17. (A) Solvent-accessible surface of <i>Pf</i>-M17 (gray) with catalytic Zn<sup>2+</sup> (site 2, yellow) and regulatory Zn<sup>2+</sup> (site 1, gray) indicated. Stick representation shows the binding positions of <b>1</b> (yellow) and <b>6k</b> (teal). Zn<sup>2+</sup> occupies site 2 (yellow) when <i>Pf</i>-M17 is in complex with <b>1</b> but not in complex with <b>6k</b>. (B) Structure of <b>6k</b> in complex with <i>Pf</i>-M17 (gray sticks). Molecular interactions between <b>6k</b> (teal) and the site 1 Zn<sup>2+</sup> and S1′ subsite are indicated by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Binding of <b>6k</b> Is Partially Reversible</h3><div class="NLM_p last">We performed washout experiments to determine whether binding of <b>6k</b>, which displaces the catalytic Zn<sup>2+</sup>, is reversible. We treated the enzyme with either ethylenediaminetetraacetic acid (EDTA), <b>6k</b>, or bestatin (competitive substrate-analogue inhibitor), washed the protein with metal-free buffer, and then monitored the time-dependent activity on addition of metal cofactor and substrate (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Figure 4</a>). A short buffer exchange (2 h) was sufficient to recover the activity of EDTA-treated <i>Pf</i>-M17. However, longer wash steps were required to completely remove bestatin (normal activity of bestatin-treated <i>Pf</i>-M17 was observed after a 5 h wash). In contrast, after the 5 h wash, only minimal activity was observed in the <i>Pf</i>-M17 sample treated with compound <b>6k</b>. Further washing recovered more of the activity, but after 7 h of buffer exchange, only approximately 20% of activity was recovered in the <b>6k</b>-treated <i>Pf</i>-M17 sample. Therefore, while <b>6k</b> treatment appears to be reversible, it likely requires long wash times to recover activity. Since EDTA-treated enzyme recovers quickly, the slow recovery of the <b>6k</b>-treated sample is likely a result of a slow compound off-rate rather than metal removal.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Antiparasitic Activity of Key Compounds</h3><div class="NLM_p">We have previously shown that <b>1</b> potently inhibits <i>P. falciparum</i> growth in vitro, including the multidrug-resistant strain Dd2.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We triaged the current compound series for assessment in an in vitro <i>P. falciparum</i> phenotypic assay by selecting only those compounds that demonstrated potent dual <i>Pf</i>-M1 and <i>Pf</i>-M17 inhibitory capability (<i>K</i><sub>i</sub> ≤ 200 nM against one <i>Pf</i> target, and ≤400 nM against the second). The compounds were tested against both drug-resistant (Dd2) and drug-sensitive (3D7) strains of <i>P. falciparum</i>, as well as against HEK293 cells for preliminary cytotoxicity assessment. For comparison, we also reexamined the parent compound <b>1</b> alongside the current series as well as a number of reference compounds (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In addition to <b>1</b>, which demonstrated potent antiparasitic activity (IC<sub>50</sub><i>Pf</i>-3D7 = 83.1 ± 16.1 nM, <i>Pf</i>-Dd2 = 81.7 ± 6.8 nM), three compounds from the series demonstrated potent inhibition of <i>Pf</i>-3D7 and <i>Pf-</i>Dd2 proliferation. The most active compounds included <b>6l</b>, <b>6n</b>, and <b>6q</b>, which all inhibited parasitemia with IC<sub>50</sub> values less than 100 nM, while other compounds examined demonstrated IC<sub>50</sub> values between 100 and 360 nM. Compound <b>6l</b> exhibited the most substantial improvement in antiparasitic activity compared to the parent compound, showing IC<sub>50</sub> values of 14.6 ± 0.8 nM against <i>Pf</i>-3D7 and 13.8 ± 0.5 nM against <i>Pf</i>-Dd2. Under our assay conditions, this activity is comparable to clinically used antimalarial drugs pyronaridine and chloroquine (IC<sub>50</sub><i>Pf</i>-3D7 = 7.0 ± 6.0 and 11.7 ± 3.5 nM, respectively), approaching the range of the gold standard clinical treatments artesunate and dihydroartemisinin (DHA, IC<sub>50</sub><i>Pf</i>-3D7 = 1.6 ± 0.5 and 0.5 ± 0.1 nM, respectively). Further, the compound series showed limited cytotoxicity against HEK293 with little inhibition of cellular proliferation at 10 μM. At 40 μM, we did observe inhibitory effects against HEK293; however, we were unable to calculate IC<sub>50</sub> values as all compounds failed to reach a full inhibition plateau. Approximate selectivity indices were calculated for compounds that showed >51% inhibition at 40 μM and generally suggested excellent selectivity range (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The compound series therefore demonstrates substantial improvement in antimalarial activity against cultured <i>P. falciparum</i> parasites and represents an exciting progression of our antimalarial compounds targeted against both the M1 and M17 aminopeptidases of <i>P. falciparum</i>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Resistant <i>P. falciparum</i> Strains by Key Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (nM) ± SD</th><th class="rowsep1 colsep0" align="center">CC<sub>50</sub> (nM) ± SD</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">% inhibition of HEK293 cells at</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center" char="±"><i>Pf</i>-3D7</th><th class="colsep0 rowsep0" align="center"><i>Pf</i>-Dd2</th><th class="colsep0 rowsep0" align="center">HEK293<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">10 μM</th><th class="colsep0 rowsep0" align="center" char="±">40 μM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">selectivity index<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">artesunate</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.5</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">42.3 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chloroquine</td><td class="colsep0 rowsep0" align="char" char="±">11.7 ± 3.5</td><td class="colsep0 rowsep0" align="left">90.3 ± 29.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">17.3 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">57.0 ± 8.6</td><td class="colsep0 rowsep0" align="left">≥1709</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DHA</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">31.0 ± 6.0</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">puromycin</td><td class="colsep0 rowsep0" align="char" char="±">110.8 ± 101.2</td><td class="colsep0 rowsep0" align="left">106.6 ± 100.9</td><td class="colsep0 rowsep0" align="left">500.1 ± 69.3</td><td class="colsep0 rowsep0" align="char" char="±">104.9 ± 2.9</td><td class="colsep0 rowsep0" align="char" char="±">104.9 ± 3.0</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyrimethamine</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 3.2</td><td class="colsep0 rowsep0" align="left">NI</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">34.4 ± 6.4</td><td class="colsep0 rowsep0" align="char" char="±">53.7 ± 6.8</td><td class="colsep0 rowsep0" align="left">≥1960</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyronaridine</td><td class="colsep0 rowsep0" align="char" char="±">7.0 ± 6.0</td><td class="colsep0 rowsep0" align="left">7.9 ± 5.5</td><td class="colsep0 rowsep0" align="left">3549.5 ±272.2</td><td class="colsep0 rowsep0" align="char" char="±">102.0 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">95.6 ± 6.4</td><td class="colsep0 rowsep0" align="left">507</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">83.1 ± 16.1</td><td class="colsep0 rowsep0" align="left">81.7 ± 6.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">80.7 ± 11.7</td><td class="colsep0 rowsep0" align="left">≥241</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="char" char="±">126.5 ± 31.8</td><td class="colsep0 rowsep0" align="left">120.2 ± 26.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">48.2 ± 5.3</td><td class="colsep0 rowsep0" align="left">≥158</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="char" char="±">356.9 ± 49.9</td><td class="colsep0 rowsep0" align="left">312.8 ± 110.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">42.9 ± 23.2</td><td class="colsep0 rowsep0" align="left">≥56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6l</b></td><td class="colsep0 rowsep0" align="char" char="±">14.6 ± 0.8</td><td class="colsep0 rowsep0" align="left">13.8 ± 0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">98.4 ± 2.6</td><td class="colsep0 rowsep0" align="left">≥1370</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6m</b></td><td class="colsep0 rowsep0" align="char" char="±">135.8 ± 11.5</td><td class="colsep0 rowsep0" align="left">108.8 ± 0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">37.6 ± 7.9</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6n</b></td><td class="colsep0 rowsep0" align="char" char="±">55.4 ± 4.2</td><td class="colsep0 rowsep0" align="left">29.2 ± 3.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">6.3 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 2.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6o</b></td><td class="colsep0 rowsep0" align="char" char="±">168.3 ± 27.6</td><td class="colsep0 rowsep0" align="left">124.7 ± 4.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">–1.0 ± 2.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6q</b></td><td class="colsep0 rowsep0" align="char" char="±">76.8 ± 22.1</td><td class="colsep0 rowsep0" align="left">24.1 ± 3.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">10.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">82.4 ± 10.4</td><td class="colsep0 rowsep0" align="left">≥260</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6r</b></td><td class="colsep0 rowsep0" align="char" char="±">219.5 ± 40.2</td><td class="colsep0 rowsep0" align="left">120.1 ± 0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">19.7 ± 38.9</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">CC<sub>50</sub> values could not be calculated for compounds with inhibition not reaching 50% at 40 μM, or whose dose–response curve did not reach full inhibition plateau at the tested concentration range.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Artesunate and DHA were tested at 10 μM top concentration.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Actual SI values calculated by CC<sub>50</sub>/IC<sub>50</sub> (puromycin and pyronaridine). Approximate SI values (indicated by ≥) calculated by assuming that compounds showing 51–100% inhibition at 40 μM would have a CC<sub>50</sub> of ≥20 μM.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Compound <b>6l</b> Does Not Inhibit MMPs</h3><div class="NLM_p last">To investigate the potential for off-target effects of the compound series, we examined the ability of <b>6l</b>, the compound with the most potent cellular antiparasitic activity, to inhibit a panel of matrix metalloproteinases (MMPs). We assessed the activity of MMP2, 7, 8, 9, or 13 following inhibition with increasing concentration of <b>6l</b> or control compounds (Marimastat or Tosedostat, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Table 4</a>). As expected, the gelatinases (MMP2 and MMP9) were potently inhibited by Marimastat (IC<sub>50</sub> = 0.43 and 3.1 nM, respectively, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">Supp Table 4</a>) and Tosedostat (IC<sub>50</sub> = 0.19 and 1.5 μM, respectively), whereas <b>6l</b> weakly inhibited MMP2 (IC<sub>50</sub> = 17 μM) and did not inhibit MMP9 (IC<sub>50</sub> > 1 mM). Similar observations were made for the collagenases (MMP8 and MMP13) as well as matrilysin (MMP7), which were all inhibited tightly by Marimastat and Tosedostat, but weakly, or not at all, by <b>6l</b>. Collectively, these findings show that <b>6l</b> shows almost no off-target inhibitory effects on MMPs. We additionally chose to examine the potential of <b>6l</b> to inhibit two human N-terminal aminopeptidases, aminopeptidase N (APN or CD13), and insulin-regulated aminopeptidase (IRAP). While <b>6l</b> showed only very weak inhibition of IRAP (no inhibition observed at <b>6l</b> concentrations less than 200 μM), it inhibits APN with reasonable affinity (<i>K</i><sub>i</sub> = 0.3 ± μM).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antimalarial combination therapies have been the gold standard of malarial treatment since the ability of the <i>Plasmodium</i> parasite to generate resistance to drug monotherapies was understood. We have extended this strategy and used rational drug discovery to design compounds capable of potent dual inhibition of the <i>P. falciparum</i> M1 and M17 aminopeptidases, both key players of the essential hemoglobin digestion pathway. On the basis of the SAR of previously examined compound series, we generated novel hydroxamic acid-based compounds substituted with a range of hydrophobic moieties to probe the S1′ subsites of <i>Pf</i>-M1 and <i>Pf</i>-M17. Further, we proposed that the high identity of the M1 and M17 aminopeptidases between <i>Plasmodium</i> species would allow our compounds to act similarly against the <i>P. vivax</i> homologs. Herein, we have examined the ability of our compound series to inhibit the M1 and M17 aminopeptidases from both <i>P. falciparum</i> and <i>P. vivax</i>.</div><div class="NLM_p">The compound series demonstrated substantial variability in the inhibition of <i>Pf</i>-M1 (nM to μM), which did not follow any clear and observable trend. By examination of the crystal structures of <i>Pf</i>-M1 bound to key compounds of the series, we determined that this variation was due to different compound binding modes. Interestingly, the variation in inhibition potency was also observed for <i>Pv</i>-M1. However, while the overall trends were conserved, we found that the compounds inhibited <i>Pv</i>-M1 approximately 10-fold more potently than <i>Pf</i>-M1. This is despite high overall sequence conservation, and 100% identity in inhibitor binding residues (based on the <i>Pf</i>-M1 crystal structures). The 10-fold change in inhibitor binding potencies is therefore likely to result from enzyme differences beyond the active site arrangement. Such differences could include the size/shape of the active site resulting from secondary/tertiary structure beyond the binding pocket. Alternatively, the difference may result from mechanistic features beyond active site chemistry, such as protein flexibility. Analysis of the M1 aminopeptidase superfamily has shown that conformational dynamics plays a critical role in substrate recognition and catalysis.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> It is therefore possible that differences in the enzyme conformational dynamics exist that cannot be predicted from the protein sequences and that these dynamics play a role in inhibitor binding.</div><div class="NLM_p">Similarly to M1 aminopeptidases, the inhibitor binding residues of the M17 homologs from <i>P. falciparum</i> and <i>P. vivax</i> are also highly conserved. This includes the binuclear metal-binding site, which possess a highly conserved arrangement through the enzyme superfamily. The two metal sites bind divalent metal ions, most commonly Zn<sup>2+</sup>, and have been characterized as regulatory and catalytic sites (site 1 and site 2, respectively). The catalytic metal is coordinated by the side chains of conserved Lys, Asp, and Glu residues (Lys374, Asp379, and Glu461 in <i>Pf</i>-M17), and the regulatory metal is coordinated by the side chains of a conserved Asp and Glu (Asp379 and Glu461 in <i>Pf-</i>M17) as well as the side-chain and main-chain oxygen of another Asp (Asp459 in <i>Pf-</i>M17). Occupation of the catalytic site is absolutely required for catalytic activity.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The observation that <b>6k</b> and <b>6i</b> are competing with the catalytic Zn<sup>2+</sup> is therefore completely unexpected, and has substantial implications for drug discovery. By competing with both metal cofactor and substrate, the compound mechanism of inhibition has evolved, and competitive models of binding that calculate inhibition constants on the basis of assay substrate concentration and affinity as well as inhibitor and enzyme concentration may no longer be appropriate. Our strategy to target both <i>Pv</i>-M17 and <i>Pf</i>-M17 raises further questions about the ability of inhibitors to displace the metal cofactors. The trend in inhibitor binding potencies of <i>Pf</i>- versus <i>Pv</i>-M17 diverged for compounds containing a methylene spacer (<b>6l−r</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Differences in the ability of the compounds to displace the catalytic Zn<sup>2+</sup> of the <i>Pf</i>- versus <i>Pv</i>-M17 could account for the variation in compound binding trends. It is possible that differences in active site architecture and/or metal binding behavior between the <i>Pf</i>- and <i>Pv</i>-M17 enzymes exist, which are not predicted by the close sequence similarity. In the wake of the observations for <i>Pf</i>-M17 reported here, the complete characterization of <i>Pv</i>-M17 metal binding behavior should be prioritized.</div><div class="NLM_p">In some cases, hydroxamate inhibitors developed as anticancer agents have suffered clinical failure. Discussions regarding the liabilities of the chemical class largely revolve around the potential for off-target activity against other zinc-dependent enzymes, which might lead to toxicity. However, the previous generations of hydroxamates were safely tested in thousands of humans for a variety of cancers.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> The only toxicity noted was some muscle tenderness in the upper body girdle. This led to a very small number of patients limiting dosing, which resulted in ineffective treatment for those patients.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> Otherwise, the hydroxamate inhibitors (Marimastat and Batimastat) were considered safe for humans, demonstrating only minor off-target activity at clinically used doses.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> Irrespectively, given the reputation of hydroxamate inhibitors, we assessed the potential for the current series to cross-react. We examined the ability of <b>6l</b> to inhibit a panel of MMPs (MMP2, 7, 8, 9, and 13), and additionally, two human N-terminal aminopeptidases (IRAP and APN). Compound <b>6l</b> exhibits very weak to no activity against the MMPs and IRAP, demonstrating low potential for off-target activity. However, inhibition of APN, the closest human homolog of the <i>Plasmodium</i> M1 aminopeptidases, was observed. APN is an anticancer therapeutic target, and it has clinically demonstrated that inhibition of APN activity does not result in any harmful side effects.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Therefore, while designing selectivity over APN should be considered in future optimization of this inhibitor series, we do not anticipate a high degree of selectivity over APN to be required for safe use of the compounds in humans.</div><div class="NLM_p last">Physiological activity of a multitarget inhibitor is difficult to predict from enzyme inhibition data, as the effect in live parasites may not be linearly correlated with inhibition of either/both targets.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> Throughout the development of the <i>Pf</i>-M1/<i>Pf</i>-M17 dual inhibitor compound series, we have observed a broad correlation of improved cellular potency with increasing either <i>Pf</i>-M1 or <i>Pf</i>-M17 inhibition potency.<a onclick="showRef(event, 'ref15 ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref15 ref17 ref20">(15,17,20)</a> Within the current series, we observed a substantial (>5-fold) improvement in antiplasmodial activity with compound <b>6l</b>. While exciting, the improvement is curious, in that it is does not directly reflect the <i>Pf</i>-M1 and <i>Pf</i>-M17 enzyme inhibition; <b>6l</b> is not the most potent dual inhibitor of the series, yet it clearly demonstrates the greatest potency of the series in the whole-cell in vitro assay. Compound <b>6l</b> is therefore a highly potent outlier. We propose three potential reasons for this deviation: (1) increasing the hydrophobicity of the compounds has a large effect on cellular penetration, (2) <b>6l</b> targets additional cellular processes, and (3) the conditions of the enzyme assays do not strictly reflect cellular conditions. Irrespectively, <b>6l</b> is a potent inhibitor of the four molecular targets examined herein, and demonstrates potent activity against cultured malaria parasites; it therefore represents a promising lead for further development of potent antimalarial therapeutics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The rapid spread of drug-resistant <i>Plasmodium</i> parasites is a major threat to global health. We have previously used a multitarget strategy to rationally design inhibitors capable of potent inhibition of the <i>Pf</i>-M1 and <i>Pf</i>-M17 aminopeptidases and validated their use in culture against both drug-resistant and drug-sensitive strains of the parasite. Herein, we have expanded our strategy to target the M1 and M17 aminopeptidases from <i>P. vivax</i> with the aim to develop compounds capable of cross-species antimalarial activity. We designed a series of inhibitors that possess a novel chemical scaffold and mapped their structure–activity relationships against the four molecular targets in vitro. Excitingly, compounds possessing potent inhibitory activity against all four enzymes also demonstrated potent activity against cultured parasites and showed no observable toxicity against human cells. This novel series of hydroxamic acid compounds therefore represents an exciting lead in the design of novel antimalarial therapeutics. They operate via a novel, known mechanism of action and further have the potential to be clinically effective against multiple <i>Plasmodium</i> species.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Synthetic Materials and Methods</h4><div class="NLM_p">Chemicals and solvents were purchased from standard suppliers and used without further purification. <sup>1</sup>H NMR, <sup>13</sup>C NMR, and <sup>19</sup>F NMR spectra were recorded on a Bruker Avance Nanobay III 400 MHz Ultrashield Plus spectrometer at 400.13, 100.61, and 376.50 MHz, respectively. Chemical shifts (δ) are recorded in parts per million (ppm) with reference to the chemical shift of the deuterated solvent. Unless otherwise stated, samples were dissolved in CDCl<sub>3</sub>. Coupling constants (<i>J</i>) and carbon–fluorine coupling constants (<i>J</i><sub>CF</sub>) are recorded in hertz and multiplicities are described by singlet (s), doublet (d), triplet (t), quadruplet (q), broad (br), multiplet (m), doublet of doublets (dd), and doublet of triplets (dt). Overlapped nonequivalent <sup>13</sup>C peaks were identified by heteronuclear single quantum coherence and heteronuclear multiple bond correlation experiments and are indicated with (2C) after the identified overlapped signal. Liquid chromatography–mass spectrometry (LC–MS) was performed using either system A or B. System A: an Agilent 6100 Series Single Quad coupled to an Agilent 1200 Series high-performance liquid chromatography (HPLC) system using a Phenomenex Luna C8 (2) 50 × 4.6 mm<sup>2</sup>, 5 μm column. The following buffers were used: buffer A: 0.1% formic acid in H<sub>2</sub>O; buffer B: 0.1% formic acid in MeCN. Samples were run at a flow rate of 0.5 mL/min for 10 min: 0–4 min 5–100% buffer B in buffer A, 4–7 min 100% buffer B, 7–9 min 100–5% buffer B in buffer A, 9–10 min 5% buffer B in buffer A. Mass spectra were acquired in positive- and negative-ion modes with a scan range of 100–1000 <i>m</i>/<i>z</i>. UV detection was carried out at 254 nm. System B: an Agilent 6120 Series Single Quad coupled to an Agilent 1260 Series HPLC using a Poroshell 120 EC-C18 50 × 3.0 mm<sup>2</sup>, 2.7 μm column. The following buffers were used: buffer A: 0.1% formic acid in H<sub>2</sub>O; buffer B: 0.1% formic acid in MeCN. Samples were run at a flow rate of 0.5 mL/min for 5 min; 0–1 min 5% buffer B in buffer A, 1–2.5 min 5–100% buffer B in buffer A, 2.5–3.8 min 100% buffer B, 3.8–4 min 100–5% buffer B in buffer A, 4–5 min 5% buffer B in buffer A. Mass spectra were acquired in positive- and negative-ion modes with a scan range of 100–1000 <i>m</i>/<i>z</i>. UV detection was carried out at 214 and 254 nm.</div><div class="NLM_p last">Preparative HPLC was performed using an Agilent 1260 infinity coupled with a binary preparative pump and Agilent 1260 FC-PS fraction collector, using Agilent OpenLAB CDS software (Rev C.01.04) and an Altima C8 22 × 250 mm<sup>2</sup> 5 μm column. The following buffers were used: buffer A: 0.1% trifluoroacetyl (TFA) in H<sub>2</sub>O; buffer B: 0.1% TFA in MeCN, with sample being run at a gradient of 5–100% buffer B in buffer A over 20 min, at a flow rate of 20 mL/min. All screening compounds were of >95% purity unless specified in the individual monologue.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure A: Formation of Amide Bond Using Acid Chlorides</h3><div class="NLM_p last">The amine (1.0 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL/mmol of amine). The flask was evacuated and flushed with nitrogen. Et<sub>3</sub>N (2.2 equiv) was added followed by the acid chloride (1.1 equiv). The reaction mixture was stirred at rt for 2 h. Water was added and the aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub> (three times). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash column chromatography (FCC).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure B: Formation of Amide Bond Using HCTU</h3><div class="NLM_p last">The acid (1.05 equiv) and HCTU (1.1 equiv) were stirred in DMF (1 mL/mmol of amine). <i>N</i>,<i>N</i>-Diisopropylethylamine (2.2 equiv) was added followed by a solution of the amine (1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL/mmol of amine). The reaction mixture was stirred at room temperature for 2 h. Half-saturated NaHCO<sub>3(aq)</sub> was added, and the mixture was extracted with Et<sub>2</sub>O (three times). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by FCC.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure C: Formation of Amide Bond Using EDCI</h3><div class="NLM_p last">A mixture of amine (1.0 equiv), acid (1.2 equiv), <i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.2 equiv), and DMAP (1.3 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL/mmol of amine) was stirred at rt under N<sub>2</sub> overnight. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with 2 M HCl<sub>(aq)</sub>, saturated NaHCO<sub>3(aq)</sub>, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by FCC.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</h3><div class="NLM_p">The appropriate methyl ester (1.0 equiv) was dissolved in anhydrous MeOH (5 mL/mmol of ester) at rt. NH<sub>2</sub>OH·HCl (4.0 equiv) was added followed by KOH (5 M in anhydrous MeOH, 5.0 equiv). The mixture was stirred at rt overnight and monitored by LC–MS analysis. The mixtures were directly dry-loaded onto ISOLUTE HM-N (Biotage), before purification by FCC (eluent MeOH/CH<sub>2</sub>Cl<sub>2</sub> 0:100–10:90).</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 2-Amino-2-(4-bromophenyl)acetate (<b>3</b>)</h4><div class="NLM_p last">To a mixture of 2-amino-2-(4-bromophenyl)acetic acid (2.0 g, 8.7 mmol) in MeOH (87 mL) was added concentrated H<sub>2</sub>SO<sub>4</sub> (0.8 mL, 15.7 mmol) dropwise. The reaction mixture was refluxed for 30 h. The solvent was concentrated in vacuo and the resulting residue was basified with saturated NaHCO<sub>3</sub> (50 mL) and then extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the title compound as a yellow oil (2.0 g, 94%). <sup>1</sup>H NMR δ 7.51–7.45 (m, 2H), 7.30–7.24 (m, 2H), 4.59 (s, 1H), 3.70 (s, 3H), 1.85 (s, 2H); <sup>13</sup>C NMR δ 174.1, 139.3, 132.0, 128.7, 122.2, 58.3, 52.7; <i>m</i>/<i>z</i> MS (positive electrospray ionization (ES<sup>+</sup>)) C<sub>9</sub>H<sub>11</sub>BrNO<sub>2</sub> [MH]<sup>+</sup> calcd 244.0; found 244.1; LC–MS <i>t</i><sub>R</sub>: 3.2 min.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 2-Amino-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>4</b>)</h4><div class="NLM_p last">Compound <b>3</b> (2.0 g, 8.2 mmol) and 3,4,5-trifluorophenylboronic acid (2.2 g, 12.3 mmol) were dispersed in degassed THF (30 mL) and degassed 1 M Na<sub>2</sub>CO<sub>3(aq)</sub> (10 mL). A steady stream of N<sub>2</sub> was bubbled through the mixture for 5 min, before adding PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.58 g, 0.82 mmol). The mixture was refluxed for 2 h and then the THF was concentrated in vacuo. The mixture was diluted with EtOAc (50 mL) and water (50 mL), and the aqueous layer was extracted further with EtOAc (2 × 50 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by FCC (MeOH/CH<sub>2</sub>Cl<sub>2</sub> 0:100–10:90) to give the title compound as a beige foam (1.6 g, 65%). <sup>1</sup>H NMR (dimethyl sulfoxide (DMSO)-<i>d</i><sub>6</sub>) δ 9.04 (br s, 2H), 7.85 (d, <i>J</i> = 8.1 Hz, 2H), 7.82–7.68 (m, 2H), 7.61 (d, <i>J</i> = 8.2 Hz, 2H), 5.40 (s, 1H), 3.74 (s, 3H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.70 (d, <i>J</i> = 21.7 Hz), −162.73 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 168.9, 150.7 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.8/4.1 Hz), 138.6 (dt, <i>J</i><sub>CF</sub> = 250.4/15.8 Hz), 138.0, 135.9 (td, <i>J</i><sub>CF</sub> = 8.1/4.5 Hz), 132.9, 128.9, 127.5, 111.8–111.2 (m), 55.0, 53.3; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>15</sub>H<sub>13</sub>F<sub>3</sub>NO<sub>2</sub> [MH]<sup>+</sup> calcd 296.1; found 296.1; LC–MS <i>t</i><sub>R</sub>: 3.0 min.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl 2-Isobutyramido-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5a</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using isobutyryl chloride (78 μL, 0.75 mmol) to give 141 mg (57%) of white solid. <sup>1</sup>H NMR δ 7.54–7.38 (m, 4H), 7.21–7.09 (m, 2H), 6.58 (d, <i>J</i> = 6.5 Hz, 1H), 5.61 (d, <i>J</i> = 6.9 Hz, 1H), 3.75 (s, 3H), 2.58–2.36 (m, 1H), 1.19 (d, <i>J</i> = 6.9 Hz, 3H), 1.16 (d, <i>J</i> = 6.9 Hz, 3H); <sup>19</sup>F NMR δ −133.91 (d, <i>J</i> = 20.6 Hz), −162.19 (dd, <i>J</i> = 20.7/20.7 Hz); <sup>13</sup>C NMR δ 176.4, 171.4, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.7/10.1/4.2 Hz), 141.0–137.9 (m, 2C), 137.2, 136.7 (td, <i>J</i><sub>CF</sub> = 7.7/4.5 Hz), 128.0, 127.5, 111.4–110.8 (m), 55.9, 53.0, 35.3, 19.5, 19.4; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>19</sub>H<sub>19</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 366.1; found 365.9; LC–MS <i>t</i><sub>R</sub>: 3.5 min.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 2-Propionamido-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5b</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using propionyl chloride (65 μL, 0.75 mmol) to give 205 mg (86%) of pale yellow solid. <sup>1</sup>H NMR δ 7.51–7.43 (m, 4H), 7.21–7.09 (m, 2H), 6.54 (d, <i>J</i> = 6.7 Hz, 1H), 5.63 (d, <i>J</i> = 7.0 Hz, 1H), 3.76 (s, 3H), 2.30 (qd, <i>J</i> = 7.6/3.2 Hz, 2H), 1.17 (t, <i>J</i> = 7.6 Hz, 3H); <sup>19</sup>F NMR δ −133.88 (d, <i>J</i> = 20.4 Hz), −162.14 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 173.2, 171.4, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.7/10.1/4.3 Hz), 139.4 (dt, <i>J</i><sub>CF</sub> = 34.1/15.3 Hz), 138.4, 137.2, 136.6 (td, <i>J</i><sub>CF</sub> = 7.8/4.7 Hz), 128.1, 127.5, 111.5–110.8 (m), 56.0, 53.0, 29.4, 9.6; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>18</sub>H<sub>17</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 352.1; found 351.9; LC–MS <i>t</i><sub>R</sub>: 3.4 min.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 2-(3′,4′,5′-Trifluoro-[1,1′-biphenyl]-4-yl)-2-(3,3,3-trifluoropropanamido)acetate (<b>5c</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using trifluoromethylacetic acid (63 μL, 0.71 mmol) to give 140 mg (51%) of white solid. <sup>1</sup>H NMR δ 7.46 (dd, <i>J</i> = 22.6/8.1 Hz, 4H), 7.23–7.09 (m, 2H), 7.00 (d, <i>J</i> = 6.0 Hz, 1H), 5.62 (d, <i>J</i> = 6.6 Hz, 1H), 3.77 (s, 3H), 3.15 (q, <i>J</i> = 10.5 Hz, 2H); <sup>19</sup>F NMR δ −62.85, −133.79 (d, <i>J</i> = 20.5 Hz), −161.95 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 170.8, 162.1 (app. d, <i>J</i><sub>CF</sub> = 3.4 Hz), 151.6 (ddd, <i>J</i><sub>CF</sub> = 250.1/9.9/4.3 Hz), 139.60 (dt, <i>J</i><sub>CF</sub> = 251.5/14.8 Hz), 138.9, 136.8–136.3 (m), 136.2, 128.0, 127.7, 123.9 (app. d, <i>J</i><sub>CF</sub> = 276.8 Hz), 111.5–110.9 (m), 56.5, 53.4, 41.6 (q, <i>J</i><sub>CF</sub> = 29.8 Hz); <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>18</sub>H<sub>14</sub>F<sub>6</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 406.1; found 406.1; LC–MS <i>t</i><sub>R</sub>: 3.8 min.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 2-(2,3,3,3-Tetrafluoropropanamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5d</b>)</h4><div class="NLM_p last">Compound <b>4</b> (150 mg, 0.51 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_4" aria-label="General Procedure C: Formation of Amide Bond Using EDCI">General Procedure C: Formation of Amide Bond Using EDCI</a> using 2,3,3,3-tetrafluoropropanoic acid (59 μL, 0.61 mmol) to give 110 mg (51%, mixture of diastereomers) of white solid. <sup>1</sup>H NMR δ 7.56–7.41 (m, 5H), 7.22–7.11 (m, 2H), 5.64 (d, <i>J</i> = 6.8 Hz, 1H), 5.23–4.98 (m, 1H), 3.80 (s, 3H); <sup>19</sup>F NMR δ −75.86 (dd, <i>J</i> = 33.7/11.2 Hz), −133.74 (dd, <i>J</i> = 36.3/20.5 Hz), −161.85 (dt, <i>J</i> = 41.1/20.5 Hz), −202.47 to −202.75 (m); <i>m</i>/<i>z</i> MS (ES<sup>–</sup>) C<sub>18</sub>H<sub>11</sub>F<sub>7</sub>NO<sub>3</sub> [M]<sup>−</sup> calcd 422.1; found 422.0; LC–MS <i>t</i><sub>R</sub>: 3.5 min.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 2-(2,2,3,3,3-Pentafluoropropanamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5e</b>)</h4><div class="NLM_p last">Compound <b>4</b> (150 mg, 0.51 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_4" aria-label="General Procedure C: Formation of Amide Bond Using EDCI">General Procedure C: Formation of Amide Bond Using EDCI</a> using 2,2,3,3,3-pentafluoropropanoic acid (64 μL, 0.61 mmol) to give 15 mg (7%) of white solid. <sup>1</sup>H NMR δ 7.58 (d, <i>J</i> = 6.1 Hz, 1H), 7.54–7.41 (m, 4H), 7.22–7.12 (m, 2H), 5.59 (d, <i>J</i> = 6.7 Hz, 1H), 3.81 (s, 3H); <sup>19</sup>F NMR δ −82.71–82.74 (m), −122.91–122.96 (m), −133.68 (d, <i>J</i> = 20.5 Hz), −161.72 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 169.8, 157.1, 151.6 (ddd, <i>J</i> = 250.1/10.0/4.3 Hz), 139.7 (dt, <i>J</i> = 252.6/15.3 Hz), 139.4–139.2 (m), 136.7–136.1 (m), 135.0, 128.0, 127.9, 117.9 (dt, <i>J</i> = 285.6/33.8 Hz), 111.6–111.1 (m), 107.9–106.1 (m), 56.5, 53.7; <i>m</i>/<i>z</i> MS (ES<sup>–</sup>) C<sub>18</sub>H<sub>10</sub>F<sub>8</sub>NO<sub>3</sub> [M]<sup>−</sup> calcd 440.1; found 440.1; LC–MS <i>t</i><sub>R</sub>: 3.5 min.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2-(Cyclopropanecarboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5f</b>)</h4><div class="NLM_p last">Compound <b>4</b> (140 mg, 0.47 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using cyclopropanecarbonyl chloride (47 μL, 0.52 mmol) to give 150 mg (87%) of white solid. <sup>1</sup>H NMR δ 7.52–7.43 (m, 4H), 7.20–7.10 (m, 2H), 6.75 (br d, <i>J</i> = 6.8 Hz, 1H), 5.65 (d, <i>J</i> = 6.9 Hz, 1H), 3.76 (s, 3H), 1.52–1.44 (m, 1H), 1.04–0.92 (m, 2H), 0.86–0.70 (m, 2H); <sup>19</sup>F NMR δ −133.89 (d, <i>J</i> = 20.5 Hz), −162.18 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 173.2, 171.4, 151.4 (ddd, <i>J</i><sub>CF</sub> = 249.7/10.0/4.2 Hz), 141.1–137.8 (m), 138.2, 137.2, 136.6 (td, <i>J</i><sub>CF</sub> = 7.8/4.6 Hz), 128.0, 127.4, 111.2–110.8 (m), 56.2, 52.9, 14.5, 7.60, 7.56; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>19</sub>H<sub>17</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 364.1; found 363.9; LC–MS <i>t</i><sub>R</sub>: 3.5 min.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 2-(Cyclobutanecarboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5g</b>)</h4><div class="NLM_p last">Compound <b>3</b> (160 mg, 0.66 mmol) was converted to methyl 2-(4-bromophenyl)-2-(cyclobutanecarboxamido)acetate according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using cyclobutanecarbonyl chloride (82 μL, 0.72 mmol). The crude product was reacted with 3,4,5-trifluorophenylboronic acid (138 mg, 0.79 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (14 mg, 0.02 mmol), and Na<sub>2</sub>CO<sub>3</sub> (1 M, 1.3 mL) in THF (3.9 mL) in a sealed microwave vial and heated at 100 °C for 2 h. After cooling, the mixture was diluted with EtOAc (10 mL) and water (10 mL), and the mixture was extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by FCC to give 220 mg (89%) of a colorless oil. <sup>1</sup>H NMR δ 7.51–7.40 (m, 4H), 7.21–7.10 (m, 2H), 6.46 (br d, <i>J</i> = 6.8 Hz, 1H), 5.61 (d, <i>J</i> = 6.9 Hz, 1H), 3.76 (s, 3H), 3.10 (pd, <i>J</i> = 8.5/0.9 Hz, 1H), 2.37–2.12 (m, 4H), 2.03–1.83 (m, 2H); <sup>19</sup>F NMR δ −133.87 (d, <i>J</i> = 20.6 Hz), −162.12 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 175.2, 171.3, 151.5 (ddd, <i>J</i> = 249.7/10.0/4.2 Hz), 139.4 (dt, <i>J</i> = 252.2/15.4 Hz), 138.4, 136.9, 136.7–136.4 (m), 128.0, 127.4, 111.5–110.6 (m), 56.1, 53.0, 39.6, 25.26, 25.25, 18.2; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 378.1; found 377.9; LC–MS <i>t</i><sub>R</sub>: 3.5 min.</div></div><div id="sec5_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 2-(Cyclopentanecarboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5h</b>)</h4><div class="NLM_p last">Compound <b>4</b> (130 mg, 0.44 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using cyclopentanecarbonyl chloride (60 μL, 0.48 mmol) to give 70 mg (41%) of yellow foamy solid. <sup>1</sup>H NMR δ 7.51–7.37 (m, 4H), 7.19–7.08 (m, 2H), 6.66 (d, <i>J</i> = 6.9 Hz, 1H), 5.62 (d, <i>J</i> = 7.0 Hz, 1H), 3.74 (s, 3H), 2.70–2.59 (m, 1H), 1.95–1.49 (m, 8H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.2 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 175.9, 171.5, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.8/10.0/4.2 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.0/15.4 Hz), 138.4–138.3 (m), 137.2, 136.7 (td, <i>J</i><sub>CF</sub> = 7.8/4.6 Hz), 128.0, 127.5, 111.6–110.9 (m), 56.1, 53.1, 45.5, 30.4, 30.3, 26.0 (2C); <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 392.1; found 392.1; LC–MS <i>t</i><sub>R</sub>: 6.8 min.</div></div><div id="sec5_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 2-(Cyclohexanecarboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5i</b>)</h4><div class="NLM_p last">Compound <b>4</b> (130 mg, 0.44 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using cyclohexanecarbonyl chloride (64 μL, 0.48 mmol) to give 50 mg (28%) of pale yellow solid. <sup>1</sup>H NMR δ 7.51–7.37 (m, 4H), 7.21–7.07 (m, 2H), 6.59 (d, <i>J</i> = 6.9 Hz, 1H), 5.61 (d, <i>J</i> = 7.0 Hz, 1H), 3.75 (s, 3H), 2.19 (tt, <i>J</i> = 11.7/3.5 Hz, 1H), 1.96–1.62 (m, 5H), 1.53–1.13 (m, 5H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.2 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 175.5, 171.5, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.8/10.0/4.3 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.2/15.4 Hz), 138.5–138.4 (m), 137.3, 136.7 (td, <i>J</i><sub>CF</sub> = 7.9/4.8 Hz), 128.0, 127.5, 111.5–110.8 (m), 55.9, 53.1, 45.2, 29.7, 29.5, 25.79, 25.75, 25.7; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 406.2; found 406.2; LC–MS <i>t</i><sub>R</sub>: 4.0 min.</div></div><div id="sec5_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 2-(Tetrahydro-2<i>H</i>-pyran-4-carboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5j</b>)</h4><div class="NLM_p last">Compound <b>4</b> (120 mg, 0.41 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using tetrahydropyrancarboxylic acid (56 mg, 0.43 mmol) to give 126 mg (76%) of white solid. <sup>1</sup>H NMR δ 7.50–7.40 (m, 4H), 7.20–7.09 (m, 2H), 6.64 (d, <i>J</i> = 6.8 Hz, 1H), 5.60 (d, <i>J</i> = 6.8 Hz, 1H), 4.08–3.96 (m, 2H), 3.76 (s, 3H), 3.47–3.37 (m, 2H), 2.51–2.40 (m, 1H), 1.88–1.73 (m, 4H); <sup>19</sup>F NMR δ −133.8 (d, <i>J</i> = 20.5 Hz), −162.0 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 174.0, 171.3, 151.6 (ddd, <i>J</i><sub>CF</sub> = 250.0/10.1/4.3 Hz), 139.6 (dt, <i>J</i><sub>CF</sub> = 252.3/15.2 Hz), 138.7, 136.9, 136.7–136.4 (m), 128.0, 127.7, 111.5–110.9 (m), 67.3, 56.1, 53.3, 42.0, 38.8, 29.2, 29.1; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>NO<sub>4</sub> [MH]<sup>+</sup> calcd 408.1; found 408.2; LC–MS <i>t</i><sub>R</sub>: 3.7 min.</div></div><div id="sec5_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 2-((3<i>r</i>,5<i>r</i>,7<i>r</i>)-Adamantane-1-carboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5k</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using 1-adamantanecarbonyl chloride (148 mg, 0.75 mmol) to give 150 mg (48%) of white solid. <sup>1</sup>H NMR δ 7.50–7.40 (m, 4H), 7.21–7.09 (m, 2H), 6.77 (d, <i>J</i> = 6.6 Hz, 1H), 5.57 (d, <i>J</i> = 6.6 Hz, 1H), 3.75 (s, 3H), 2.10–2.02 (m, 3H), 1.89 (d, <i>J</i> = 2.7 Hz, 6H), 1.80–1.65 (m, 6H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.6 Hz), −162.2 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 177.7, 171.5, 151.6 (ddd, <i>J</i><sub>CF</sub> = 249.7/10.0/4.3 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.2/15.4 Hz), 138.5–138.4 (m), 137.2, 136.7 (td, <i>J</i><sub>CF</sub> = 7.7/4.4 Hz), 127.9, 127.6, 111.4–110.9 (m), 56.0, 53.1, 39.2, 36.5, 28.1; LC–MS <i>t</i><sub>R</sub>: 4.4 min (compound did not ionize).</div></div><div id="sec5_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 2-(3,3-Dimethylbutanamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5l</b>)</h4><div class="NLM_p last">Compound <b>4</b> (149 mg, 0.50 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_2" aria-label="General Procedure A: Formation of Amide Bond Using Acid Chlorides">General Procedure A: Formation of Amide Bond Using Acid Chlorides</a> using 3,3-dimethylbutyryl chloride (77 μL, 0.56 mmol) to give 110 mg (55%) of white solid. <sup>1</sup>H NMR δ 7.50–7.41 (m, 4H), 7.20–7.10 (m, 2H), 6.47 (d, <i>J</i> = 6.7 Hz, 1H), 5.62 (d, <i>J</i> = 6.9 Hz, 1H), 3.75 (s, 3H), 2.13 (s, 2H), 1.03 (s, 9H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.6 Hz), −162.2 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 171.4, 171.2, 151.6 (ddd, <i>J</i><sub>CF</sub> = 249.8/10.0/4.3 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.3/15.3 Hz), 138.66–138.33 (m), 137.2, 137.0–136.0 (m), 128.2, 127.5, 111.4–111.0 (m), 56.1, 53.1, 50.3, 31.2, 29.9; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>21</sub>H<sub>23</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 394.2; found 394.2; LC–MS <i>t</i><sub>R</sub>: 4.0 min.</div></div><div id="sec5_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl 2-(2-Cyclopropylacetamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5m</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using cyclopropylacetic acid (70 μL, 0.71 mmol) to give 141 mg (55%) of white solid. <sup>1</sup>H NMR δ 7.50–7.42 (m, 4H), 7.19–7.08 (m, 3H), 5.64 (d, <i>J</i> = 7.0 Hz, 1H), 3.75 (s, 3H), 2.28–2.14 (m, 2H), 1.08–0.95 (m, 1H), 0.68–0.60 (m, 2H), 0.28–0.18 (m, 2H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.2 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 172.1, 171.3, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.8/10.0/4.2 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.1/15.3 Hz), 138.5–138.4 (m), 137.1, 136.6 (td, <i>J</i><sub>CF</sub> = 7.8/4.7 Hz), 128.0, 127.5, 111.6–110.8 (m), 56.0, 53.1, 41.2, 7.1, 4.71, 4.68; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 378.1; found 378.1; LC–MS <i>t</i><sub>R</sub>: 3.8 min.</div></div><div id="sec5_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 2-(2-Cyclobutylacetamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5n</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using cyclobutylacetic acid (74 μL, 0.71 mmol) to give 160 mg (60%) of white solid. <sup>1</sup>H NMR δ 7.49–7.38 (m, 4H), 7.17–7.09 (m, 2H), 6.73 (d, <i>J</i> = 6.9 Hz, 1H), 5.60 (d, <i>J</i> = 6.9 Hz, 1H), 3.74 (s, 3H), 2.78–2.59 (m, 1H), 2.38 (d, <i>J</i> = 7.7 Hz, 2H), 2.20–2.05 (m, 2H), 1.96–1.65 (m, 4H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.2 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 172.0, 171.3, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.8/10.0/4.3 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.2/15.4 Hz), 138.4 (d, <i>J</i><sub>CF</sub> = 1.6 Hz), 137.0, 136.6 (td, <i>J</i><sub>CF</sub> = 7.8/4.6 Hz), 128.0, 127.5, 111.3–110.9 (m), 56.0, 53.1, 43.4, 32.7, 28.42, 28.40, 18.6; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 392.1; found 392.1; LC–MS <i>t</i><sub>R</sub>: 3.9 min.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Methyl 2-(2-Cyclopentylacetamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5o</b>)</h3><div class="NLM_p last">Compound <b>4</b> (120 mg, 0.41 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using cyclopentylacetic acid (54 μL, 0.43 mmol) to give 140 mg (85%) of white solid. <sup>1</sup>H NMR δ 7.51–7.40 (m, 4H), 7.20–7.10 (m, 2H), 6.59 (d, <i>J</i> = 6.9 Hz, 1H), 5.63 (d, <i>J</i> = 6.9 Hz, 1H), 3.75 (s, 3H), 2.33–2.16 (m, 3H), 1.90–1.46 (m, 6H), 1.24–1.05 (m, 2H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.2 (dd, <i>J</i> = 20.6/20.6 Hz); <sup>13</sup>C NMR δ 172.4, 171.4, 151.6 (ddd, <i>J</i><sub>CF</sub> = 249.8/10.1/4.4 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.2/15.5 Hz), 138.5–138.4 (m), 137.2, 136.7–136.6 (m), 128.1, 127.5, 111.5–110.9 (m), 56.1, 53.1, 42.8, 37.2, 32.68, 32.65, 25.09, 25.08; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 406.2; found 406.2; LC–MS <i>t</i><sub>R</sub>: 4.0 min.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Methyl 2-(2-Cyclohexylacetamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5p</b>)</h3><div class="NLM_p">Compound <b>4</b> (120 mg, 0.41 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using cyclohexylacetic acid (61 mg, 0.43 mmol) to give 97 mg (57%) of white solid. <sup>1</sup>H NMR δ 7.50–7.41 (m, 4H), 7.20–7.10 (m, 2H), 6.52 (d, <i>J</i> = 6.8 Hz, 1H), 5.63 (d, <i>J</i> = 6.9 Hz, 1H), 3.75 (s, 3H), 2.18–2.07 (m, 2H), 1.86–1.57 (m, 6H), 1.34–0.85 (m, 5H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.2 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 172.0, 171.4, 151.6 (ddd, <i>J</i><sub>CF</sub> = 249.8/9.9/4.2 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 254.8/15.3 Hz), 138.6–138.4 (m), 137.2, 136.8–136.4 (m), 128.1, 127.6, 111.5–111.0 (m), 56.1, 53.1, 44.6, 35.5, 33.3, 33.2, 26.3, 26.2 (2C); <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>23</sub>H<sub>25</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 420.2; found 420.3; LC–MS <i>t</i><sub>R</sub>: 4.1 min.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 2-(2-(Cuban-1-yl)acetamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5q</b>)</h4><div class="NLM_p last">Compound <b>4</b> (270 mg, 0.91 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using 2-((2<i>r</i>,3<i>r</i>,5<i>r</i>,6<i>r</i>,7<i>r</i>,8<i>r</i>)-cuban-1-yl)acetic acid (156 mg, 0.96 mmol) to give 261 mg (65%) of white solid. <sup>1</sup>H NMR δ 7.49–7.38 (m, 4H), 7.18–7.07 (m, 2H), 6.77 (d, <i>J</i> = 7.0 Hz, 1H), 5.62 (d, <i>J</i> = 7.0 Hz, 1H), 3.94–3.80 (m, 7H), 3.71 (s, 3H), 2.66–2.48 (m, 2H); <sup>19</sup>F NMR δ −133.9 (d, <i>J</i> = 20.5 Hz), −162.3 (dd, <i>J</i> = 20.5/20.5 Hz); <sup>13</sup>C NMR δ 171.1, 170.2, 151.4 (ddd, <i>J</i><sub>CF</sub> = 249.7/10.0/4.2 Hz), 139.3 (dt, <i>J</i><sub>CF</sub> = 26.7/15.4 Hz), 138.3–138.1 (m), 137.2, 136.6 (td, <i>J</i><sub>CF</sub> = 7.7/4.6 Hz), 127.9, 127.3, 111.3–110.4 (m), 55.8, 55.0, 52.9, 49.0, 48.3, 44.2, 40.3; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>25</sub>H<sub>21</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 440.1; found 440.2; LC–MS <i>t</i><sub>R</sub>: 3.6 min.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl 2-(2-(Bicyclo[2.2.1]heptan-2-yl)acetamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5r</b>)</h4><div class="NLM_p last">Compound <b>4</b> (200 mg, 0.68 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_3" aria-label="General Procedure B: Formation of Amide Bond Using HCTU">General Procedure B: Formation of Amide Bond Using HCTU</a> using 2-norbornaneacetic acid (104 μL, 0.71 mmol) to give 170 mg (58%) of white solid. <sup>1</sup>H NMR δ 7.50–7.39 (m, 4H), 7.19–7.07 (m, 2H), 6.91–6.77 (m, 1H), 5.68–5.57 (m, 1H), 3.75 (d, <i>J</i> = 0.8 Hz, 3H), 2.29–2.17 (m, 2H), 2.15–2.04 (m, 1H), 2.01–1.82 (m, 2H), 1.56–1.36 (m, 3H), 1.32–0.99 (m, 5H); <sup>19</sup>F NMR δ −133.9 (dd, <i>J</i> = 20.4/0.8 Hz), −162.1 (td, <i>J</i> = 20.5/2.6 Hz); <sup>13</sup>C NMR δ 172.7, 171.2, 151.5 (ddd, <i>J</i><sub>CF</sub> = 249.9/10.0/4.3 Hz), 139.5 (dt, <i>J</i><sub>CF</sub> = 252.2/15.4 Hz), 138.5, 136.8, 136.7–136.2 (m), 128.01, 128.00,* 127.48, 127.46,* 111.3–110.8 (m), 56.2, 53.1, 43.30, 43.25,* 41.21, 41.19,* 39.0, 38.9,* 37.80, 37.78,* 36.83, 36.82,* 35.32, 35.30,* 29.83, 29.80,* 28.6, 28.5* [NB: All signals with an * correspond to the second rotamer (50:50)]; <i>m</i>/<i>z</i> MS (ES<sup>+</sup>) C<sub>24</sub>H<sub>25</sub>F<sub>3</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd 432.2; found 432.2; LC–MS <i>t</i><sub>R</sub>: 4.1 min.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)isobutyramide (<b>6a</b>)</h4><div class="NLM_p last">Compound <b>5a</b> (141 mg, 0.39 mmol) was converted to the corresponding hydroxamic acid according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 130 mg (92%) of an oily white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 9.03 (s, 1H), 8.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.76–7.63 (m, 4H), 7.50 (d, <i>J</i> = 8.3 Hz, 2H), 5.42 (d, <i>J</i> = 8.5 Hz, 1H), 2.74–2.56 (m, 1H), 1.00 (d, <i>J</i> = 6.8 Hz, 3H), 0.97 (d, <i>J</i> = 6.8 Hz, 3H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.93 (d, <i>J</i> = 21.7 Hz), −163.54 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 176.1, 166.7, 150.7 (ddd, <i>J</i><sub>CF</sub> = 246.7/9.7/4.2 Hz), 139.5, 139.9–136.9 (m), 136.8–136.5 (m), 136.2, 127.6, 126.8, 111.5–110.9 (m), 53.3, 33.4, 19.6, 19.5; <i>m</i>/<i>z</i> high-resolution mass spectrometry (HRMS) time-of-flight (TOF ES<sup>+</sup>) C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 367.1264; found 367.1269; LC–MS <i>t</i><sub>R</sub>: 3.2 min; HPLC <i>t</i><sub>R</sub>: 6.1 min, >99%.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)propionamide (<b>6b</b>)</h4><div class="NLM_p last">Compound <b>5b</b> (180 mg, 0.51 mmol) was converted to the corresponding hydroxamic acid according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 156 mg (86%) of an oily white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 9.01 (s, 1H), 8.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.73–7.60 (m, 4H), 7.49 (d, <i>J</i> = 8.3 Hz, 2H), 5.42 (d, <i>J</i> = 8.4 Hz, 1H), 2.23 (q, <i>J</i> = 7.5 Hz, 2H), 0.98 (t, <i>J</i> = 7.6 Hz, 3H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.92 (d, <i>J</i> = 21.7 Hz), −163.52 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 172.9, 166.6, 150.7 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.7/4.1 Hz), 139.5, 139.9–136.8 (m), 136.8–136.3 (m), 136.2, 127.7, 126.8, 111.7–110.9 (m), 53.4, 28.1, 9.9; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>16</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 353.1108; found 353.1107; LC–MS <i>t</i><sub>R</sub>: 3.2 min; HPLC <i>t</i><sub>R</sub>: 5.9 min, >99%.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3,3,3-Trifluoro-<i>N</i>-(2-(hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)propanamide (<b>6c</b>)</h4><div class="NLM_p last">Compound <b>5c</b> (50 mg, 0.12 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 20 mg (40%) of colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.11 (s, 1H), 9.18 (d, <i>J</i> = 8.2 Hz, 1H), 9.12 (s, 1H), 7.76–7.66 (m, 4H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 5.43 (d, <i>J</i> = 8.2 Hz, 1H), 3.46 (app. q, <i>J</i> = 11.2 Hz, 2H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −61.40, −134.90 (d, <i>J</i> = 21.8 Hz), −163.41 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.9, 162.5 (q, <i>J</i><sub>CF</sub> = 3.5 Hz), 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.7/4.2 Hz), 138.8, 138.4 (dt, <i>J</i><sub>CF</sub> = 248.6/15.4 Hz), 136.6–136.3 (m), 136.4, 127.4, 126.9, 126.6–120.8 (m), 111.5–111.1 (m), 53.5 39.5–38.5 (m)*; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>13</sub>F<sub>6</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 407.0825; found 407.0835; LC–MS <i>t</i><sub>R</sub>: 3.2 min; HPLC <i>t</i><sub>R</sub>: 6.4 min, 96%. Carbon resonance denoted with * is under the DMSO reference signal.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2,3,3,3-Tetrafluoro-<i>N</i>-(2-(hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)propanamide (<b>6d</b>)</h4><div class="NLM_p last">Compound <b>5d</b> (250 mg, 0.59 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a>. The diastereomers were separated by FCC as white solids; <b>6d</b>–<b>a</b> (65 mg) and <b>6d</b>–<b>b</b> (63 mg). Diastereomer <b>6d</b>–<b>a</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.16 (s, 1H), 9.55 (d, <i>J</i> = 7.9 Hz, 1H), 9.18 (s, 1H), 7.78–7.65 (m, 4H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 5.87 (dq, <i>J</i> = 44.9/6.7 Hz, 1H), 5.47 (d, <i>J</i> = 7.8 Hz, 1H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −75.07 (d, <i>J</i> = 13.0 Hz), −134.88 (d, <i>J</i> = 21.7 Hz), −163.31 (dd, <i>J</i> = 21.8/21.8 Hz), −204.88 (q, <i>J</i> = 13.0 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.3, 160.4–159.9 (m), 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.8/4.3 Hz), 138.4 (dt, <i>J</i><sub>CF</sub> = 249.4/16.1 Hz), 137.9, 136.6, 136.5–136.1 (m), 127.4, 127.0, 121.0 (app. d, <i>J</i><sub>CF</sub> = 281.6 Hz), 111.5–111.0 (m), 83.7 (dd, <i>J</i><sub>CF</sub> = 189.8/33.3 Hz), 53.7; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>12</sub>F<sub>7</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 425.0731; found 425.0738; LC–MS <i>t</i><sub>R</sub>: 3.3 min; HPLC <i>t</i><sub>R</sub>: 6.7 min, >99%; diastereomer <b>6d</b>–<b>b</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.12 (s, 1H), 9.50 (d, <i>J</i> = 8.0 Hz, 1H), 9.19 (s, 1H), 7.80–7.63 (m, 4H), 7.51 (d, <i>J</i> = 8.3 Hz, 2H), 5.88 (dq, <i>J</i> = 44.9/6.7 Hz, 1H), 5.45 (d, <i>J</i> = 8.0 Hz, 1H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −75.16 (d, <i>J</i> = 13.0 Hz), −134.87 (d, <i>J</i> = 21.8 Hz), −163.31 (dd, <i>J</i> = 21.7/21.7 Hz), −204.97 (q, <i>J</i> = 12.9 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.3, 160.3–160.0 (m), 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.9/9.8/4.2 Hz), 138.4 (dt, <i>J</i><sub>CF</sub> = 249.6/15.7 Hz), 138.1, 136.6, 136.5–135.6 (m), 127.5, 127.0, 121.1 (qd, <i>J</i><sub>CF</sub> = 282.0/26.5 Hz), 111.5–111.0 (m), 83.9 (ddd, <i>J</i><sub>CF</sub> = 190.6/66.8/33.5 Hz), 53.7; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>12</sub>F<sub>7</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 425.0731; found 425.0745; LC–MS <i>t</i><sub>R</sub>: 3.3 min; HPLC <i>t</i><sub>R</sub>: 6.8 min, 98%.</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2,2,3,3,3-Pentafluoro-<i>N</i>-(2-(hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)propanamide (<b>6e</b>)</h4><div class="NLM_p last">Compound <b>5e</b> (160 mg, 0.36 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 80 mg (50%) of yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.10 (s, 1H), 10.28 (d, <i>J</i> = 5.3 Hz, 1H), 9.17 (s, 1H), 7.78–7.68 (m, 4H), 7.54 (d, <i>J</i> = 8.4 Hz, 2H), 5.50 (d, <i>J</i> = 4.1 Hz, 1H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −82.09, −120.88 (d, <i>J</i> = 7.3 Hz), −134.85 (d, <i>J</i> = 21.7 Hz), −163.25 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.9, 156.9 (t, <i>J</i><sub>CF</sub> = 26.3 Hz), 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.4/4.1 Hz), 139.9–136.9 (m), 136.8, 136.5–136.2 (m), 128.2, 127.0, 120.0–115.3 (m), 111.6–110.7 (m), 107.2–105.6 (m), 54.4; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>11</sub>F<sub>8</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 443.0636; found 443.0643; LC–MS <i>t</i><sub>R</sub>: 6.7 min; HPLC <i>t</i><sub>R</sub>: 7.2 min, 99%.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)cyclopropanecarboxamide (<b>6f</b>)</h4><div class="NLM_p last">Compound <b>5f</b> (150 mg, 0.41 mmol) was converted to the corresponding hydroxamic acid according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 120 mg (80%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 9.02 (s, 1H), 8.95 (d, <i>J</i> = 8.5 Hz, 1H), 7.78–7.62 (m, 4H), 7.51 (d, <i>J</i> = 8.3 Hz, 2H), 5.45 (d, <i>J</i> = 8.5 Hz, 1H), 2.00–1.78 (m, 1H), 0.73–0.60 (m, 4H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.92 (d, <i>J</i> = 21.7 Hz), −163.50 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 172.6, 166.7, 150.7 (ddd, <i>J</i> = 246.6/9.6/4.1 Hz), 139.5, 140.1–136.9 (m), 136.9–136.4 (m), 136.3, 127.7, 126.9, 111.5–110.9 (m), 53.6, 13.3, 6.8, 6.7; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>18</sub>H<sub>16</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 365.1108; found 365.1107; LC–MS <i>t</i><sub>R</sub>: 3.3 min; HPLC <i>t</i><sub>R</sub>: 7.1 min, >99%.</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)cyclobutanecarboxamide (<b>6g</b>)</h4><div class="NLM_p last">Compound <b>5g</b> (200 mg, 0.53 mmol) was converted to the corresponding hydroxamic acid according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 129 mg (64%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 9.01 (s, 1H), 8.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.77–7.60 (m, 4H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 5.42 (d, <i>J</i> = 8.4 Hz, 1H), 3.30–3.19 (m, 1H), 2.17–1.67 (m, 6H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.93 (d, <i>J</i> = 21.8 Hz), −163.52 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 173.9, 166.7, 150.7 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.6/4.0 Hz), 139.5, 139.9–136.9 (m), 136.9–136.5 (m), 136.3, 127.7, 126.9, 111.6–110.9 (m), 53.5, 38.3, 24.7, 24.6, 17.9; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>19</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 379.1264; found 379.1265; LC–MS <i>t</i><sub>R</sub>: 3.3 min.</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)cyclopentanecarboxamide (<b>6h</b>)</h4><div class="NLM_p last">Compound <b>5h</b> (60 mg, 0.15 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 20 mg (33%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.02 (d, <i>J</i> = 1.2 Hz, 1H), 9.03 (d, <i>J</i> = 1.3 Hz, 1H), 8.59 (d, <i>J</i> = 8.4 Hz, 1H), 7.74–7.65 (m, 4H), 7.49 (d, <i>J</i> = 8.3 Hz, 2H), 5.42 (d, <i>J</i> = 8.4 Hz, 1H), 2.91–2.75 (m, 1H), 1.86–1.42 (m, 8H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.93 (d, <i>J</i> = 21.8 Hz), −163.53 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 175.2, 166.5, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.6/4.1 Hz), 139.5, 137.0, 136.7–136.4 (m), 136.1, 127.5, 126.8, 111.5–110.9 (m), 53.3, 43.5, 30.07, 29.98, 25.77, 25.75; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 393.1421; found 393.1431; LC–MS <i>t</i><sub>R</sub>: 3.6 min; HPLC <i>t</i><sub>R</sub>: 6.5 min, 95%.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)cyclohexanecarboxamide (<b>6i</b>)</h4><div class="NLM_p last">Methyl 2-(cyclohexanecarboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5i</b>) (40 mg, 0.10 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 15 mg (37%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 9.02 (s, 1H), 8.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.76–7.58 (m, 4H), 7.50 (d, <i>J</i> = 8.1 Hz, 2H), 5.42 (d, <i>J</i> = 8.4 Hz, 1H), 2.48–2.29 (m, 1H), 1.78–1.52 (m, 5H), 1.47–0.98 (m, 5H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.94 (d, <i>J</i> = 21.6 Hz), −163.61 (dd, <i>J</i> = 21.6/21.6 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 175.1, 166.6, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.7/4.0 Hz), 140.1–136.8 (m), 139.5, 136.8–136.3 (m), 136.1, 127.5, 126.7, 111.6–110.8 (m), 53.1, 43.3, 29.3, 29.1, 25.5, 25.2 (2C); <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>21</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 407.1577; found 407.1589; LC–MS <i>t</i><sub>R</sub>: 3.7 min; HPLC <i>t</i><sub>R</sub>: 6.9 min, >99%.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)tetrahydro-2<i>H</i>-pyran-4-carboxamide (<b>6j</b>)</h4><div class="NLM_p last">Methyl 2-(tetrahydro-2<i>H</i>-pyran-4-carboxamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5j</b>) (100 mg, 0.25 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 65 mg (65%) of beige solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.03 (s, 1H), 9.03 (d, <i>J</i> = 1.0 Hz, 1H), 8.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.74–7.65 (m, 4H), 7.49 (d, <i>J</i> = 8.3 Hz, 2H), 5.41 (d, <i>J</i> = 8.4 Hz, 1H), 3.93–3.76 (m, 2H), 3.36–3.19 (m, 2H), 2.71–2.59 (m, 1H), 1.66–1.41 (m, 4H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.92 (d, <i>J</i> = 21.8 Hz), −163.50 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 174.0, 166.6, 150.7 (ddd, <i>J</i><sub>CF</sub> = 246.4/9.8/4.0 Hz), 139.4, 137.2, 136.8–136.5 (m), 136.3, 127.6, 126.9, 111.5–111.1 (m), 66.54, 66.52, 53.4, 40.3, 29.1, 29.0; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [MH]<sup>+</sup> calcd 409.1370; found 409.1396; LC–MS <i>t</i><sub>R</sub>: 3.4 min; HPLC <i>t</i><sub>R</sub>: 5.9 min, >99%.</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)adamantane-1-carboxamide (<b>6k</b>)</h4><div class="NLM_p last">Compound <b>5k</b> (140 mg, 0.31 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 80 mg (56%) of beige solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.03 (s, 1H), 9.09 (s, 1H), 7.74–7.63 (m, 5H), 7.50 (d, <i>J</i> = 8.3 Hz, 2H), 5.42 (d, <i>J</i> = 8.0 Hz, 1H), 2.02–1.93 (m, 3H), 1.89–1.78 (m, 6H), 1.73–1.62 (m, 6H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.92 (d, <i>J</i> = 21.8 Hz), −163.52 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 176.3, 166.5, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.7/4.2 Hz), 139.8–136.8 (m), 139.5, 136.9–136.3 (m), 136.1, 127.4, 126.8, 111.6–110.8 (m), 53.2, 40.0, 38.4, 36.0, 27.7; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 459.1890; found 459.1872; LC–MS <i>t</i><sub>R</sub>: 3.9 min; HPLC <i>t</i><sub>R</sub>: 7.8 min, 97%.</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(2-(Hydroxyamino)-2-oxo-1-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)ethyl)-3,3-dimethylbutanamide (<b>6l</b>)</h4><div class="NLM_p last">Methyl 2-(3,3-dimethylbutanamido)-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetate (<b>5l</b>) (100 mg, 0.25 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 75 mg (75%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.09 (s, 1H), 9.10 (s, 1H), 8.62 (d, <i>J</i> = 8.3 Hz, 1H), 7.85–7.73 (m, 4H), 7.59 (d, <i>J</i> = 8.3 Hz, 2H), 5.53 (d, <i>J</i> = 8.3 Hz, 1H), 2.31–2.12 (m, 2H), 1.03 (s, 9H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.94 (d, <i>J</i> = 21.7 Hz), −163.55 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 170.7, 166.6, 150.61 (ddd, <i>J</i><sub>CF</sub> = 246.3/9.7/4.1 Hz), 139.8–136.7 (m), 139.5, 136.74–136.32 (m), 136.0, 127.6, 126.7, 111.4–110.9 (m), 53.2, 47.9, 30.6, 29.7; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>20</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 395.1577; found 395.1590; LC–MS <i>t</i><sub>R</sub>: 3.3 min; HPLC <i>t</i><sub>R</sub>: 6.9 min, 97%.</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(2-Cyclopropylacetamido)-<i>N</i>-hydroxy-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetamide (<b>6m</b>)</h4><div class="NLM_p last">Compound <b>5m</b> (60 mg, 0.16 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 26 mg (43%) of pale yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.04 (s, 1H), 9.05 (s, 1H), 8.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.75–7.66 (m, 4H), 7.50 (d, <i>J</i> = 8.3 Hz, 2H), 5.44 (d, <i>J</i> = 8.4 Hz, 1H), 2.21–2.05 (m, 2H), 1.01–0.87 (m, 1H), 0.47–0.31 (m, 2H), 0.22–0.02 (m, 2H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.93 (d, <i>J</i> = 21.8 Hz), −163.51 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 171.4, 166.5, 152.13–149.08 (m), 139.5, 137.1, 136.8–136.2 (m), 136.1, 127.5, 126.8, 111.4–111.0 (m), 53.2, 7.8, 4.1, 4.0; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>19</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 379.1264; found 379.1274; LC–MS <i>t</i><sub>R</sub>: 3.5 min; HPLC <i>t</i><sub>R</sub>: 6.4 min, 95%.</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(2-Cyclobutylacetamido)-<i>N</i>-hydroxy-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetamide (<b>6n</b>)</h4><div class="NLM_p last">Compound <b>5n</b> (90 mg, 0.23 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 20 mg (22%) of yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 9.03 (s, 1H), 8.60 (d, <i>J</i> = 8.4 Hz, 1H), 7.77–7.63 (m, 4H), 7.47 (d, <i>J</i> = 8.3 Hz, 2H), 5.40 (d, <i>J</i> = 8.4 Hz, 1H), 2.60–2.51 (m, 1H), 2.34 (d, <i>J</i> = 7.4 Hz, 2H), 2.03–1.91 (m, 2H), 1.83–1.73 (m, 2H), 1.71–1.61 (m, 2H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.94 (d, <i>J</i> = 21.8 Hz), −163.52 (dd, <i>J</i> = 21.8/21.8 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 171.0, 166.5, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.6/9.6/4.1), 139.5, 137.6–136.9 (m), 136.8–136.3 (m), 136.0, 127.5, 126.7, 112.9–109.8 (m), 53.2, 41.7, 32.7, 27.7, 27.6, 18.1; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 393.1421; found 393.1433; LC–MS <i>t</i><sub>R</sub>: 3.6 min; HPLC <i>t</i><sub>R</sub>: 6.7 min, 97%.</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(2-Cyclopentylacetamido)-<i>N</i>-hydroxy-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetamide (<b>6o</b>)</h4><div class="NLM_p last">Compound <b>5o</b> (130 mg, 0.32 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 40 mg (31%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 9.03 (s, 1H), 8.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.75–7.64 (m, 4H), 7.49 (d, <i>J</i> = 8.3 Hz, 2H), 5.43 (d, <i>J</i> = 8.3 Hz, 1H), 2.27–2.18 (m, 2H), 2.17–2.05 (m, 1H), 1.72–1.37 (m, 6H), 1.18–1.06 (m, 2H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.93 (d, <i>J</i> = 21.7 Hz), −163.53 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 171.7, 166.5, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.7/9.8/4.1 Hz), 139.6–136.8 (m), 139.5, 136.7–136.4 (m), 136.1, 127.6, 126.7, 111.6–110.8 (m), 53.3, 40.9, 36.8, 31.9, 31.8, 24.50, 24.49; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>21</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 407.1577; found 407.1593; LC–MS <i>t</i><sub>R</sub>: 3.6 min; HPLC <i>t</i><sub>R</sub>: 6.8 min, 97%.</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(2-Cyclohexylacetamido)-<i>N</i>-hydroxy-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetamide (<b>6p</b>)</h4><div class="NLM_p last">Compound <b>5p</b> (80 mg, 0.19 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 24 mg (30%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 9.02 (s, 1H), 8.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.74–7.64 (m, 4H), 7.49 (d, <i>J</i> = 8.3 Hz, 2H), 5.43 (d, <i>J</i> = 8.3 Hz, 1H), 2.11 (d, <i>J</i> = 6.8 Hz, 2H), 1.76–1.49 (m, 6H), 1.25–1.03 (m, 3H), 1.03–0.80 (m, 2H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.94 (d, <i>J</i> = 21.8 Hz), −163.52 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 170.7, 166.6, 152.1–149.2 (m), 139.5–136.9 (m), 139.4, 136.9–136.2 (m), 136.1, 127.6, 126.8, 111.4–111.0 (m), 53.3, 42.7, 34.9, 32.6, 32.5, 25.9, 25.7 (2C); <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>22</sub>H<sub>24</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 421.1734; found 421.1747; LC–MS <i>t</i><sub>R</sub>: 3.7 min; HPLC <i>t</i><sub>R</sub>: 7.1 min, >99%.</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-(2-(Cuban-1-yl)acetamido)-<i>N</i>-hydroxy-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetamide (<b>6q</b>)</h4><div class="NLM_p last">Compound <b>5q</b> (200 mg, 0.46 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 95 mg (47%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 9.03 (s, 1H), 8.56 (d, <i>J</i> = 8.3 Hz, 1H), 7.75–7.65 (m, 4H), 7.47 (d, <i>J</i> = 8.3 Hz, 2H), 5.41 (d, <i>J</i> = 8.2 Hz, 1H), 4.01–3.95 (m, 1H), 3.88–3.75 (m, 6H), 2.60–2.51 (m, 2H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.9 (d, <i>J</i> = 21.8 Hz), −163.5 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 169.4, 166.5, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.8/9.7/4.0 Hz), 139.7–136.9, 139.5, 136.7–136.4 (m), 136.0, 127.5, 126.7, 111.4–110.9 (m), 55.3, 53.3, 48.5, 47.2, 43.5, 38.8; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 441.1421; found 441.1434; LC–MS <i>t</i><sub>R</sub>: 3.4 min; HPLC <i>t</i><sub>R</sub>: 7.3 min, 98%.</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(2-(Bicyclo[2.2.1]heptan-2-yl)acetamido)-<i>N</i>-hydroxy-2-(3′,4′,5′-trifluoro-[1,1′-biphenyl]-4-yl)acetamide (<b>6r</b>)</h4><div class="NLM_p last">Compound <b>5r</b> (90 mg, 0.21 mmol) was converted to the title compound according to <a class="ref internalNav" href="#sec5_5" aria-label="General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid">General Procedure D: Aminolysis of Methyl Ester to Hydroxamic Acid</a> to give 34 mg (38%) of white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.02 (d, <i>J</i> = 5.1 Hz, 1H), 9.04 (d, <i>J</i> = 3.6 Hz, 1H), 8.61 (dd, <i>J</i> = 8.3/2.7 Hz, 1H), 7.79–7.61 (m, 4H), 7.49 (dd, <i>J</i> = 8.3/3.3 Hz, 2H), 5.43 (d, <i>J</i> = 8.3 Hz, 1H), 2.25–2.02 (m, 3H), 1.94–1.72 (m, 2H), 1.47–1.25 (m, 4H), 1.14–0.95 (m, 4H); <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −134.92 (d, <i>J</i> = 21.7 Hz), −163.54 (dd, <i>J</i> = 21.7/21.7 Hz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 171.38, 171.36*, 166.6, 150.6 (ddd, <i>J</i><sub>CF</sub> = 246.5/9.6/4.0 Hz), 139.8–136.8 (m), 139.51, 139.48*, 136.7–136.4 (m), 136.1, 127.6, 126.76, 126.73*, 111.5–110.9 (m), 53.3, 41.84, 41.80*, 40.5, 40.4*, 38.8, 38.7, 37.0, 36.18, 36.13*, 34.91, 34.87*, 29.46, 29.41*, 28.43, 28.37*; <i>m</i>/<i>z</i> HRMS (TOF ES<sup>+</sup>) C<sub>23</sub>H<sub>24</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd 433.1734; found 433.1741; LC–MS <i>t</i><sub>R</sub>: 3.7 min; HPLC <i>t</i><sub>R</sub>: 7.4 min, 96%. All signals with an * correspond to the second conformer (50:50).</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Biology</h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Protein Expression and Purification</h4><div class="NLM_p">DNA coding for <i>Pv</i>-M1 (residues 195–1097) and <i>Pv</i>-M17 (residues 203–621) with C-terminal His6 tags were chemically synthesized by DNA2.0 using codons optimized for gene expression in <i>Escherichia coli</i> and provided in the pJ404 vector for expression. Cloning of C-terminally His6 tagged expression vectors for <i>Pf</i>-M1 (residues 195–1085) and <i>Pf</i>-M17 (residues 85–605) was described previously.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a></div><div class="NLM_p">The four plasmodial aminopeptidases were expressed by the autoinduction method in <i>E. coli</i> BL21(DE3). Cells were lysed by sonication in phosphate-buffered saline (PBS) pH 8.0, 300 mM NaCl, 5% glycerol, 20 mM imidazole. Clarified lysates were bound to a Ni-NTA-agarose column in nickel-affinity buffer (PBS pH8.0, 300 mM NaCl, 5% glycerol, 20 mM imidazole), and eluted in nickel-affinity buffer supplemented with 250 mM imidazole. The proteins were further purified by size exclusion chromatography on Superdex S200 10/300 gel filtration column in either 50 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES) pH 8.0, 300 mM NaCl (<i>Pv</i>-M17 and <i>Pf</i>-M17), or the same buffer supplemented with 5% glycerol (<i>Pv</i>-M1 and <i>Pf</i>-M1).</div><div class="NLM_p last">Partially purified IRAP was provided as a kind gift from Dr. Siew Chai and Peta Burns from Monash University. APN was purified from the supernatant of a stably transfected HEK293S GnT1<sup>–</sup> cell line, which was a kind gift from Prof. James Rini from the University of Toronto, Canada, using the methods reported previously.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Determination of Aminopeptidase Kinetic Parameters and Inhibition Constants</h4><div class="NLM_p">The ability of compounds to inhibit aminopeptidase activity was assessed by fluorescence assays using the fluorogenic peptide <span class="smallcaps smallerCapital">l</span>-leucine-7-amido-4-methylcoumarin hydrochloride (Sigma L2145) as substrate. The reactions were carried out in white 384-well plates, 50 μL total volume at 37°C using a spectrofluorimeter (BMG FLUOstar) with excitation at 355 nm and emission at 460 nm. The fluorescence signal was continuously monitored until a final steady state velocity, <i>v</i>, was obtained. Inhibition constants were calculated in biological triplicate from three different protein preparations. Kinetic parameters were determined for each preparation of protein in experimental triplicate.</div><div class="NLM_p">For determination of kinetic parameters, enzyme was first added to 100 mM Tris–HCl, pH 8.0 (supplemented with 1 mM CoCl<sub>2</sub> for <i>Pv</i>-M17 or 2 mM CoCl<sub>2</sub> for <i>Pf</i>-M17) for 10 min prior to the addition of substrate. Initial rates were obtained at 37 °C over a range of substrate concentrations spanning <i>K</i><sub>m</sub> (0.5–500 μM) and at fixed enzyme concentration: 20 nM <i>Pf</i>-M1, 10 nM <i>Pv</i>-M1, 150 nM <i>Pf</i>-M17, 125 nM <i>Pv</i>-M17. Calculations of Michaelis–Menten constants (<i>K</i><sub>m</sub>) were performed using GraphPad Prism software.</div><div class="NLM_p">Previous examination of compound <i>Pf</i>-M1 and <i>Pf</i>-M17 inhibitory activity was performed using the Dixon method.<a onclick="showRef(event, 'ref15 ref17 ref20 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref15 ref17 ref20 ref42 ref43">(15,17,20,42,43)</a> However, first-pass screening of the current inhibitor series demonstrated that compound inhibition constants were approaching, or indeed passing, the concentration of enzyme used in the assays. We therefore restructured our method of compound examination to use a modified Morrison equation for tight-binding inhibitors.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> For determination of the Morrison inhibition constant, <i>K</i><sub>i</sub>, enzymes were preincubated in 100 mM Tris–HCl, pH 8.0 (supplemented with 1 mM CoCl<sub>2</sub> for <i>Pv</i>-M17 or 2 mM CoCl<sub>2</sub> for <i>Pf</i>-M17) and the inhibitors for 20 min prior to the addition of substrate (20 μM for <i>Pf</i>-M1, 40 μM for <i>Pv</i>-M1, 10 μM for <i>Pf</i>-M17, 10 μM for <i>Pv</i>-M17). Substrate (<span class="smallcaps smallerCapital">l</span>-leucine-7-amido-4-methylcoumarin) concentrations were selected to allow sensitive detection of enzyme activity while not exceeding the <i>K</i><sub>m</sub> for each enzyme. First-pass inhibition assays were conducted with a compound concentration range of 500 nM to 500 pM. The concentration range was then adjusted the second-pass assay to obtain a complete inhibition curve (0–100%) in biological triplicate. The <i>K</i><sub>i</sub> values were calculated by plotting the initial rates versus inhibitor concentration, and fitting to the Morrison equation for tight-binding inhibitors in GraphPad Prism software (nonlinear regression method).</div><div class="NLM_p">To assess possible off-target activity, ability of <b>6l</b> to inhibit a panel of matrix metalloproteinases (MMPs) was examined. Purified MMPs were activated using 1 mM 4-aminophenylmercuric acetate in buffer containing 50 mM HEPES, 150 mM NaCl, 5 mM CaCl<sub>2</sub>, pH 7.0 for 1 h at room temperature, at working MMP concentrations of 1 μM (MMP2, 9, or 13) or 10 μM (MMP7 or 8). Each activated MMP was incubated at 2–20 nM concentrations with increasing inhibitor concentrations (0.1 pM to 100 μM) of <b>6l</b>, Marimastat, or Tosedostat in fluorimetry assay buffer composed of 100 mM Tris–HCl, 100 mM NaCl, 10 mM CaCl<sub>2</sub>, 0.15% Brij-35, pH 7.5 for 1 h at room temperature. Quenched fluorescent (QF)-24 substrate (ChinaPeptides Co. Ltd., Shanghai, China) was dissolved in DMSO and diluted to 10 μM working concentrations in fluorimetry assay buffer. QF assays were performed by incubating each MMP-inhibitor solution with 1 μM QF24 substrate at 37°C and measuring fluorescence at excitation and emission wavelengths of 320 and 405 nm, respectively, at 1 min intervals over 1 h using a fluorescence plate reader (POLARStar, OPTIMA, BMG Labtech, Ortenberg, Germany). IC<sub>50</sub> values for each inhibitor were calculated by plotting log(inhibitor concentration) versus activity rate (pmol of QF24 substrate cleaved/h) and applying the four-parameter Hill equation (GraphPad Prism 5.0, La Jolla, CA). Each MMP was assayed with all inhibitors in three independent experiments.</div><div class="NLM_p last">Inhibition of APN and IRAP was performed using the same aminopeptidase assay used for the plasmodial enzymes. Briefly, purified APN or partially purified IRAP was added to assay buffer (100 mM Tris pH 8) and incubated with increasing concentrations of compound for 10 min at 37 °C. Triplicate reactions were started with the addition of <span class="smallcaps smallerCapital">l</span>-leucine-7-amido-4-methylcoumarin (final concentration 25 μM) and monitored for 30 min. Data were processed as described above.</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Compound Washout Experiments</h4><div class="NLM_p last">To assess reversibility of <b>6k</b> binding to <i>Pf</i>-M17, washout experiments were performed. <i>Pf</i>-M17 at 20 μM was incubated with <b>6k</b> (150 μM), bestatin (150 μM), EDTA (2 mM), or buffer only (50 mM HEPES pH 8, 300 mM NaCl) at 4 °C overnight. Inhibitor concentrations were selected to ensure 100% saturation, and EDTA was used to completely remove metal cofactors (EDTA inhibition previously reported in ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). Protein samples were then washed with buffer (50 mM HEPES pH 8, 300 mM NaCl) by consecutive 10-fold concentration and dilution steps for up to 7 h. For analysis of activity, final washed <i>Pf</i>-M17 samples were incubated in assay buffer (1 mM MnCl<sub>2</sub>, 100 mM Tris pH 8.0) for 10 min prior to the addition of substrate (final concentration, 25 μM). Fluorescence was monitored for 30 min.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Structural Biology</h3><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Crystallization, Data Collection, and Refinement</h4><div class="NLM_p"><i>Pf</i>-M1 and <i>Pf</i>-M17 were cocrystallized with bound inhibitors by the hanging-drop method, using previously established protocols.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> For <i>Pf</i>-M1, purified protein was concentrated to 5.0 mg/mL and mixed with the appropriate compound (40 mM in 100% DMSO) to a final ligand concentration of 1 mM. Crystals grew in 20–30% poly(ethylene glycol) (PEG)8000, 0.1 M Tris pH 7.5–8.5, 0.2 M MgCl<sub>2</sub>, 10% glycerol, and, where necessary, were subjected to an additional overnight compound soak (mother liquor supplemented with 1 mM ligand) before being harvested for data collection. <i>Pf</i>-M17 was concentrated to 10 mg/mL and cocrystallized with a final ligand concentration of 1 mM in 30–40% PEG400, 0.1 M Tris pH 7.5–8.5, 0.2 M Li<sub>2</sub>SO<sub>4</sub>. Where appropriate, <i>Pf</i>-M17 crystals were soaked overnight in mother liquor supplemented with 1 mM ligand and 1 mM ZnSO<sub>4</sub> before being harvested for data collection.</div><div class="NLM_p last">Crystals were snap-frozen in liquid nitrogen, and data were collected 100k using synchrotron radiation at the Australian Synchrotron beamlines 3BM1<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and 3ID1. For <i>Pf</i>-M17, data were collected from two to three wedges of the same crystal, which were merged after integration. Data were processed using iMosflm<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> or XDS,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and Aimless<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> as part of the CCP4i program suite.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The structures were solved by molecular replacement in Phaser<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> using the structure of unliganded <i>Pf</i>-M1 (RCSB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EBG">3EBG</a>) or <i>Pf</i>-M17 (RCSB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KQZ">3KQZ</a>) as the search models. The structures were refined using Phenix,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> with 5% of reflections set aside for calculation of <i>R</i><sub>free</sub>. Between refinement cycles, the protein structure, solvent, and inhibitors were manually built into 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> and <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density maps using COOT,<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> with restraint files generated by Phenix where necessary. The coordinates and structure factors are available from the Protein Data Bank with PDB Accession codes <i>Pf</i>-M1: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA1">6EA1</a> (<b>6d</b>–<b>a</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA2">6EA2</a> (<b>6h</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAA">6EAA</a> (<b>6i</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAB">6EAB</a> (<b>6j</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE3">6EE3</a> (<b>6k</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE4">6EE4</a> (<b>6m</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE6">6EE6</a> (<b>6o</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EED">6EED</a> (<b>6p</b>) and <i>Pf</i>-M17: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE2">6EE2</a> (<b>6i</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EEE">6EEE</a> (<b>6k</b>).</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>P. falciparum</i> Growth Inhibition Assay<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></h3><div class="NLM_p">Compounds were dissolved in 100% DMSO to a final stock concentration of 10 mM. Stock solutions of reference drugs (chloroquine, artesunate, puromycin, pyronaridine, dihydroartemisinin, and pyrimethamine) were prepared at 2.5 mM (dihydroartemisinin and artesunate) or 10 mM (puromycin and pyrimethamine) in 100% DMSO. Chloroquine and pyronaridine were dissolved in water to 30 mM concentration and then 1:3 in 100% DMSO to 10 mM prior to performing serial dilutions. Puromycin (5 μM) and 0.4% DMSO were used as positive and negative controls, respectively. The compounds were tested in 16-point dose–response against the 3D7 and Dd2 strains of <i>P. falciparum</i> using three concentrations per log dose at a final concentration range of 40 μM to 0.4 nM. Stock solutions were serially diluted in 100% DMSO, before dilution 1:25 in water, then 1:10 in the final assay volume, to give a final assay top concentration of 40 μM. Reference compounds were tested using 21-point concentration-response range of 40 μM to 0.01 nM (puromycin, pyrimethamine, and chloroquine) or 10 μM to 0.003 nM (dihydroartemisinin and artesunate). The final DMSO concentration in the assay was 0.4% for all compounds except chloroquine and pyronaridine (for which it was in the range 0.27–0.40%). The experiment was performed in two biological replicates, each consisting of two technical repeats. Each biological replicate was carried out from independent compound handling processes.</div><div class="NLM_p last"><i>P. falciparum</i> parasites (3D7 and Dd2 strains) were grown in RPMI-1640 medium supplemented with 25 mM HEPES, 5% AB human male serum, 2.5 mg/mL Albumax II, and 0.37 mM hypoxanthine. Parasites were subjected to two rounds of sorbitol synchronization before undergoing compound treatment. Ring stage parasites were exposed to the compounds in 384-well imaging CellCarrier microplates (PerkinElmer), as previously described.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The plates were incubated for 72 h at 37 °C, 90% N<sub>2</sub>, 5% CO<sub>2</sub>, 5% O<sub>2</sub>, then the parasites were stained with 2-(4-amidinophenyl)-1<i>H</i>-indole-6-carboxamidine, and imaged using an Opera QEHS microplate confocal imaging system (PerkinElmer). Images were analyzed as previously described.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Briefly, raw data were normalized using the in-plate positive and negative controls to obtain normalized percent inhibition data, which were then used to calculate IC<sub>50</sub> values, through a four-parameter logistic curve fitting in Prism (GraphPad).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> HEK293 Cell Viability Assay</h3><div class="NLM_p last">Compounds were prepared for the HEK293 viability assay as described above. Human Embryonic Kidney cells (HEK293) were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum. HEK293 cells were exposed to the compounds in TC-treated 384-well plates (Greiner) for 72 h at 37 °C, 5% CO<sub>2</sub>, then the media was removed from the wells and replaced with an equal volume of 44 μM resazurin. After 5–6 h incubation under standard conditions, the total fluorescence (excitation/emission: 530/595 nm) was measured using an Envision plate reader (PerkinElmer).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01310" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01310" class="ext-link">10.1021/acs.jmedchem.8b01310</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Proposed mechanism of hemoglobin digestion and action of hydroxamate inhibitors in <i>Plasmodium</i> (Supp Figure 1); compound design schematic from substrate analogue to compound 1 (Supp Figure 2); binding mode of compound 1 to <i>Pf</i>-M1 and <i>Pf</i>-M17 (Supp Figure 3); binding of <b>6k</b> is reversible, but possesses a very low off-rate (Supp Figure 4); <i>Pf</i>-M1—<b>6d</b>–<b>a</b>, <b>6h</b>, <b>6i</b>, and <b>6j</b> data collection and refinement statistics (Supp Table 1); <i>Pf</i>-M1—<b>6k</b>, <b>6m</b>, <b>6o</b>, and <b>6p</b> data collection and refinement statistics (Supp Table 2); <i>Pf</i>-M17—<b>6i</b>, and <b>6k</b> data collection and refinement statistics (Supp Table 3); activity of <b>6l</b> against a panel of matrix metalloproteinases (Supp Table 4) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular-formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv">jm8b01310_si_001.csv (1.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_002.pdf">jm8b01310_si_002.pdf (1.39 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><i>Pf</i>-Mg1—<b>6d</b>–<b>a</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA1">6EA1</a>; <i>Pf</i>-M1—<b>6h</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA2">6EA2</a>; <i>Pf</i>-M1—<b>6i</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAA">6EAA</a>; <i>Pf</i>-M1—<b>6j</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAB">6EAB</a>; <i>Pf</i>-M1—<b>6k</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE3">6EE3</a>; <i>Pf</i>-M1—<b>6m</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE4">6EE4</a>; <i>Pf</i>-M1—<b>6o</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE6">6EE6</a>; <i>Pf</i>-M1—<b>6p</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EED">6EED</a>; <i>Pf</i>-M17—<b>6i</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE2">6EE2</a>; <i>Pf</i>-M17—<b>6k</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EEE">6EEE</a></p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01310" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Scammells</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Melbourne, VIC 3052, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2930-895X" title="Orcid link">http://orcid.org/0000-0003-2930-895X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7222170617005c2111131f1f171e1e01321f1d1c13011a5c171607"><span class="__cf_email__" data-cfemail="f1a194859483dfa292909c9c949d9d82b19c9e9f908299df949584">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheena McGowan</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Melbourne, VIC 3800, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6863-1106" title="Orcid link">http://orcid.org/0000-0001-6863-1106</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e8bb808d8d8689c6a58baf879f8986a8858786899b80c68d8c9d"><span class="__cf_email__" data-cfemail="e7b48f82828986c9aa84a088908689a78a888986948fc9828392">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalie
B. Vinh</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Melbourne, VIC 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nyssa Drinkwater</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Melbourne, VIC 3800, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tess R. Malcolm</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Melbourne, VIC 3800, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Kassiou</span> - <span class="hlFld-Affiliation affiliation">School of Chemistry, University
of Sydney, Sydney, NSW 2006, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6655-0529" title="Orcid link">http://orcid.org/0000-0002-6655-0529</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonardo Lucantoni</span> - <span class="hlFld-Affiliation affiliation">Discovery
Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter M. Grin</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry &
Molecular Biology and , Centre for Blood Research, University
of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georgina S. Butler</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry &
Molecular Biology, 
    Department of Oral Biological and Medical
Sciences, 
     and , Centre for Blood Research, University
of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Duffy</span> - <span class="hlFld-Affiliation affiliation">Discovery
Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. Overall</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry &
Molecular Biology, 
    Department of Oral Biological and Medical
Sciences, 
     and , Centre for Blood Research, University
of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5844-2731" title="Orcid link">http://orcid.org/0000-0001-5844-2731</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicky M. Avery</span> - <span class="hlFld-Affiliation affiliation">Discovery
Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.B.V. and N.D. contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors, and all authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e7486-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge the National Health and Medical Research Council (Project Grant 1063786 to S.M. and P.J.S.). C.M.O. holds a Canada Research Chair in Protease Proteomics and Systems Biology, and the work was supported by a Canadian Institutes of Health Research grant (MOP-37937) to C.M.O., by the British Columbia Proteomics Network (C.M.O.) and the Canada Foundation for Innovation (C.M.O). The authors thank Dr. Siew Chai and Peta Burns from Monash University for the kind gift of human insulin-regulated aminopeptidase (IRAP), and Prof. James Rini from the University of Toronto for the stably transfected HEK293S GnT1<sup>–</sup> cell line. The Australian Red Cross Blood Service is gratefully acknowledged for the provision of human blood for in vitro cultivation of <i>P. falciparum</i> lines.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term"><i>Pf</i>-M1</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> M1 aminopeptidase</p></td></tr><tr><td class="NLM_term"><i>Pf</i>-M17</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> M17 aminopeptidase</p></td></tr><tr><td class="NLM_term"><i>Pv</i>-M1</td><td class="NLM_def"><p class="first last"><i>P. vivax</i> M1 aminopeptidase</p></td></tr><tr><td class="NLM_term"><i>Pv</i>-M17</td><td class="NLM_def"><p class="first last"><i>P. vivax</i> M17 aminopeptidase</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">APN</td><td class="NLM_def"><p class="first last">aminopeptidase N</p></td></tr><tr><td class="NLM_term">IRAP</td><td class="NLM_def"><p class="first last">insulin-regulated aminopeptidase</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report</i>; CC BY-NC-SA 3.0 IGO; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva,
Switzerland</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Malaria%2520Report%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjitra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstey, N. M.</span></span> <span> </span><span class="NLM_article-title">Vivax malaria: Neglected and not benign</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.2007.77.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.4269%2Fajtmh.2007.77.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2007&pages=79-87&author=R.+N.+Priceauthor=E.+Tjitraauthor=C.+A.+Guerraauthor=S.+Yeungauthor=N.+J.+Whiteauthor=N.+M.+Anstey&title=Vivax+malaria%3A+Neglected+and+not+benign&doi=10.4269%2Fajtmh.2007.77.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.2007.77.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.2007.77.79%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DTjitra%26aufirst%3DE.%26aulast%3DGuerra%26aufirst%3DC.%2BA.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DAnstey%26aufirst%3DN.%2BM.%26atitle%3DVivax%2520malaria%253A%2520Neglected%2520and%2520not%2520benign%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2007%26volume%3D77%26spage%3D79%26epage%3D87%26doi%3D10.4269%2Fajtmh.2007.77.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdell, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muwanguzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Schalkwyk, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gkrania-Klotsas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiodini, P.</span></span> <span> </span><span class="NLM_article-title">pfk13-Independent treatment failure in four imported cases of <i>Plasmodium falciparum</i> malaria treated with artemether-lumefantrine in the united kingdom</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e02382</span> <span class="refDoi"> DOI: 10.1128/AAC.02382-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1128%2FAAC.02382-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=C.+J.+Sutherlandauthor=P.+L.+Lansdellauthor=M.+Sandersauthor=J.+Muwanguziauthor=D.+A.+van+Schalkwykauthor=H.+Kaurauthor=D.+Nolderauthor=J.+Tuckerauthor=H.+M.+Bennettauthor=T.+D.+Ottoauthor=M.+Berrimanauthor=T.+A.+Patelauthor=R.+Lynnauthor=E.+Gkrania-Klotsasauthor=P.+Chiodini&title=pfk13-Independent+treatment+failure+in+four+imported+cases+of+Plasmodium+falciparum+malaria+treated+with+artemether-lumefantrine+in+the+united+kingdom&doi=10.1128%2FAAC.02382-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FAAC.02382-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02382-16%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DC.%2BJ.%26aulast%3DLansdell%26aufirst%3DP.%2BL.%26aulast%3DSanders%26aufirst%3DM.%26aulast%3DMuwanguzi%26aufirst%3DJ.%26aulast%3Dvan%2BSchalkwyk%26aufirst%3DD.%2BA.%26aulast%3DKaur%26aufirst%3DH.%26aulast%3DNolder%26aufirst%3DD.%26aulast%3DTucker%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DH.%2BM.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DT.%2BA.%26aulast%3DLynn%26aufirst%3DR.%26aulast%3DGkrania-Klotsas%26aufirst%3DE.%26aulast%3DChiodini%26aufirst%3DP.%26atitle%3Dpfk13-Independent%2520treatment%2520failure%2520in%2520four%2520imported%2520cases%2520of%2520Plasmodium%2520falciparum%2520malaria%2520treated%2520with%2520artemether-lumefantrine%2520in%2520the%2520united%2520kingdom%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2FAAC.02382-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sovannaroth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jittamala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chutasmit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchatsoonthorn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runcharoen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Nhien, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Htut, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aye, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokuolu, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaosebikan, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folaranmi, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayxay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanthavong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongvanthong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyamboko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanello, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshefu, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valecha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashraheil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peshu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacInnis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeeyapant, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakulthaew, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intharabut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihokhern, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunasol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrow, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flegg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowe, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepniewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Spread of artemisinin resistance in <i>Plasmodium falciparum</i> malaria</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1314981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1056%2FNEJMoa1314981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25075834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=411-423&author=E.+A.+Ashleyauthor=M.+Dhordaauthor=R.+M.+Fairhurstauthor=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=J.+M.+Andersonauthor=S.+Maoauthor=B.+Samauthor=C.+Sophaauthor=C.+M.+Chuorauthor=C.+Nguonauthor=S.+Sovannarothauthor=S.+Pukrittayakameeauthor=P.+Jittamalaauthor=K.+Chotivanichauthor=K.+Chutasmitauthor=C.+Suchatsoonthornauthor=R.+Runcharoenauthor=T.+T.+Hienauthor=N.+T.+Thuy-Nhienauthor=N.+V.+Thanhauthor=N.+H.+Phuauthor=Y.+Htutauthor=K.+T.+Hanauthor=K.+H.+Ayeauthor=O.+A.+Mokuoluauthor=R.+R.+Olaosebikanauthor=O.+O.+Folaranmiauthor=M.+Mayxayauthor=M.+Khanthavongauthor=B.+Hongvanthongauthor=P.+N.+Newtonauthor=M.+A.+Onyambokoauthor=C.+I.+Fanelloauthor=A.+K.+Tshefuauthor=N.+Mishraauthor=N.+Valechaauthor=A.+P.+Phyoauthor=F.+Nostenauthor=P.+Yiauthor=R.+Tripuraauthor=S.+Borrmannauthor=M.+Bashraheilauthor=J.+Peshuauthor=M.+A.+Faizauthor=A.+Ghoseauthor=M.+A.+Hossainauthor=R.+Samadauthor=M.+R.+Rahmanauthor=M.+M.+Hasanauthor=A.+Islamauthor=O.+Miottoauthor=R.+Amatoauthor=B.+MacInnisauthor=J.+Stalkerauthor=D.+P.+Kwiatkowskiauthor=Z.+Bozdechauthor=A.+Jeeyapantauthor=P.+Y.+Cheahauthor=T.+Sakulthaewauthor=J.+Chalkauthor=B.+Intharabutauthor=K.+Silamutauthor=S.+J.+Leeauthor=B.+Vihokhernauthor=C.+Kunasolauthor=M.+Imwongauthor=J.+Tarningauthor=W.+J.+Taylorauthor=S.+Yeungauthor=C.+J.+Woodrowauthor=J.+A.+Fleggauthor=D.+Dasauthor=J.+Smithauthor=M.+Venkatesanauthor=C.+V.+Ploweauthor=K.+Stepniewskaauthor=P.+J.+Guerinauthor=A.+M.+Dondorpauthor=N.+P.+Dayauthor=N.+J.+White&title=Spread+of+artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa1314981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Spread of artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Ashley, E. A.; Dhorda, M.; Fairhurst, R. M.; Amaratunga, C.; Lim, P.; Suon, S.; Sreng, S.; Anderson, J. M.; Mao, S.; Sam, B.; Sopha, C.; Chuor, C. M.; Nguon, C.; Sovannaroth, S.; Pukrittayakamee, S.; Jittamala, P.; Chotivanich, K.; Chutasmit, K.; Suchatsoonthorn, C.; Runcharoen, R.; Hien, T. T.; Thuy-Nhien, N. T.; Thanh, N. V.; Phu, N. H.; Htut, Y.; Han, K.-T.; Aye, K. H.; Mokuolu, O. A.; Olaosebikan, R. R.; Folaranmi, O. O.; Mayxay, M.; Khanthavong, M.; Hongvanthong, B.; Newton, P. N.; Onyamboko, M. A.; Fanello, C. I.; Tshefu, A. K.; Mishra, N.; Valecha, N.; Phyo, A. P.; Nosten, F.; Yi, P.; Tripura, R.; Borrmann, S.; Bashraheil, M.; Peshu, J.; Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.; Hasan, M. M.; Islam, A.; Miotto, O.; Amato, R.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.; Bozdech, Z.; Jeeyapant, A.; Cheah, P. Y.; Sakulthaew, T.; Chalk, J.; Intharabut, B.; Silamut, K.; Lee, S. J.; Vihokhern, B.; Kunasol, C.; Imwong, M.; Tarning, J.; Taylor, W. J.; Yeung, S.; Woodrow, C. J.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Plowe, C. V.; Stepniewska, K.; Guerin, P. J.; Dondorp, A. M.; Day, N. P.; White, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-423, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria.  Mapping the geog. extent of resistance is essential for planning containment and elimination strategies.  Methods: Between May 2011 and Apr. 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa).  Patients received artesunate, administered orally at a daily dose of either 2 mg per kg of body wt. per day or 4 mg per kg, for 3 days, followed by a std. 3-day course of artemisinin-based combination therapy.  Parasite counts in peripheral-blood samples were measured every 6 h, and the parasite clearance half-lives were detd.  Results: The median parasite clearance half-lives ranged from 1.9 h in the Democratic Republic of Congo to 7.0 h at the Thailand-Cambodia border.  Slowly clearing infections (parasite clearance half-life >5 h), strongly assocd. with single point mutations in the "propeller" region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from Southern Vietnam to central Myanmar.  The incidence of pre-treatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.  In Western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was assocd. with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days.  Conclusions: Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is assocd. with mutations in kelch13.  Prolonged courses of artemisinin- based combination therapies are currently efficacious in areas where std. 3-day treatments are failing. (Funded by the U.K. Department of International Development and others).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aJ4A3O4W8rVg90H21EOLACvtfcHk0lh-K_FbSIL1xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF&md5=bb2f2a4d554ba6a1f4c605868be43f6e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1314981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1314981%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DNguon%26aufirst%3DC.%26aulast%3DSovannaroth%26aufirst%3DS.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DChutasmit%26aufirst%3DK.%26aulast%3DSuchatsoonthorn%26aufirst%3DC.%26aulast%3DRuncharoen%26aufirst%3DR.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DThuy-Nhien%26aufirst%3DN.%2BT.%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DPhu%26aufirst%3DN.%2BH.%26aulast%3DHtut%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DK.%2BT.%26aulast%3DAye%26aufirst%3DK.%2BH.%26aulast%3DMokuolu%26aufirst%3DO.%2BA.%26aulast%3DOlaosebikan%26aufirst%3DR.%2BR.%26aulast%3DFolaranmi%26aufirst%3DO.%2BO.%26aulast%3DMayxay%26aufirst%3DM.%26aulast%3DKhanthavong%26aufirst%3DM.%26aulast%3DHongvanthong%26aufirst%3DB.%26aulast%3DNewton%26aufirst%3DP.%2BN.%26aulast%3DOnyamboko%26aufirst%3DM.%2BA.%26aulast%3DFanello%26aufirst%3DC.%2BI.%26aulast%3DTshefu%26aufirst%3DA.%2BK.%26aulast%3DMishra%26aufirst%3DN.%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DTripura%26aufirst%3DR.%26aulast%3DBorrmann%26aufirst%3DS.%26aulast%3DBashraheil%26aufirst%3DM.%26aulast%3DPeshu%26aufirst%3DJ.%26aulast%3DFaiz%26aufirst%3DM.%2BA.%26aulast%3DGhose%26aufirst%3DA.%26aulast%3DHossain%26aufirst%3DM.%2BA.%26aulast%3DSamad%26aufirst%3DR.%26aulast%3DRahman%26aufirst%3DM.%2BR.%26aulast%3DHasan%26aufirst%3DM.%2BM.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DMacInnis%26aufirst%3DB.%26aulast%3DStalker%26aufirst%3DJ.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DJeeyapant%26aufirst%3DA.%26aulast%3DCheah%26aufirst%3DP.%2BY.%26aulast%3DSakulthaew%26aufirst%3DT.%26aulast%3DChalk%26aufirst%3DJ.%26aulast%3DIntharabut%26aufirst%3DB.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DVihokhern%26aufirst%3DB.%26aulast%3DKunasol%26aufirst%3DC.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DW.%2BJ.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWoodrow%26aufirst%3DC.%2BJ.%26aulast%3DFlegg%26aufirst%3DJ.%2BA.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DM.%26aulast%3DPlowe%26aufirst%3DC.%2BV.%26aulast%3DStepniewska%26aufirst%3DK.%26aulast%3DGuerin%26aufirst%3DP.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DSpread%2520of%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D411%26epage%3D423%26doi%3D10.1056%2FNEJMoa1314981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istvan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluzman, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8840</span>– <span class="NLM_lpage">8845</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601876103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.0601876103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=16731623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVChsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=8840-8845&author=J.+Liuauthor=E.+S.+Istvanauthor=I.+Y.+Gluzmanauthor=J.+Grossauthor=D.+E.+Goldberg&title=Plasmodium+falciparum+ensures+its+amino+acid+supply+with+multiple+acquisition+pathways+and+redundant+proteolytic+enzyme+systems&doi=10.1073%2Fpnas.0601876103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems</span></div><div class="casAuthors">Liu, Jun; Istvan, Eva S.; Gluzman, Ilya Y.; Gross, Julia; Goldberg, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8840-8845</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Degrdn. of host Hb by the human malaria parasite Plasmodium falciparum is a massive metabolic process.  What role this degrdn. plays and whether it is essential for parasite survival have not been established, nor have the roles of the various degradative enzymes been clearly defined.  The authors report that P. falciparum can grow in medium contg. a single amino acid (isoleucine, the only amino acid missing from human Hb).  In this medium, growth of Hb-degrading enzyme gene knockout lines (missing falcipain-2 and plasmepsins alone or in combination) is impaired.  Blockade of plasmepsins with the potent inhibitor pepstatin A has a minimal effect on WT parasite growth but kills falcipain-2 knockout parasites at low concns. and is even more potent on falcipain-2, plasmepsin I and IV triple knockout parasites.  It is concluded that: (i) Hb degrdn. is necessary for parasite survival; (ii) Hb degrdn. is sufficient to supply most of the parasite's amino acid requirements; (iii) external amino acid acquisition and Hb digestion are partially redundant nutrient pathways; (iv) Hb degrdn. uses dual protease families with overlapping function; and (v) Hb-degrading plasmepsins are not promising drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlSCICNnyrZLVg90H21EOLACvtfcHk0lhz2q4f2RCqJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVChsrk%253D&md5=d97f115a4b219c4c88f9f781b28b52d5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601876103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601876103%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DIstvan%26aufirst%3DE.%2BS.%26aulast%3DGluzman%26aufirst%3DI.%2BY.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26atitle%3DPlasmodium%2520falciparum%2520ensures%2520its%2520amino%2520acid%2520supply%2520with%2520multiple%2520acquisition%2520pathways%2520and%2520redundant%2520proteolytic%2520enzyme%2520systems%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D8840%26epage%3D8845%26doi%3D10.1073%2Fpnas.0601876103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1042/bj3390363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1042%2Fbj3390363" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1999&pages=363-370&author=P.+Loriaauthor=S.+Millerauthor=M.+Foleyauthor=L.+Tilley&title=Inhibition+of+the+peroxidative+degradation+of+haem+as+the+basis+of+action+of+chloroquine+and+other+quinoline+antimalarials&doi=10.1042%2Fbj3390363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbj3390363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3390363%26sid%3Dliteratum%253Aachs%26aulast%3DLoria%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DFoley%26aufirst%3DM.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520the%2520peroxidative%2520degradation%2520of%2520haem%2520as%2520the%2520basis%2520of%2520action%2520of%2520chloroquine%2520and%2520other%2520quinoline%2520antimalarials%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D339%26spage%3D363%26epage%3D370%26doi%3D10.1042%2Fbj3390363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbut, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velmourougane, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onder, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span> <span> </span><span class="NLM_article-title">Bestatin-based chemical biology strategy reveals distinct roles for malaria M1-and M17-family aminopeptidases</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">E526</span>– <span class="NLM_lpage">E534</span>, <span class="refDoi"> DOI: 10.1073/pnas.1105601108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.1105601108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E526-E534&author=M.+B.+Harbutauthor=G.+Velmourouganeauthor=S.+Dalalauthor=G.+Reissauthor=J.+C.+Whisstockauthor=O.+Onderauthor=D.+Brissonauthor=S.+McGowanauthor=M.+Klembaauthor=D.+C.+Greenbaum&title=Bestatin-based+chemical+biology+strategy+reveals+distinct+roles+for+malaria+M1-and+M17-family+aminopeptidases&doi=10.1073%2Fpnas.1105601108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1105601108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1105601108%26sid%3Dliteratum%253Aachs%26aulast%3DHarbut%26aufirst%3DM.%2BB.%26aulast%3DVelmourougane%26aufirst%3DG.%26aulast%3DDalal%26aufirst%3DS.%26aulast%3DReiss%26aufirst%3DG.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DOnder%26aufirst%3DO.%26aulast%3DBrisson%26aufirst%3DD.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DKlemba%26aufirst%3DM.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26atitle%3DBestatin-based%2520chemical%2520biology%2520strategy%2520reveals%2520distinct%2520roles%2520for%2520malaria%2520M1-and%2520M17-family%2520aminopeptidases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3DE526%26epage%3DE534%26doi%3D10.1073%2Fpnas.1105601108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Working in concert: The metalloaminopeptidases from <i>Plasdmodium falciparum</i></span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1016/j.sbi.2013.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.sbi.2013.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=23948130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Klur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=828-835&author=S.+McGowan&title=Working+in+concert%3A+The+metalloaminopeptidases+from+Plasdmodium+falciparum&doi=10.1016%2Fj.sbi.2013.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Working in concert: the metalloaminopeptidases from Plasmodium falciparum</span></div><div class="casAuthors">McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria remains the world's most prevalent human parasitic disease.  Because of the rapid spread of drug resistance in parasites, there is an urgent need to identify diverse new drug targets.  One group of proteases that are emerging as targets for novel antimalarials are the metalloaminopeptidases.  These enzymes catalyze the removal of the N-terminal amino acids from proteins and peptides.  Given the restricted specificities of each of these enzymes for different N-terminal amino acids, it is thought that they act in concert to facilitate protein turnover.  Here we review recent structure and functional data relating to the development of the Plasmodium falciparum metalloaminopeptidases as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsJoUmCMyXorVg90H21EOLACvtfcHk0ljItbD7JEnGiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Klur%252FM&md5=2730eb149ef16f20d95fdfed21a49fd1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2013.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2013.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DWorking%2520in%2520concert%253A%2520The%2520metalloaminopeptidases%2520from%2520Plasdmodium%2520falciparum%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D23%26spage%3D828%26epage%3D835%26doi%3D10.1016%2Fj.sbi.2013.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemba, M.</span></span> <span> </span><span class="NLM_article-title">Roles for two aminopeptidases in vacuolar hemoglobin catabolism in <i>Plasmodium falciparum</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">35978</span>– <span class="NLM_lpage">35987</span>, <span class="refDoi"> DOI: 10.1074/jbc.M703643200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1074%2Fjbc.M703643200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=17895246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKrsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=35978-35987&author=S.+Dalalauthor=M.+Klemba&title=Roles+for+two+aminopeptidases+in+vacuolar+hemoglobin+catabolism+in+Plasmodium+falciparum&doi=10.1074%2Fjbc.M703643200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum</span></div><div class="casAuthors">Dalal, Seema; Klemba, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">35978-35987</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">During the erythrocytic stage of its life cycle, the human malaria parasite P. falciparum catabolizes large quantities of host-cell Hb in an acidic organelle, the food vacuole.  A current model for the catabolism of globin-derived oligopeptides invokes peptide transport out of the food vacuole followed by hydrolysis to amino acids by cytosolic aminopeptidases.  To test this model, we have examd. the roles of 4 parasite aminopeptidases during the erythrocytic cycle.  Localization of tagged aminopeptidases, coupled with biochem. anal. of enriched food vacuoles, revealed the presence of amino acid-generating pathways in the food vacuole as well as the cytosol.  Based on the localization data and in vitro assays, we propose a specific role for 1 of the plasmodial enzymes, aminopeptidase P, in the catabolism of proline-contg. peptides in both the vacuole and the cytosol.  We establish an apparent requirement for 3 of the 4 aminopeptidases (including the 2 food vacuole enzymes) for efficient parasite proliferation.  To gain insight into the impact of aminopeptidase inhibition on parasite development, we examd. the effect of the presence of amino acids in the culture medium of the parasite on the toxicity of the aminopeptidase inhibitor bestatin.  The ability of bestatin to block parasite replication was only slightly affected when 19 of 20 amino acids were withdrawn from the medium, indicating that exogenous amino acids cannot compensate for the loss of aminopeptidase activity.  Together, these results support the development of aminopeptidase inhibitors as novel chemotherapeutics directed against malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS44RDNvaul7Vg90H21EOLACvtfcHk0liA3TT4L5mRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKrsbvN&md5=fdd8ca959749a9f2e51d74511ecf41bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M703643200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M703643200%26sid%3Dliteratum%253Aachs%26aulast%3DDalal%26aufirst%3DS.%26aulast%3DKlemba%26aufirst%3DM.%26atitle%3DRoles%2520for%2520two%2520aminopeptidases%2520in%2520vacuolar%2520hemoglobin%2520catabolism%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D35978%26epage%3D35987%26doi%3D10.1074%2Fjbc.M703643200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span> <span> </span><span class="NLM_article-title">Identification of phosphinate dipeptide analog inhibitors directed against the <i>Plasmodium falciparum</i> M17 leucine aminopeptidase as lead antimalarial compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6024</span>– <span class="NLM_lpage">6031</span>, <span class="refDoi"> DOI: 10.1021/jm070733v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070733v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1WmtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6024-6031&author=T.+S.+Skinner-Adamsauthor=J.+Lowtherauthor=F.+Teuscherauthor=C.+M.+Stackauthor=J.+Grembeckaauthor=A.+Muchaauthor=P.+Kafarskiauthor=K.+R.+Trenholmeauthor=J.+P.+Daltonauthor=D.+L.+Gardiner&title=Identification+of+phosphinate+dipeptide+analog+inhibitors+directed+against+the+Plasmodium+falciparum+M17+leucine+aminopeptidase+as+lead+antimalarial+compounds&doi=10.1021%2Fjm070733v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Phosphinate Dipeptide Analog Inhibitors Directed against the Plasmodium falciparum M17 Leucine Aminopeptidase as Lead Antimalarial Compounds</span></div><div class="casAuthors">Skinner-Adams, Tina S.; Lowther, Jonathan; Teuscher, Franka; Stack, Colin M.; Grembecka, Jolanta; Mucha, Artur; Kafarski, Pawel; Trenholme, Katharine R.; Dalton, John P.; Gardiner, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6024-6031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previous studies have pinpointed the M17 leucyl aminopeptidase of Plasmodium falciparum (PfLAP) as a target for the development of new antimalarials.  This metallo-exopeptidase functions in the terminal stages of Hb digestion and is inhibited by bestatin, a natural analog of Phe-Leu.  By screening novel phosphinate dipeptide analogs for inhibitory activity against recombinant PfLAP, the authors have discovered two compds., 4 (hPheP[CH2]Phe) and 5 (hPheP[CH2]Tyr), with inhibitory consts. better than bestatin.  These compds. are fast, tight-binding inhibitors that make improved contacts within the active site of PfLAP.  Both compds. inhibit the growth of P. falciparum in vitro, exhibiting IC50 values against the chloroquine-resistant clone Dd2 of 20-40 and 12-23 μM, resp.  While bestatin exhibited some in vivo activity against Plasmodium chabaudi chabaudi, compd. 4 reduced parasite burden by 92%.  These studies establish the PfLAP as a prime target for the development of antimalarial drugs and provide important new lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryDK8YFccd3rVg90H21EOLACvtfcHk0liA3TT4L5mRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1WmtLzL&md5=ceed62d0395c7fc729c6071a26688282</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm070733v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070733v%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DTeuscher%26aufirst%3DF.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520phosphinate%2520dipeptide%2520analog%2520inhibitors%2520directed%2520against%2520the%2520Plasmodium%2520falciparum%2520M17%2520leucine%2520aminopeptidase%2520as%2520lead%2520antimalarial%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6024%26epage%3D6031%26doi%3D10.1021%2Fjm070733v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peatey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krige, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nsangou, D. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thivierge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardinerd, D. L.</span></span> <span> </span><span class="NLM_article-title">The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3244</span>– <span class="NLM_lpage">3249</span>, <span class="refDoi"> DOI: 10.1128/AAC.06245-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1128%2FAAC.06245-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22450967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslWrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3244-3249&author=T.+S.+Skinner-Adamsauthor=C.+L.+Peateyauthor=K.+Andersonauthor=K.+R.+Trenholmeauthor=D.+Krigeauthor=C.+L.+Brownauthor=C.+Stackauthor=D.+M.+M.+Nsangouauthor=R.+T.+Mathewsauthor=K.+Thiviergeauthor=J.+P.+Daltonauthor=D.+L.+Gardinerd&title=The+aminopeptidase+inhibitor+CHR-2863+is+an+orally+bioavailable+inhibitor+of+murine+malaria&doi=10.1128%2FAAC.06245-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria</span></div><div class="casAuthors">Skinner-Adams, Tina S.; Peatey, Christopher L.; Anderson, Karen; Trenholme, Katharine R.; Krige, David; Brown, Christopher L.; Stack, Colin; Nsangou, Desire M. M.; Mathews, Rency T.; Thivierge, Karine; Dalton, John P.; Gardiner, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3244-3249</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Malaria remains a significant risk in many areas of the world, with resistance to the current antimalarial pharmacopeia an ever-increasing problem.  The M1 alanine aminopeptidase (PfM1AAP) and M17 leucine aminopeptidase (PfM17LAP) are believed to play a role in the terminal stages of digestion of host Hb and thereby generate a pool of free amino acids that are essential for parasite growth and development.  Here, we show that an orally bioavailable aminopeptidase inhibitor, CHR-2863, is efficacious against murine malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX3MLziI05o7Vg90H21EOLACvtfcHk0liUqHVBu8v29A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslWrtbs%253D&md5=2bd3240c1ec39ef630f727573c4f32eb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.06245-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06245-11%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DPeatey%26aufirst%3DC.%2BL.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DKrige%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DC.%2BL.%26aulast%3DStack%26aufirst%3DC.%26aulast%3DNsangou%26aufirst%3DD.%2BM.%2BM.%26aulast%3DMathews%26aufirst%3DR.%2BT.%26aulast%3DThivierge%26aufirst%3DK.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DGardinerd%26aufirst%3DD.%2BL.%26atitle%3DThe%2520aminopeptidase%2520inhibitor%2520CHR-2863%2520is%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520murine%2520malaria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3244%26epage%3D3249%26doi%3D10.1128%2FAAC.06245-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bounaadja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouray, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarnus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florent, I.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">382</span> <span class="refDoi"> DOI: 10.1186/s12936-017-2032-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1186%2Fs12936-017-2032-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=28934959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFegt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&author=L.+Bounaadjaauthor=M.+Schmittauthor=S.+Albrechtauthor=E.+Mourayauthor=C.+Tarnusauthor=I.+Florent&title=Selective+inhibition+of+PfA-M1%2C+over+PfA-M17%2C+by+an+amino-benzosuberone+derivative+blocks+malaria+parasites+development+in+vitro+and+in+vivo&doi=10.1186%2Fs12936-017-2032-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo</span></div><div class="casAuthors">Bounaadja, Lotfi; Schmitt, Marjorie; Albrecht, Sebastien; Mouray, Elisabeth; Tarnus, Celine; Florent, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">382/1-382/13</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background:Plasmodium falciparum M1 family aminopeptidase is currently considered as a promising target for anti-malarial chemotherapy.  Several series of inhibitors developed by various research groups display IC50/Ki values down to nM range on native PfA-M1 or recombinant forms and block the parasite development in culture at [um]M to sub-[um]M concns.  A handful of these inhibitors has been tested on murine models of malaria and has shown anti plasmodial in vivo activity.  However, most of these inhibitors do also target the other neutral malarial aminopeptidase, PfA-M17, often with lower Ki values, which questions the relative involvement and importance of each enzyme in the parasite biol.  Results: An amino-benzosuberone deriv. from a previously published collection of chems. targeting specifically the M1-aminopeptidases has been identified; it is highly potent on PfA-M1 (Ki = 50 nM) and devoid of inhibitory activity on PfA-M17 (no inhibition up to 100 [um]M).  This amino-benzosuberone deriv. (T5) inhibits, in the [um]M range, the in vitro growth of two P. falciparum strains, 3D7 and FcB1, resp. chloroquino-sensitive and resistant.  Evaluated in vivo, on the murine non-lethal model of malaria Plasmodium chabaudi chabaudi, this amino-benzosuberone deriv. was able to reduce the parasite burden by 44 and 40% in a typical 4-day Peters assay at a daily dose of 12 and 24 mg/kg by i.p. route of administration.  Conclusions: The evaluation of a highly selective inhibitor of PfA-M1, over PfA-M17, active on Plasmodium parasites in vitro and in vivo, highlights the relevance of PfA-M1 in the biol. development of the parasite as well as in the list of promising anti-malarial targets to be considered in combination with current or future anti-malarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrPhTiYVZNfLVg90H21EOLACvtfcHk0liUqHVBu8v29A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFegt7zI&md5=d67b7ef6e4f9cce311d4a3bd3341d66d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs12936-017-2032-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-017-2032-4%26sid%3Dliteratum%253Aachs%26aulast%3DBounaadja%26aufirst%3DL.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DMouray%26aufirst%3DE.%26aulast%3DTarnus%26aufirst%3DC.%26aulast%3DFlorent%26aufirst%3DI.%26atitle%3DSelective%2520inhibition%2520of%2520PfA-M1%252C%2520over%2520PfA-M17%252C%2520by%2520an%2520amino-benzosuberone%2520derivative%2520blocks%2520malaria%2520parasites%2520development%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26doi%3D10.1186%2Fs12936-017-2032-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anvikar, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahi, S.</span></span> <span> </span><span class="NLM_article-title">Screening and in vitro evaluation of potential <i>Plasmodium falciparum</i> leucyl aminopeptidase inhibitors</span>. <i>Curr. Comput.-Aided Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.2174/1573409912666160722111053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.2174%2F1573409912666160722111053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=27449897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=282-293&author=M.+Chaudharyauthor=V.+Singhauthor=A.+R.+Anvikarauthor=S.+Sahi&title=Screening+and+in+vitro+evaluation+of+potential+Plasmodium+falciparum+leucyl+aminopeptidase+inhibitors&doi=10.2174%2F1573409912666160722111053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors</span></div><div class="casAuthors">Chaudhary, Meenakshi; Singh, Vineeta; Anvikar, Anup R.; Sahi, Shakti</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">282-293</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Plasmodium falciparum leucyl aminopeptidase (PfA-M17) regulates the intracellular pool of amino acids required for the growth and development of parasites.  Thus, PfA-M17 is a promising target for anti-malarial drug development.  Method: In the present study, structure-based drug design was used to identify novel PfA-M17 inhibitors, which were subsequently validated by in vitro PfA-M17 and human LAP3 enzyme inhibition assay.  A library of 3,147,882 compds. was screened using receptor-based virtual screening against the active site of PfA-M17, and three levels of accuracy were used: high-throughput virtual screening, gridbased ligand docking with energetics (Glide std. precision) and Glide extra precision.  Results: Seventeen screened compds. were selected and tested in the rPfA-M17 enzyme inhibition assay.  Of these nine compds. were found to be effective inhibitors.  To test the target activity, all nine PfA-M17 inhibitors were tested against rhLAP3, the human homolog of PfA-M17.  One compd. (compd. 2) was found to be moderately effective against PfA-M17 (Ki = 287 M) with limited inhibitory activity against hLAP3 (Ki of 4,464 M).  Subsequently, induced fit docking and pharmacophore modeling were used to further understand more precise ligand-protein interactions in the protein-inhibitor complexes.  Conclusion: Among the 9 effective PfA-M17 inhibitors, 5 compds. were found effective in the P. falciparum schizont maturation inhibition (SMI) assay.  A good correlation (r =0.83) was obsd. between the rPfA-M17 enzyme inhibition concn. and SMI assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLtqAaJGA_YbVg90H21EOLACvtfcHk0lik7Q-AQFV-TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7zK&md5=9b6c76b8498ce291bce8ea3586a646e6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1573409912666160722111053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573409912666160722111053%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DAnvikar%26aufirst%3DA.%2BR.%26aulast%3DSahi%26aufirst%3DS.%26atitle%3DScreening%2520and%2520in%2520vitro%2520evaluation%2520of%2520potential%2520Plasmodium%2520falciparum%2520leucyl%2520aminopeptidase%2520inhibitors%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2016%26volume%3D12%26spage%3D282%26epage%3D293%26doi%3D10.2174%2F1573409912666160722111053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deprez-Poulain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flipo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piveteau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dassonneville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florent, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10909</span>– <span class="NLM_lpage">10917</span>, <span class="refDoi"> DOI: 10.1021/jm301506h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301506h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10909-10917&author=R.+Deprez-Poulainauthor=M.+Flipoauthor=C.+Piveteauauthor=F.+Lerouxauthor=S.+Dassonnevilleauthor=I.+Florentauthor=L.+Maesauthor=P.+Cosauthor=B.+Deprez&title=Structure-activity+relationships+and+blood+distribution+of+antiplasmodial+aminopeptidase-1+inhibitors&doi=10.1021%2Fjm301506h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors</span></div><div class="casAuthors">Deprez-Poulain, Rebecca; Flipo, Marion; Piveteau, Catherine; Leroux, Florence; Dassonneville, Sandrine; Florent, Isabelle; Maes, Louis; Cos, Paul; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10909-10917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria is a severe infectious disease that causes between 655 000 and 1.2 million deaths annually.  To overcome the resistance to current drugs, new biol. targets are needed for drug development.  Aminopeptidase M1 (PfAM1), a zinc metalloprotease, has been proposed as a new drug target to fight malaria.  Herein, we disclosed the structure-activity relationships of a selective family of hydroxamate PfAM1 inhibitors based on the malonic template.  In particular, we performed a fluoro-scanning around hit 1 that enlightened the key positions of the halogen for activity.  The docking of the best inhibitor 2 is consistent with in vitro results.  The stability of 2 was evaluated in microsomes, in plasma, and toward glutathione.  The in vivo distribution study performed with the nanomolar hydroxamate inhibitor BDM14471 revealed that it reaches its site of action.  However, it fails to kill the parasite at concns. relevant to the enzymic inhibitory potency, suggesting that killing the parasite remains a challenge for potent and drug-like catalytic-site binding PfAM1 inhibitors.  In all, this study provides important insights for the design of inhibitors of PfAM1 and the validity of this target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy63Ha4C-69LVg90H21EOLACvtfcHk0lhlCexVsJkasw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL&md5=79f58a63feb789266e494450a5950390</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm301506h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301506h%26sid%3Dliteratum%253Aachs%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DFlorent%26aufirst%3DI.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DStructure-activity%2520relationships%2520and%2520blood%2520distribution%2520of%2520antiplasmodial%2520aminopeptidase-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10909%26epage%3D10917%26doi%3D10.1021%2Fjm301506h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinh, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loganathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent dual inhibitors of <i>Plasmodium falciparum</i> M1 and M17 aminopeptidases through optimization of S1 pocket interactions</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.ejmech.2016.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=26807544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2mur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=43-64&author=N.+Drinkwaterauthor=N.+B.+Vinhauthor=S.+N.+Mistryauthor=R.+S.+Bamertauthor=C.+Ruggeriauthor=J.+P.+Holleranauthor=S.+Loganathanauthor=A.+Paiardiniauthor=S.+A.+Charmanauthor=A.+K.+Powellauthor=V.+M.+Averyauthor=S.+McGowanauthor=P.+J.+Scammells&title=Potent+dual+inhibitors+of+Plasmodium+falciparum+M1+and+M17+aminopeptidases+through+optimization+of+S1+pocket+interactions&doi=10.1016%2Fj.ejmech.2016.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions</span></div><div class="casAuthors">Drinkwater, Nyssa; Vinh, Natalie B.; Mistry, Shailesh N.; Bamert, Rebecca S.; Ruggeri, Chiara; Holleran, John P.; Loganathan, Sasdekumar; Paiardini, Alessandro; Charman, Susan A.; Powell, Andrew K.; Avery, Vicky M.; McGowan, Sheena; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-64</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Malaria remains a global health problem, and though international efforts for treatment and eradication have made some headway, the emergence of drug-resistant parasites threatens this progress.  Antimalarial therapeutics acting via novel mechanisms are urgently required.  Plasmodium falciparum M1 and M17 are neutral aminopeptidases which are essential for parasite growth and development.  Previous work in our group has identified inhibitors capable of dual inhibition of PfA-M1 and PfA-M17, and revealed further regions within the protease S1 pockets that could be exploited in the development of ligands with improved inhibitory activity.  Herein, we report the structure-based design and synthesis of novel hydroxamic acid analogs that are capable of potent inhibition of both PfA-M1 and PfA-M17.  Furthermore, the developed compds. potently inhibit Pf growth in culture, including the multi-drug resistant strain Dd2.  The ongoing development of dual PfA-M1/PfA-M17 inhibitors continues to be an attractive strategy for the design of novel antimalarial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWA9kTGB140LVg90H21EOLACvtfcHk0liwsCO4iYYYrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2mur8%253D&md5=0ca2a60568b2469364c5a75070d67da2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DVinh%26aufirst%3DN.%2BB.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DHolleran%26aufirst%3DJ.%2BP.%26aulast%3DLoganathan%26aufirst%3DS.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPowell%26aufirst%3DA.%2BK.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520dual%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520M1%2520and%2520M17%2520aminopeptidases%2520through%2520optimization%2520of%2520S1%2520pocket%2520interactions%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D110%26spage%3D43%26epage%3D64%26doi%3D10.1016%2Fj.ejmech.2016.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Bacerio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Monte-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charli, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, M. D.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> M1-aminopeptidase: A promising target for the development of antimalarials</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.2174/1389450115666141024115641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.2174%2F1389450115666141024115641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25341419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFaku77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1144-1165&author=J.+Gonzalez-Bacerioauthor=R.+Fandoauthor=A.+del+Monte-Martinezauthor=J.+L.+Charliauthor=M.+D.+Chavez&title=Plasmodium+falciparum+M1-aminopeptidase%3A+A+promising+target+for+the+development+of+antimalarials&doi=10.2174%2F1389450115666141024115641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum M1-Aminopeptidase: A Promising Target for the Development of Antimalarials</span></div><div class="casAuthors">Gonzalez-Bacerio, Jorge; Fando, Rafael; Monte-Martinez, Alberto del; Charli, Jean-Louis; los A. Chavez, Maria de</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1144-1165</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria is a devastating human parasitic disease that receives enhanced attention due to the emergence of resistance to traditional drugs.  Thus, the search for new mol. targets is a major goal.  PfAM1 is an aminopeptidase from Plasmodium falciparum, William H.  Welch 1897, belonging to the M1 family of metalloproteases, which is a promising target of inhibitors to block the intra-erythrocytic stages of the parasite.  Since its identification in 1998, many efforts have been done to validate PfAM1 as an appropriate target of antimalarials.  The present work is a crit. review of the main structural, functional and kinetic characteristics of PfAM1, as well as a summary of the effects of key inhibitors at mol. and cellular levels.  The systematization of exptl. results should contribute to a better understanding of the properties of PfAM1 as a target of antimalarials and promote research projects focused on the development of PfAM1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohGJzUeQgJVLVg90H21EOLACvtfcHk0liwsCO4iYYYrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFaku77P&md5=04b1c966fda73cce0d5c7259a96bdf0a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1389450115666141024115641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666141024115641%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Bacerio%26aufirst%3DJ.%26aulast%3DFando%26aufirst%3DR.%26aulast%3Ddel%2BMonte-Martinez%26aufirst%3DA.%26aulast%3DCharli%26aufirst%3DJ.%2BL.%26aulast%3DChavez%26aufirst%3DM.%2BD.%26atitle%3DPlasmodium%2520falciparum%2520M1-aminopeptidase%253A%2520A%2520promising%2520target%2520for%2520the%2520development%2520of%2520antimalarials%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26spage%3D1144%26epage%3D1165%26doi%3D10.2174%2F1389450115666141024115641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loganathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Two-pronged attack: Dual inhibition of <i>Plasmodium falciparum</i> M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9168</span>– <span class="NLM_lpage">9183</span>, <span class="refDoi"> DOI: 10.1021/jm501323a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501323a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9168-9183&author=S.+N.+Mistryauthor=N.+Drinkwaterauthor=C.+Ruggeriauthor=K.+K.+Sivaramanauthor=S.+Loganathanauthor=S.+Fletcherauthor=M.+Dragauthor=A.+Paiardiniauthor=V.+M.+Averyauthor=P.+J.+Scammellsauthor=S.+McGowan&title=Two-pronged+attack%3A+Dual+inhibition+of+Plasmodium+falciparum+M1+and+M17+metalloaminopeptidases+by+a+novel+series+of+hydroxamic+acid-based+inhibitors&doi=10.1021%2Fjm501323a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Two-Pronged Attack: Dual Inhibition of Plasmodium falciparum M1 and M17 Metalloaminopeptidases by a Novel Series of Hydroxamic Acid-Based Inhibitors</span></div><div class="casAuthors">Mistry, Shailesh N.; Drinkwater, Nyssa; Ruggeri, Chiara; Sivaraman, Komagal Kannan; Loganathan, Sasdekumar; Fletcher, Sabine; Drag, Marcin; Paiardini, Alessandro; Avery, Vicky M.; Scammells, Peter J.; McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9168-9183</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasmodium parasites, the causative agents of malaria, have developed resistance to most of the current antimalarial therapies, including artemisinin combination therapies which are widely described as the last line of defense.  Antimalarial agents with a novel mode of action are urgently required.  Two Plasmodium falciparum aminopeptidases, PfA-M1 and PfA-M17, play crucial roles in the erythrocytic stage of infection and have been validated as potential antimalarial targets.  Using compd.-bound crystal structures of both enzymes, the authors have used a structure-guided approach to develop a novel series of inhibitors capable of potent inhibition of both PfA-M1 and PfA-M17 activity and parasite growth in culture.  Herein the authors describe the design, synthesis, and evaluation of a series of hydroxamic acid-based inhibitors I [R1 = PhCO, 2-FC6H4CO, 3-H2NC6H4CO, etc.; R2 = HO, HONH] and demonstrate the compds. to be exciting new leads for the development of novel antimalarial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTJUvJd2YOGLVg90H21EOLACvtfcHk0li9MITgcgfdmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E&md5=6b6fe308bc3b434d686268e65014d9c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm501323a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501323a%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DLoganathan%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DTwo-pronged%2520attack%253A%2520Dual%2520inhibition%2520of%2520Plasmodium%2520falciparum%2520M1%2520and%2520M17%2520metalloaminopeptidases%2520by%2520a%2520novel%2520series%2520of%2520hydroxamic%2520acid-based%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9168%26epage%3D9183%26doi%3D10.1021%2Fjm501323a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan-Sivaraman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Screening the medicines for malaria venture “malaria box” against the <i>Plasmodium falciparum</i> aminopeptidases, M1, M17 and M18</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>, <span class="NLM_elocation-id">e0115859</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0115859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1371%2Fjournal.pone.0115859" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Paiardiniauthor=R.+S.+Bamertauthor=K.+Kannan-Sivaramanauthor=N.+Drinkwaterauthor=S.+N.+Mistryauthor=P.+J.+Scammellsauthor=S.+McGowan&title=Screening+the+medicines+for+malaria+venture+%E2%80%9Cmalaria+box%E2%80%9D+against+the+Plasmodium+falciparum+aminopeptidases%2C+M1%2C+M17+and+M18&doi=10.1371%2Fjournal.pone.0115859"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0115859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0115859%26sid%3Dliteratum%253Aachs%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DKannan-Sivaraman%26aufirst%3DK.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DScreening%2520the%2520medicines%2520for%2520malaria%2520venture%2520%25E2%2580%259Cmalaria%2520box%25E2%2580%259D%2520against%2520the%2520Plasmodium%2520falciparum%2520aminopeptidases%252C%2520M1%252C%2520M17%2520and%2520M18%26jtitle%3DPLoS%2520One%26date%3D2015%26doi%3D10.1371%2Fjournal.pone.0115859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span> <span> </span><span class="NLM_article-title">Identification and validation of a potent dual inhibitor of the <i>P. falciparum</i> M1 and M17 aminopeptidases using virtual screening</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>, <span class="NLM_elocation-id">e0138957</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0138957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1371%2Fjournal.pone.0138957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Ruggeriauthor=N.+Drinkwaterauthor=K.+K.+Sivaramanauthor=R.+S.+Bamertauthor=S.+McGowanauthor=A.+Paiardini&title=Identification+and+validation+of+a+potent+dual+inhibitor+of+the+P.+falciparum+M1+and+M17+aminopeptidases+using+virtual+screening&doi=10.1371%2Fjournal.pone.0138957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138957%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DPaiardini%26aufirst%3DA.%26atitle%3DIdentification%2520and%2520validation%2520of%2520a%2520potent%2520dual%2520inhibitor%2520of%2520the%2520P.%2520falciparum%2520M1%2520and%2520M17%2520aminopeptidases%2520using%2520virtual%2520screening%26jtitle%3DPLoS%2520One%26date%3D2015%26doi%3D10.1371%2Fjournal.pone.0138957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieńczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from <i>Plasmodium falciparum</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5213</span>– <span class="NLM_lpage">5217</span>, <span class="refDoi"> DOI: 10.1021/jm4005972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVegs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5213-5217&author=K.+K.+Sivaramanauthor=A.+Paiardiniauthor=M.+Sie%C5%84czykauthor=C.+Ruggeriauthor=C.+A.+Oelligauthor=J.+P.+Daltonauthor=P.+J.+Scammellsauthor=M.+Dragauthor=S.+McGowan&title=Synthesis+and+structure-activity+relationships+of+phosphonic+arginine+mimetics+as+inhibitors+of+the+M1+and+M17+aminopeptidases+from+Plasmodium+falciparum&doi=10.1021%2Fjm4005972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Phosphonic Arginine Mimetics as Inhibitors of the M1 and M17 Aminopeptidases from Plasmodium falciparum</span></div><div class="casAuthors">Sivaraman, Komagal Kannan; Paiardini, Alessandro; Sienczyk, Marcin; Ruggeri, Chiara; Oellig, Christine A.; Dalton, John P.; Scammells, Peter J.; Drag, Marcin; McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5213-5217</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The malaria parasite Plasmodium falciparum employs two metallo-aminopeptidases, PfA-M1 and PfA-M17, which are essential for parasite survival.  Compds. that inhibit the activity of either enzyme represent leads for the development of new antimalarial drugs.  Here authors report the synthesis and structure-activity relationships of a small library of phosphonic acid arginine mimetics that probe the S1 pocket of both enzymes and map the necessary interactions that would be important for a dual inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj1_wrwtPtGrVg90H21EOLACvtfcHk0ljXmGPhrKE-pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVegs7k%253D&md5=f62af0810115619662b8e99a18e47959</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm4005972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005972%26sid%3Dliteratum%253Aachs%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DSie%25C5%2584czyk%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DOellig%26aufirst%3DC.%2BA.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520phosphonic%2520arginine%2520mimetics%2520as%2520inhibitors%2520of%2520the%2520M1%2520and%2520M17%2520aminopeptidases%2520from%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5213%26epage%3D5217%26doi%3D10.1021%2Fjm4005972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> neutral aminopeptidases: New targets for anti-malarials</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2009.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.tibs.2009.08.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=53-61&author=T.+S.+Skinner-Adamsauthor=C.+M.+Stackauthor=K.+R.+Trenholmeauthor=C.+L.+Brownauthor=J.+Grembeckaauthor=J.+Lowtherauthor=A.+Muchaauthor=M.+Dragauthor=P.+Kafarskiauthor=S.+McGowanauthor=J.+C.+Whisstockauthor=D.+L.+Gardinerauthor=J.+P.+Dalton&title=Plasmodium+falciparum+neutral+aminopeptidases%3A+New+targets+for+anti-malarials&doi=10.1016%2Fj.tibs.2009.08.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2009.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2009.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DC.%2BL.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DPlasmodium%2520falciparum%2520neutral%2520aminopeptidases%253A%2520New%2520targets%2520for%2520anti-malarials%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D53%26epage%3D61%26doi%3D10.1016%2Fj.tibs.2009.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thivierge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nsangou, D. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title">Anti-malaria drug development targeting the M1 alanyl and M17 leucyl aminopeptidases</span>. <i>Arkivoc</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0013.424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.3998%2Fark.5550190.0013.424" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=330-346&author=K.+Thiviergeauthor=R.+T.+Mathewauthor=D.+M.+M.+Nsangouauthor=F.+Da+Silvaauthor=S.+Cottonauthor=T.+S.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=C.+L.+Brownauthor=C.+M.+Stackauthor=D.+L.+Gardinerauthor=J.+P.+Dalton&title=Anti-malaria+drug+development+targeting+the+M1+alanyl+and+M17+leucyl+aminopeptidases&doi=10.3998%2Fark.5550190.0013.424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0013.424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0013.424%26sid%3Dliteratum%253Aachs%26aulast%3DThivierge%26aufirst%3DK.%26aulast%3DMathew%26aufirst%3DR.%2BT.%26aulast%3DNsangou%26aufirst%3DD.%2BM.%2BM.%26aulast%3DDa%2BSilva%26aufirst%3DF.%26aulast%3DCotton%26aufirst%3DS.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DC.%2BL.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DAnti-malaria%2520drug%2520development%2520targeting%2520the%2520M1%2520alanyl%2520and%2520M17%2520leucyl%2520aminopeptidases%26jtitle%3DArkivoc%26date%3D2012%26spage%3D330%26epage%3D346%26doi%3D10.3998%2Fark.5550190.0013.424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, <i>Plasmodium falciparum</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e31938</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0031938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1371%2Fjournal.pone.0031938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22359643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=M.+Porebaauthor=S.+McGowanauthor=T.+S.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=D.+L.+Gardinerauthor=J.+C.+Whisstockauthor=J.+Toauthor=G.+S.+Salvesenauthor=J.+P.+Daltonauthor=M.+Drag&title=Fingerprinting+the+substrate+specificity+of+M1+and+M17+aminopeptidases+of+human+malaria%2C+Plasmodium+falciparum&doi=10.1371%2Fjournal.pone.0031938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum</span></div><div class="casAuthors">Poreba, Marcin; McGowan, Sheena; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.; Whisstock, James C.; To, Joyce; Salvesen, Guy S.; Dalton, John P.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e31938</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Plasmodium falciparum, the causative agent of human malaria, expresses two aminopeptidases, PfM1AAP and PfM17LAP, crit. to generating a free amino acid pool used by the intraerythrocytic stage of the parasite for proteins synthesis, growth and development.  These exopeptidases are potential targets for the development of a new class of anti-malaria drugs.  To define the substrate specificity of recombinant forms of these two malaria aminopeptidases we used a new library consisting of 61 fluorogenic substrates derived both from natural and unnatural amino acids.  We obtained a detailed substrate fingerprint for recombinant forms of the enzymes revealing that PfM1AAP exhibits a very broad substrate tolerance, capable of efficiently hydrolyzing neutral and basic amino acids, while PfM17LAP has narrower substrate specificity and preferentially cleaves bulky, hydrophobic amino acids.  The substrate library was also exploited to profile the activity of the native aminopeptidases in sol. cell lysates of P. falciparum malaria.  This data showed that PfM1AAP and PfM17LAP are responsible for majority of the aminopeptidase activity in these exts.  These studies provide specific substrate and mechanistic information important for understanding the function of these aminopeptidases and could be exploited in the design of new inhibitors to specifically target these for anti-malaria treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUDBqzvuxULVg90H21EOLACvtfcHk0liOgtgXsYrAHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWjtLs%253D&md5=8af793987903ec128043350c9443a84d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031938%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DTo%26aufirst%3DJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DFingerprinting%2520the%2520substrate%2520specificity%2520of%2520M1%2520and%2520M17%2520aminopeptidases%2520of%2520human%2520malaria%252C%2520Plasmodium%2520falciparum%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0031938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birru, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradoc-Davies, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the <i>Plasmodium falciparum</i> M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">2449</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1073/pnas.0911813107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.0911813107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20133789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1aksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2449-2454&author=S.+McGowanauthor=C.+A.+Oelligauthor=W.+A.+Birruauthor=T.+T.+Caradoc-Daviesauthor=C.+M.+Stackauthor=J.+Lowtherauthor=T.+Skinner-Adamsauthor=A.+Muchaauthor=P.+Kafarskiauthor=J.+Grembeckaauthor=K.+R.+Trenholmeauthor=A.+M.+Buckleauthor=D.+L.+Gardinerauthor=J.+P.+Daltonauthor=J.+C.+Whisstock&title=Structure+of+the+Plasmodium+falciparum+M17+aminopeptidase+and+significance+for+the+design+of+drugs+targeting+the+neutral+exopeptidases&doi=10.1073%2Fpnas.0911813107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases</span></div><div class="casAuthors">McGowan, Sheena; Oellig, Christine A.; Birru, Woldeamanuel A.; Caradoc-Davies, Tom T.; Stack, Colin M.; Lowther, Jonathan; Skinner-Adams, Tina; Mucha, Artur; Kafarski, Pawel; Grembecka, Olanta; Trenholme, Katharine R.; Buckle, Ashley M.; Gardiner, Donald L.; Dalton, John P.; Whisstock, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2449-2454, S2449/1-S2449/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Current therapeutics and prophylactics for malaria are under severe challenge as a result of the rapid emergence of drug-resistant parasites.  The human malaria parasite Plasmodium falciparum expresses two neutral aminopeptidases, PfA-M1 and PfA-M17, which function in regulating the intracellular pool of amino acids required for growth and development inside the red blood cell.  These enzymes are essential for parasite viability and are validated therapeutic targets.  We previously reported the x-ray crystal structure of the monomeric PfA-M1 and proposed a mechanism for substrate entry and free amino acid release from the active site.  Here, we present the x-ray crystal structure of the hexameric leucine aminopeptidase, PfA-M17, alone and in complex with two inhibitors with antimalarial activity.  The six active sites of the PfA-M17 hexamer are arranged in a disk-like fashion so that they are oriented inwards to form a central catalytic cavity; flexible loops that sit at each of the six entrances to the catalytic cavern function to regulate substrate access.  In stark contrast to PfA-M1, PfA-M17 has a narrow and hydrophobic primary specificity pocket which accounts for its highly restricted substrate specificity.  We also explicate the essential roles for the metal-binding centers in these enzymes (two in PfA-M17 and one in PfA-M1) in both substrate and drug binding.  Our detailed understanding of the PfA-M1 and PfA-M17 active sites now permits a rational approach in the development of a unique class of two-target and/or combination antimalarial therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYqQSNGkAH4LVg90H21EOLACvtfcHk0liOgtgXsYrAHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1aksrs%253D&md5=e4dde6cdc5f04346b5abefbaa1e92f1f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0911813107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0911813107%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DOellig%26aufirst%3DC.%2BA.%26aulast%3DBirru%26aufirst%3DW.%2BA.%26aulast%3DCaradoc-Davies%26aufirst%3DT.%2BT.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DBuckle%26aufirst%3DA.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26atitle%3DStructure%2520of%2520the%2520Plasmodium%2520falciparum%2520M17%2520aminopeptidase%2520and%2520significance%2520for%2520the%2520design%2520of%2520drugs%2520targeting%2520the%2520neutral%2520exopeptidases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D2449%26epage%3D2454%26doi%3D10.1073%2Fpnas.0911813107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of the essential <i>Plasmodium falciparum</i> M1 neutral aminopeptidase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2537</span>– <span class="NLM_lpage">2542</span>, <span class="refDoi"> DOI: 10.1073/pnas.0807398106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.0807398106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=19196988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislahsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=2537-2542&author=S.+McGowanauthor=C.+J.+Porterauthor=J.+Lowtherauthor=C.+M.+Stackauthor=S.+J.+Goldingauthor=T.+S.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=F.+Teuscherauthor=S.+M.+Donnellyauthor=J.+Grembeckaauthor=A.+Muchaauthor=P.+Kafarskiauthor=R.+DeGoriauthor=A.+M.+Buckleauthor=D.+L.+Gardinerauthor=J.+C.+Whisstockauthor=J.+P.+Dalton&title=Structural+basis+for+the+inhibition+of+the+essential+Plasmodium+falciparum+M1+neutral+aminopeptidase&doi=10.1073%2Fpnas.0807398106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase</span></div><div class="casAuthors">McGowan, Sheena; Porter, Corrine J.; Lowther, Jonathan; Stack, Colin M.; Golding, Sarah J.; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Teuscher, Franka; Donnelly, Sheila M.; Grembecka, Jolanta; Mucha, Artur; Kafarski, Pawel; DeGori, Ross; Buckle, Ashley M.; Gardiner, Donald L.; Whisstock, James C.; Dalton, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2537-2542</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Plasmodium falciparum parasites are responsible for the major global disease malaria, which results in >2 million deaths each year.  With the rise of drug-resistant malarial parasites, novel drug targets and lead compds. are urgently required for the development of new therapeutic strategies.  Here, we address this important problem by targeting the malarial neutral aminopeptidases that are involved in the terminal stages of Hb digestion and essential for the provision of amino acids used for parasite growth and development within the erythrocyte.  We characterize the structure and substrate specificity of one such aminopeptidase, PfA-M1, a validated drug target.  The X-ray crystal structure of PfA-M1 alone and in complex with the generic inhibitor, bestatin, and a phosphinate dipeptide analog with potent in vitro and in vivo antimalarial activity, hPheP[CH2]Phe, reveals features within the protease active site that are crit. to its function as an aminopeptidase and can be exploited for drug development.  These results set the groundwork for the development of antimalarial therapeutics that target the neutral aminopeptidases of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-6_ZNvWMUP7Vg90H21EOLACvtfcHk0lgwCT8MCXJ4Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislahsrY%253D&md5=23bc5efa86832c3fbc10e900f42f3216</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0807398106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0807398106%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DGolding%26aufirst%3DS.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DTeuscher%26aufirst%3DF.%26aulast%3DDonnelly%26aufirst%3DS.%2BM.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DDeGori%26aufirst%3DR.%26aulast%3DBuckle%26aufirst%3DA.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520the%2520essential%2520Plasmodium%2520falciparum%2520M1%2520neutral%2520aminopeptidase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D2537%26epage%3D2542%26doi%3D10.1073%2Fpnas.0807398106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lua, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of the <i>Plasmodium falciparum</i> M17 leucyl aminopeptidase - a protease involved in amino acid regulation with potential for antimalarial drug development</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">2069</span>– <span class="NLM_lpage">2080</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609251200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1074%2Fjbc.M609251200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=2069-2080&author=C.+M.+Stackauthor=J.+Lowtherauthor=E.+Cunninghamauthor=S.+Donnellyauthor=D.+L.+Gardinerauthor=K.+R.+Trenholmeauthor=T.+S.+Skinner-Adamsauthor=F.+Teuscherauthor=J.+Grembeckaauthor=A.+Muchaauthor=P.+Kafarskiauthor=L.+Luaauthor=A.+Bellauthor=J.+P.+Dalton&title=Characterization+of+the+Plasmodium+falciparum+M17+leucyl+aminopeptidase+-+a+protease+involved+in+amino+acid+regulation+with+potential+for+antimalarial+drug+development&doi=10.1074%2Fjbc.M609251200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609251200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609251200%26sid%3Dliteratum%253Aachs%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DE.%26aulast%3DDonnelly%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTeuscher%26aufirst%3DF.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DLua%26aufirst%3DL.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520Plasmodium%2520falciparum%2520M17%2520leucyl%2520aminopeptidase%2520-%2520a%2520protease%2520involved%2520in%2520amino%2520acid%2520regulation%2520with%2520potential%2520for%2520antimalarial%2520drug%2520development%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D2069%26epage%3D2080%26doi%3D10.1074%2Fjbc.M609251200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuzmič, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregar, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janc, J. W.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening of enzyme inhibitors: Simultaneous determination of tight-binding inhibition constants and enzyme concentration</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1006/abio.2000.4685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1006%2Fabio.2000.4685" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2000&pages=45-50&author=P.+Kuzmi%C4%8Dauthor=K.+C.+Elrodauthor=L.+M.+Cregarauthor=S.+Siderisauthor=R.+Raiauthor=J.+W.+Janc&title=High-throughput+screening+of+enzyme+inhibitors%3A+Simultaneous+determination+of+tight-binding+inhibition+constants+and+enzyme+concentration&doi=10.1006%2Fabio.2000.4685"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1006%2Fabio.2000.4685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2000.4685%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmi%25C4%258D%26aufirst%3DP.%26aulast%3DElrod%26aufirst%3DK.%2BC.%26aulast%3DCregar%26aufirst%3DL.%2BM.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DRai%26aufirst%3DR.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26atitle%3DHigh-throughput%2520screening%2520of%2520enzyme%2520inhibitors%253A%2520Simultaneous%2520determination%2520of%2520tight-binding%2520inhibition%2520constants%2520and%2520enzyme%2520concentration%26jtitle%3DAnal.%2520Biochem.%26date%3D2000%26volume%3D286%26spage%3D45%26epage%3D50%26doi%3D10.1006%2Fabio.2000.4685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Determination of accurate K<sub>i</sub> values for tight-binding enzyme inhibitors: An in silico study of experimental error and assay design</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2003.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.ab.2003.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=15033511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFKhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2004&pages=61-67&author=D.+J.+Murphy&title=Determination+of+accurate+Ki+values+for+tight-binding+enzyme+inhibitors%3A+An+in+silico+study+of+experimental+error+and+assay+design&doi=10.1016%2Fj.ab.2003.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design</span></div><div class="casAuthors">Murphy, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-67</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Detn. of accurate KI values for tight-binding enzyme inhibitors is important from both a basic biochem. point of view (understanding the differences in affinity of related mols.) and a medicinal chem. vantage (developing structure-activity relationships (SAR)).  It is advantageous to directly fit the quadratic equation describing tight-binding behavior, known commonly as the Morrison equation, to obtain these KI values.  The results of simulated expts. that examine the effect of assay design and exptl. error on the ability to accurately det. KI values at several [E]0/KI-app ratios are described.  Input ("true") values of the uninhibited velocity, inhibition const., and total enzyme concn. were used to calc. the velocity at various inhibitor concns.  Gaussian error was introduced into the velocities and the simulated reactions were fit to est. v0, KI, and [E]0.  Recommendations for optimizing the inhibitor dilns. within the context of a 96-well-plate format and simple serial diln. steps are made.  These include using three points to det. the enzyme concn. ([I] = 0, 0.5[E]0, and [E]0), using a narrow diln. series with only two or three points to det. the asymptote at high inhibitor concn., and avoidance of fixing [E]0 to a const. value in the fitting if at all possible.  The risks and rewards of fixing [E]0 to a const. value, esp. the effect on SAR, are also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGiaWGV4W5tLVg90H21EOLACvtfcHk0lgwCT8MCXJ4Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFKhtrg%253D&md5=f93d7f5648fc310736f4a80c10ef3edd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2003.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2003.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DDetermination%2520of%2520accurate%2520Ki%2520values%2520for%2520tight-binding%2520enzyme%2520inhibitors%253A%2520An%2520in%2520silico%2520study%2520of%2520experimental%2520error%2520and%2520assay%2520design%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D327%26spage%3D61%26epage%3D67%26doi%3D10.1016%2Fj.ab.2003.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velmourougane, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbut, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinhardt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1021/jm101227t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101227t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1655-1666&author=G.+Velmourouganeauthor=M.+B.+Harbutauthor=S.+Dalalauthor=S.+McGowanauthor=C.+A.+Oelligauthor=N.+Meinhardtauthor=J.+C.+Whisstockauthor=M.+Klembaauthor=D.+C.+Greenbaum&title=Synthesis+of+new+%28-%29-bestatin-based+inhibitor+libraries+reveals+a+novel+binding+mode+in+the+S1+pocket+of+the+essential+malaria+M1+metalloaminopeptidase&doi=10.1021%2Fjm101227t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm101227t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101227t%26sid%3Dliteratum%253Aachs%26aulast%3DVelmourougane%26aufirst%3DG.%26aulast%3DHarbut%26aufirst%3DM.%2BB.%26aulast%3DDalal%26aufirst%3DS.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DOellig%26aufirst%3DC.%2BA.%26aulast%3DMeinhardt%26aufirst%3DN.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DKlemba%26aufirst%3DM.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520of%2520new%2520%2528-%2529-bestatin-based%2520inhibitor%2520libraries%2520reveals%2520a%2520novel%2520binding%2520mode%2520in%2520the%2520S1%2520pocket%2520of%2520the%2520essential%2520malaria%2520M1%2520metalloaminopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1655%26epage%3D1666%26doi%3D10.1021%2Fjm101227t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, W.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, B. W.</span></span> <span> </span><span class="NLM_article-title">Metalloaminopeptidases: Common functional themes in disparate structural surroundings</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">4581</span>– <span class="NLM_lpage">4607</span>, <span class="refDoi"> DOI: 10.1021/cr0101757</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0101757" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4581-4607&author=W.%0AT.+Lowtherauthor=B.+W.+Matthews&title=Metalloaminopeptidases%3A+Common+functional+themes+in+disparate+structural+surroundings&doi=10.1021%2Fcr0101757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloaminopeptidases: Common functional themes in disparate structural surroundings</span></div><div class="casAuthors">Lowther, W. Todd; Matthews, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4581-4607</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include leucine aminopeptidase, Aeromonas proteolytica and Streptomyces griseus aminopeptidases, methionine aminopeptidase, aminopeptidase P, and prolidase.  Common structure-function motifs of these metalloaminopeptidases are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ2R9gHtRNlLVg90H21EOLACvtfcHk0liO-PLG-Z2aRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSgu7c%253D&md5=b517a222a63badcbebd0c6d68bebe13f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcr0101757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0101757%26sid%3Dliteratum%253Aachs%26aulast%3DLowther%26aufirst%3DW.%2BT.%26aulast%3DMatthews%26aufirst%3DB.%2BW.%26atitle%3DMetalloaminopeptidases%253A%2520Common%2520functional%2520themes%2520in%2520disparate%2520structural%2520surroundings%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4581%26epage%3D4607%26doi%3D10.1021%2Fcr0101757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maric, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinsin, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span> <span> </span><span class="NLM_article-title">The M17 leucine aminopeptidase of the malaria parasite <i>Plasmodium falciparum</i>: Importance of active site metal ions in the binding of substrates and inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5435</span>– <span class="NLM_lpage">5439</span>, <span class="refDoi"> DOI: 10.1021/bi9003638</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9003638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5435-5439&author=S.+Maricauthor=S.+M.+Donnellyauthor=M.+W.+Robinsinauthor=T.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=D.+L.+Gardinerauthor=J.+P.+Daltonauthor=C.+M.+Stackauthor=J.+Lowther&title=The+M17+leucine+aminopeptidase+of+the+malaria+parasite+Plasmodium+falciparum%3A+Importance+of+active+site+metal+ions+in+the+binding+of+substrates+and+inhibitors&doi=10.1021%2Fbi9003638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The M17 Leucine Aminopeptidase of the Malaria Parasite Plasmodium falciparum: Importance of Active Site Metal Ions in the Binding of Substrates and Inhibitors</span></div><div class="casAuthors">Maric, Selma; Donnelly, Sheila M.; Robinson, Mark W.; Skinner-Adams, Tina; Trenholme, Katharine R.; Gardiner, Donald L.; Dalton, John P.; Stack, Colin M.; Lowther, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5435-5439</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M17 leucine aminopeptidase of the intraerythrocytic stages of the malaria parasite Plasmodium falciparum (PfLAP) plays a role in releasing amino acids from host Hb that are used for parasite protein synthesis, growth, and development.  This enzyme represents a target at which new antimalarials could be designed since metalloaminopeptidase inhibitors prevent the growth of the parasites in vitro and in vivo.  A study on the metal ion binding characteristics of recombinant P. falciparum M17 leucine aminopeptidase (rPfLAP) shows that the active site of this exopeptidase contains two metal-binding sites, a readily exchangeable site (site 1) and a tight binding site (site 2).  The enzyme retains activity when the metal ion is removed from site 1, while removal of metal ions from both sites results in an inactive apoenzyme that cannot be reactivated by the addn. of divalent metal cations.  The metal ion at site 1 is readily exchangeable with several divalent metal ions and displays a preference in the order of preference Zn2+ > Mn2+ > Co2+ > Mg2+.  While it is likely that native PfLAP contains a Zn2+ in site 2, the metal ion located in site 1 may be dependent on the type and concn. of metal ions in the cytosolic compartment of the parasite.  Importantly, the type of metal ion present at site 1 influences not only the catalytic efficiency of the enzyme for peptide substrates but also the mode of binding by bestatin, a metal-chelating inhibitor of M17 aminopeptidases with antimalarial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3w8yqPIYgT7Vg90H21EOLACvtfcHk0liO-PLG-Z2aRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsLo%253D&md5=a440cc1c00ce86fb3130444536cf3cf6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi9003638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9003638%26sid%3Dliteratum%253Aachs%26aulast%3DMaric%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DS.%2BM.%26aulast%3DRobinsin%26aufirst%3DM.%2BW.%26aulast%3DSkinner-Adams%26aufirst%3DT.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DLowther%26aufirst%3DJ.%26atitle%3DThe%2520M17%2520leucine%2520aminopeptidase%2520of%2520the%2520malaria%2520parasite%2520Plasmodium%2520falciparum%253A%2520Importance%2520of%2520active%2520site%2520metal%2520ions%2520in%2520the%2520binding%2520of%2520substrates%2520and%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D5435%26epage%3D5439%26doi%3D10.1021%2Fbi9003638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">From crystal to compound: Structure-based antimalarial drug discovery</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1042/BJ20140240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1042%2FBJ20140240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2014&pages=349-369&author=N.+Drinkwaterauthor=S.+McGowan&title=From+crystal+to+compound%3A+Structure-based+antimalarial+drug+discovery&doi=10.1042%2FBJ20140240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1042%2FBJ20140240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20140240%26sid%3Dliteratum%253Aachs%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DFrom%2520crystal%2520to%2520compound%253A%2520Structure-based%2520antimalarial%2520drug%2520discovery%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D461%26spage%3D349%26epage%3D369%26doi%3D10.1042%2FBJ20140240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kyrieleis, O. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goettig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefersauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandstetter, H.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the tricorn interacting factor F3 from thermoplasma acidophilum, a zinc aminopeptidase in three different conformations</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.jmb.2005.03.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2005&pages=787-800&author=O.+J.+P.+Kyrieleisauthor=P.+Goettigauthor=R.+Kiefersauerauthor=R.+Huberauthor=H.+Brandstetter&title=Crystal+structures+of+the+tricorn+interacting+factor+F3+from+thermoplasma+acidophilum%2C+a+zinc+aminopeptidase+in+three+different+conformations&doi=10.1016%2Fj.jmb.2005.03.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DKyrieleis%26aufirst%3DO.%2BJ.%2BP.%26aulast%3DGoettig%26aufirst%3DP.%26aulast%3DKiefersauer%26aufirst%3DR.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DCrystal%2520structures%2520of%2520the%2520tricorn%2520interacting%2520factor%2520F3%2520from%2520thermoplasma%2520acidophilum%252C%2520a%2520zinc%2520aminopeptidase%2520in%2520three%2520different%2520conformations%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D349%26spage%3D787%26epage%3D800%26doi%3D10.1016%2Fj.jmb.2005.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratikos, E.</span></span> <span> </span><span class="NLM_article-title">The role of conformational dynamics in antigen trimming by intracellular aminopeptidases</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">946</span> <span class="refDoi"> DOI: 10.3389/fimmu.2017.00946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.3389%2Ffimmu.2017.00946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=28824657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWntLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=A.+Papakyriakouauthor=E.+Stratikos&title=The+role+of+conformational+dynamics+in+antigen+trimming+by+intracellular+aminopeptidases&doi=10.3389%2Ffimmu.2017.00946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The role of conformational dynamics in antigen trimming by intracellular aminopeptidases</span></div><div class="casAuthors">Papakyriakou, Athanasios; Stratikos, Efstratios</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">946/1-946/7</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Antigenic peptides presented by the major histocompatibility complex class I (MHC-I) mols. for recognition by cytotoxic T-lymphocytes are processed by members of the oxytocinase sub-family of M1 aminopeptidases ERAP1, ERAP2, and IRAP.  These three homologous zinc metallopeptidases trim N-terminally extended precursor antigenic peptides down to the correct length for loading onto the MHC-I but can also destroy some antigenic peptides by over-trimming, therefore, influencing the antigenic peptide repertoire and immunodominance hierarchy.  Polymorphic variation has been found to affect their trimming function and predispose to human disease in complex and poorly understood patterns.  Structural and biochem. anal. have pointed toward a complicated trimming mechanism that involves a major conformational transition during each catalytic cycle.  Here, we provide an overview of current knowledge on the structure and mechanism of action of those enzymes with a focus on the proposed key role of conformational dynamics in their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIey33g_W7hrVg90H21EOLACvtfcHk0ljIsyEg53W-0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWntLbE&md5=64704c46e5ee1e4c6733521ed9afeb49</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00946%26sid%3Dliteratum%253Aachs%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DStratikos%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520conformational%2520dynamics%2520in%2520antigen%2520trimming%2520by%2520intracellular%2520aminopeptidases%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26doi%3D10.3389%2Ffimmu.2017.00946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span> <span> </span><span class="NLM_article-title">Towards third generation matrix metalloproteinase inhibitors for cancer therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6603043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1038%2Fsj.bjc.6603043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=16538215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=941-946&author=C.+M.+Overallauthor=O.+Kleifeld&title=Towards+third+generation+matrix+metalloproteinase+inhibitors+for+cancer+therapy&doi=10.1038%2Fsj.bjc.6603043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Towards third generation matrix metalloproteinase inhibitors for cancer therapy</span></div><div class="casAuthors">Overall, C. M.; Kleifeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The failure of matrix metalloproteinase (MMP) inhibitor drug clin. trials in cancer was partly due to the inadvertent inhibition of MMP antitargets that counterbalanced the benefits of MMP target inhibition.  We explore how MMP inhibitor drugs might be developed to achieve potent selectivity for validated MMP targets yet therapeutically spare MMP antitargets that are crit. in host protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWaFApPMIKRLVg90H21EOLACvtfcHk0lgjQ8GTC2whSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D&md5=5e672a6e9495ec2e283856edc6e61a60</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603043%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTowards%2520third%2520generation%2520matrix%2520metalloproteinase%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D941%26epage%3D946%26doi%3D10.1038%2Fsj.bjc.6603043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span> <span> </span><span class="NLM_article-title">Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1038/nrc1821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&author=C.+M.+Overallauthor=O.+Kleifeld&title=Validating+matrix+metalloproteinases+as+drug+targets+and+anti-targets+for+cancer+therapy&doi=10.1038%2Fnrc1821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lgjQ8GTC2whSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DValidating%2520matrix%2520metalloproteinases%2520as%2520drug%2520targets%2520and%2520anti-targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D227%26epage%3D239%26doi%3D10.1038%2Fnrc1821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span> <span> </span><span class="NLM_article-title">Strategies for MMP inhibition in cancer: Innovations for the post-trial era</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrc884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1038%2Fnrc884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=12209155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslamsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=657-672&author=C.+M.+Overallauthor=C.+Lopez-Otin&title=Strategies+for+MMP+inhibition+in+cancer%3A+Innovations+for+the+post-trial+era&doi=10.1038%2Fnrc884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for MMP inhibition in cancer: innovations for the post-trial era</span></div><div class="casAuthors">Overall, Christopher Mark; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">657-672</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For more than two decades, the view that tumor-assocd. matrix metalloproteinases (MMPs) were required for peritumor tissue degrdn. and metastasis dominated the drive to develop MMP inhibitors as anticancer therapeutics.  Until recently, clin. trials with MMP inhibitors have yielded disappointing results, highlighting the need for better insight into the mechanisms by which this growing family of multifunctional enzymes contribute to tumor growth.  It is now recognized that MMP activity is tightly regulated at several levels, providing new avenues for blocking these enzymes.  What are the different approaches that can be used to target MMPs, and which of these might lead to new therapeutic strategies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorJX_WvW8wvLVg90H21EOLACvtfcHk0lgjQ8GTC2whSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslamsro%253D&md5=1d37c018f346969782f80585027ef989</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrc884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc884%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DLopez-Otin%26aufirst%3DC.%26atitle%3DStrategies%2520for%2520MMP%2520inhibition%2520in%2520cancer%253A%2520Innovations%2520for%2520the%2520post-trial%2520era%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D657%26epage%3D672%26doi%3D10.1038%2Fnrc884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitzerd, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbrugge, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossenkoppele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Positioning of aminopeptidase inhibitors in next generation cancer therapy</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.1007/s00726-013-1648-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1007%2Fs00726-013-1648-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=24385243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=793-808&author=S.+M.+Hitzerdauthor=S.+E.+Verbruggeauthor=G.+Ossenkoppeleauthor=G.+Jansenauthor=G.+J.+Peters&title=Positioning+of+aminopeptidase+inhibitors+in+next+generation+cancer+therapy&doi=10.1007%2Fs00726-013-1648-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Positioning of aminopeptidase inhibitors in next generation cancer therapy</span></div><div class="casAuthors">Hitzerd, Sarina M.; Verbrugge, Sue Ellen; Ossenkoppele, Gert; Jansen, Gerrit; Peters, Godefridus J.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">793-808</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">A review.  Aminopeptidases represent a class of (zinc) metalloenzymes that catalyze the cleavage of amino acids nearby the N-terminus of polypeptides, resulting in hydrolysis of peptide bonds.  Aminopeptidases operate downstream of the ubiquitin-proteasome pathway and are implicated in the final step of intracellular protein degrdn. either by trimming proteasome-generated peptides for antigen presentation or full hydrolysis into free amino acids for recycling in renewed protein synthesis.  This review focuses on the function and subcellular location of five key aminopeptidases (aminopeptidase N, leucine aminopeptidase, puromycin-sensitive aminopeptidase, leukotriene A4 hydrolase and endoplasmic reticulum aminopeptidase 1/2) and their assocn. with different diseases, in particular cancer and their current position as target for therapeutic intervention by aminopeptidase inhibitors.  Historically, bestatin was the first prototypical aminopeptidase inhibitor that entered the clinic 35 years ago and is still used for the treatment of lung cancer.  More recently, new generation aminopeptidase inhibitors became available, including the aminopeptidase inhibitor prodrug tosedostat, which is currently tested in phase II clin. trials for acute myeloid leukemia.  Beyond bestatin and tosedostat, medicinal chem. has emerged with addnl. series of potential aminopeptidases inhibitors which are still in an early phase of (pre)clin. investigations.  The expanded knowledge of the unique mechanism of action of aminopeptidases has revived interest in aminopeptidase inhibitors for drug combination regimens in anti-cancer treatment.  In this context, this review will discuss relevant features and mechanisms of action of aminopeptidases and will also elaborate on factors contributing to aminopeptidase inhibitor efficacy and/or loss of efficacy due to drug resistance-related phenomena.  Together, a growing body of data point to aminopeptidase inhibitors as attractive tools for combination chemotherapy, hence their implementation may be a step forward in a new era of personalized treatment of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABQrQu0W5GrVg90H21EOLACvtfcHk0lidffeiCAO-mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVOltQ%253D%253D&md5=c17cc3a379f6a21b0126d672f3680dc6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00726-013-1648-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-013-1648-0%26sid%3Dliteratum%253Aachs%26aulast%3DHitzerd%26aufirst%3DS.%2BM.%26aulast%3DVerbrugge%26aufirst%3DS.%2BE.%26aulast%3DOssenkoppele%26aufirst%3DG.%26aulast%3DJansen%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DPositioning%2520of%2520aminopeptidase%2520inhibitors%2520in%2520next%2520generation%2520cancer%2520therapy%26jtitle%3DAmino%2520Acids%26date%3D2014%26volume%3D46%26spage%3D793%26epage%3D808%26doi%3D10.1007%2Fs00726-013-1648-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. X.</span></span> <span> </span><span class="NLM_article-title">Resistance-resistant antibiotics</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.tips.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25458541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=664-674&author=E.+Oldfieldauthor=X.+X.+Feng&title=Resistance-resistant+antibiotics&doi=10.1016%2Fj.tips.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance-resistant antibiotics</span></div><div class="casAuthors">Oldfield, Eric; Feng, Xinxin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">664-674</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New antibiotics are needed because drug resistance is increasing while the introduction of new antibiotics is decreasing.  We discuss here six possible approaches to develop 'resistance-resistant' antibiotics.  First, multitarget inhibitors in which a single compd. inhibits more than one target may be easier to develop than conventional combination therapies with two new drugs.  Second, inhibiting multiple targets in the same metabolic pathway is expected to be an effective strategy owing to synergy.  Third, discovering multiple-target inhibitors should be possible by using sequential virtual screening.  Fourth, repurposing existing drugs can lead to combinations of multitarget therapeutics.  Fifth, targets need not be proteins.  Sixth, inhibiting virulence factor formation and boosting innate immunity may also lead to decreased susceptibility to resistance.  Although it is not possible to eliminate resistance, the approaches reviewed here offer several possibilities for reducing the effects of mutations and, in some cases, suggest that sensitivity to existing antibiotics may be restored in otherwise drug-resistant organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFcN1H0q81rVg90H21EOLACvtfcHk0lidffeiCAO-mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP&md5=1fd8f53ba0e90abbc83a6616db24568a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DX.%2BX.%26atitle%3DResistance-resistant%2520antibiotics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D664%26epage%3D674%26doi%3D10.1016%2Fj.tips.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verlinden, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span> <span> </span><span class="NLM_article-title">Resisting resistance: Is there a solution for malaria?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1517/17460441.2016.1154037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1517%2F17460441.2016.1154037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=395-406&author=B.+K.+Verlindenauthor=A.+Louwauthor=L.+M.+Birkholtz&title=Resisting+resistance%3A+Is+there+a+solution+for+malaria%3F&doi=10.1517%2F17460441.2016.1154037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1517%2F17460441.2016.1154037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2016.1154037%26sid%3Dliteratum%253Aachs%26aulast%3DVerlinden%26aufirst%3DB.%2BK.%26aulast%3DLouw%26aufirst%3DA.%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26atitle%3DResisting%2520resistance%253A%2520Is%2520there%2520a%2520solution%2520for%2520malaria%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D395%26epage%3D406%26doi%3D10.1517%2F17460441.2016.1154037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, J. M.</span></span> <span> </span><span class="NLM_article-title">The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">36804</span>– <span class="NLM_lpage">36813</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.398842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1074%2Fjbc.M112.398842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22932899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOqsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=36804-36813&author=A.+H.+M.+Wongauthor=D.+X.+Zhouauthor=J.+M.+Rini&title=The+X-ray+crystal+structure+of+human+aminopeptidase+N+reveals+a+novel+dimer+and+the+basis+for+peptide+processing&doi=10.1074%2Fjbc.M112.398842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The X-ray Crystal Structure of Human Aminopeptidase N Reveals a Novel Dimer and the Basis for Peptide Processing</span></div><div class="casAuthors">Wong, Alan H. M.; Zhou, Dongxia; Rini, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">36804-36813</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human aminopeptidase N (hAPN/hCD13) is a dimeric membrane protein and a member of the M1 family of zinc metallopeptidases.  Within the rennin-angiotensin system, its enzymic activity is responsible for processing peptide hormones angiotensin III and IV.  In addn., hAPN is also involved in cell adhesion, endocytosis, and signal transduction and it is an important target for cancer therapy.  Reported here are the high resoln. x-ray crystal structures of the dimeric ectodomain of hAPN and its complexes with angiotensin IV and the peptidomimetic inhibitors, amastatin and bestatin.  Each monomer of the dimer is found in what has been termed the closed form in other M1 enzymes and each monomer is characterized by an internal cavity surrounding the catalytic site as well as a unique substrate/inhibitor-dependent loop ordering, which in the case of the bestatin complex suggests a new route to inhibitor design.  The hAPN structure provides the first example of a dimeric M1 family member and the obsd. structural features, in conjunction with a model for the open form, provide novel insights into the mechanism of peptide processing and signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1AkeQE7nfNLVg90H21EOLACvtfcHk0ljOkb8ncofnaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOqsrnF&md5=7b4950107a47e98f51b22d02695b8363</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.398842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.398842%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DA.%2BH.%2BM.%26aulast%3DZhou%26aufirst%3DD.%2BX.%26aulast%3DRini%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520X-ray%2520crystal%2520structure%2520of%2520human%2520aminopeptidase%2520N%2520reveals%2520a%2520novel%2520dimer%2520and%2520the%2520basis%2520for%2520peptide%2520processing%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D36804%26epage%3D36813%26doi%3D10.1074%2Fjbc.M112.398842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, P. J.</span></span> <span> </span><span class="NLM_article-title">The use of Dixon plots to study enzyme inhibition</span>. <i>Biochim. Biophys. Acta, Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/0005-2744(72)90074-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2F0005-2744%2872%2990074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=4631005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADyaE3sXjvFyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1972&pages=251-253&author=P.+J.+Butterworth&title=The+use+of+Dixon+plots+to+study+enzyme+inhibition&doi=10.1016%2F0005-2744%2872%2990074-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Dixon plots to study enzyme inhibition</span></div><div class="casAuthors">Butterworth, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-3</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">The use of the Dixon method of plotting enzyme inhibition data is considered for cases where the interaction between the inhibitor and enzyme is more complex than for classical competitive and noncompetitive inhibition.  It is concluded that the use of Dixon plots in conjunction with Lineweaver-Burk plots can be a valuable aid in the identification of inhibition behavior.  The inhibition patterns considered include mixed, hyperbolic-competitive, and 2 forms of uncompetitive inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCE_-4fgfoZrVg90H21EOLACvtfcHk0ljOkb8ncofnaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXjvFyrtQ%253D%253D&md5=221e08a1552a324cd9a562574aa33afe</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2872%2990074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252872%252990074-5%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520use%2520of%2520Dixon%2520plots%2520to%2520study%2520enzyme%2520inhibition%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Enzymol.%26date%3D1972%26volume%3D289%26spage%3D251%26epage%3D253%26doi%3D10.1016%2F0005-2744%2872%2990074-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1002/prot.24771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1002%2Fprot.24771" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2015&pages=789-795&author=N.+Drinkwaterauthor=R.+S.+Bamertauthor=K.+K.+Sivaramanauthor=A.+Paiardiniauthor=S.+McGowan&title=X-ray+crystal+structures+of+an+orally+available+aminopeptidase+inhibitor%2C+Tosedostat%2C+bound+to+anti-malarial+drug+targets+PfA-M1+and+PfA-M17&doi=10.1002%2Fprot.24771"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fprot.24771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24771%26sid%3Dliteratum%253Aachs%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DX-ray%2520crystal%2520structures%2520of%2520an%2520orally%2520available%2520aminopeptidase%2520inhibitor%252C%2520Tosedostat%252C%2520bound%2520to%2520anti-malarial%2520drug%2520targets%2520PfA-M1%2520and%2520PfA-M17%26jtitle%3DProteins%26date%3D2015%26volume%3D83%26spage%3D789%26epage%3D795%26doi%3D10.1002%2Fprot.24771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowieson, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clift, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrop, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panjikar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riboldi-Tunnicliffe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradoc-Davies, T.</span></span> <span> </span><span class="NLM_article-title">MX1: A bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at The Australian Synchrotron</span>. <i>J. Synchrotron Radiat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1107/S1600577514021717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS1600577514021717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25537608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFeitLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=187-190&author=N.+P.+Cowiesonauthor=D.+Aragaoauthor=M.+Cliftauthor=D.+J.+Ericssonauthor=C.+Geeauthor=S.+J.+Harropauthor=N.+Mudieauthor=S.+Panjikarauthor=J.+R.+Priceauthor=A.+Riboldi-Tunnicliffeauthor=R.+Williamsonauthor=T.+Caradoc-Davies&title=MX1%3A+A+bending-magnet+crystallography+beamline+serving+both+chemical+and+macromolecular+crystallography+communities+at+The+Australian+Synchrotron&doi=10.1107%2FS1600577514021717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">MX1: a bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at the Australian Synchrotron</span></div><div class="casAuthors">Cowieson, Nathan Philip; Aragao, David; Clift, Mark; Ericsson, Daniel J.; Gee, Christine; Harrop, Stephen J.; Mudie, Nathan; Panjikar, Santosh; Price, Jason R.; Riboldi-Tunnicliffe, Alan; Williamson, Rachel; Caradoc-Davies, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-190</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">1600-5775</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MX1 is a bending-magnet crystallog. beamline at the 3 GeV Australian Synchrotron.  The beamline delivers hard X-rays in the energy range from 8 to 18 keV to a focal spot at the sample position of 120 μm FWHM.  The beamline end station and ancillary equipment facilitate local and remote access for both chem. and biol. macromol. crystallog.  Here, the design of the beamline and end station are discussed.  The beamline has enjoyed a full user program for the last seven years and scientific highlights from the user program are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonncGct23S27Vg90H21EOLACvtfcHk0ljOkb8ncofnaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFeitLrO&md5=2f00508e17ab0c8584519b30c3f0505b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS1600577514021717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600577514021717%26sid%3Dliteratum%253Aachs%26aulast%3DCowieson%26aufirst%3DN.%2BP.%26aulast%3DAragao%26aufirst%3DD.%26aulast%3DClift%26aufirst%3DM.%26aulast%3DEricsson%26aufirst%3DD.%2BJ.%26aulast%3DGee%26aufirst%3DC.%26aulast%3DHarrop%26aufirst%3DS.%2BJ.%26aulast%3DMudie%26aufirst%3DN.%26aulast%3DPanjikar%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DJ.%2BR.%26aulast%3DRiboldi-Tunnicliffe%26aufirst%3DA.%26aulast%3DWilliamson%26aufirst%3DR.%26aulast%3DCaradoc-Davies%26aufirst%3DT.%26atitle%3DMX1%253A%2520A%2520bending-magnet%2520crystallography%2520beamline%2520serving%2520both%2520chemical%2520and%2520macromolecular%2520crystallography%2520communities%2520at%2520The%2520Australian%2520Synchrotron%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2015%26volume%3D22%26spage%3D187%26epage%3D190%26doi%3D10.1107%2FS1600577514021717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battye, T. G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontogiannis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span> <span> </span><span class="NLM_article-title">iMosflm: A new graphical interface for diffraction-image processing with mosflm</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1107/S0907444910048675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444910048675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=21460445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=271-281&author=T.+G.+G.+Battyeauthor=L.+Kontogiannisauthor=O.+Johnsonauthor=H.+R.+Powellauthor=A.+G.+W.+Leslie&title=iMosflm%3A+A+new+graphical+interface+for+diffraction-image+processing+with+mosflm&doi=10.1107%2FS0907444910048675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM</span></div><div class="casAuthors">Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen; Powell, Harold R.; Leslie, Andrew G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">IMOSFLM is a graphical user interface to the diffraction data-integration program MOSFLM.  It is designed to simplify data processing by dividing the process into a series of steps, which are normally carried out sequentially.  Each step has its own display pane, allowing control over parameters that influence that step and providing graphical feedback to the user.  Suitable values for integration parameters are set automatically, but addnl. menus provide a detailed level of control for experienced users.  The image display and the interfaces to the different tasks (indexing, strategy calcn., cell refinement, integration and history) are described.  The most important parameters for each step and the best way of assessing success or failure are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeZl2UOMg3_bVg90H21EOLACvtfcHk0lilqFcvAhrtVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D&md5=852651253f8d9c9a81e0513b6633c705</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444910048675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910048675%26sid%3Dliteratum%253Aachs%26aulast%3DBattye%26aufirst%3DT.%2BG.%2BG.%26aulast%3DKontogiannis%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DiMosflm%253A%2520A%2520new%2520graphical%2520interface%2520for%2520diffraction-image%2520processing%2520with%2520mosflm%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D271%26epage%3D281%26doi%3D10.1107%2FS0907444910048675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lilqFcvAhrtVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lilqFcvAhrtVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lgkqjwW1xZyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgkqjwW1xZyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">Phenix: A comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=Phenix%3A+A+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgkqjwW1xZyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPhenix%253A%2520A%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: Model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0liUydheH0N3hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liUydheH0N3hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span> <span> </span><span class="NLM_article-title">Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.2012.11-0302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.4269%2Fajtmh.2012.11-0302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22232455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1ymu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=84-92&author=S.+Duffyauthor=V.+M.+Avery&title=Development+and+optimization+of+a+novel+384-well+anti-malarial+imaging+assay+validated+for+high-throughput+screening&doi=10.4269%2Fajtmh.2012.11-0302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening</span></div><div class="casAuthors">Duffy, Sandra; Avery, Vicky M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Tropical Medicine and Hygiene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-92</span>CODEN:
                <span class="NLM_cas:coden">AJTHAB</span>;
        ISSN:<span class="NLM_cas:issn">0002-9637</span>.
    
            (<span class="NLM_cas:orgname">American Society of Tropical Medicine and Hygiene</span>)
        </div><div class="casAbstract">With the increasing occurrence of drug resistance in the malaria parasite, Plasmodium falciparum, there is a great need for new and novel anti-malarial drugs.  We have developed a 384-well, high-throughput imaging assay for the detection of new anti-malarial compds., which was initially validated by screening a marine natural product library, and subsequently used to screen more than 3 million data points from a variety of compd. sources.  Founded on another fluorescence-based P. falciparum growth inhibition assay, the DNA-intercalating dye 4',6-diamidino-2-phenylindole, was used to monitor changes in parasite no.  Fluorescent images were acquired on the PerkinElmer Opera High Throughput confocal imaging system and analyzed with a spot detection algorithm using the Acapella data processing software.  Further optimization of this assay sought to increase throughput, assay stability, and compatibility with our high-throughput screening equipment platforms.  The assay typically yielded Z'-factor values of 0.5-0.6, with signal-to-noise ratios of 12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9mpHAvJlL67Vg90H21EOLACvtfcHk0lg3b9_lCN5Ckw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1ymu7k%253D&md5=60ae874f46758c03566acfdc948e1188</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.2012.11-0302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.2012.11-0302%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DDevelopment%2520and%2520optimization%2520of%2520a%2520novel%2520384-well%2520anti-malarial%2520imaging%2520assay%2520validated%2520for%2520high-throughput%2520screening%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2012%26volume%3D86%26spage%3D84%26epage%3D92%26doi%3D10.4269%2Fajtmh.2012.11-0302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Belinda Mills, R. Elwyn Isaac, <span class="NLM_string-name hlFld-ContribAuthor">Richard Foster</span>. </span><span class="cited-content_cbyCitation_article-title">Metalloaminopeptidases of the Protozoan Parasite Plasmodium falciparum as Targets for the Discovery of Novel Antimalarial Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1763-1785. <a href="https://doi.org/10.1021/acs.jmedchem.0c01721" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01721%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetalloaminopeptidases%252Bof%252Bthe%252BProtozoan%252BParasite%252BPlasmodium%252Bfalciparum%252Bas%252BTargets%252Bfor%252Bthe%252BDiscovery%252Bof%252BNovel%252BAntimalarial%252BDrugs%26aulast%3DMills%26aufirst%3DBelinda%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30092020%26date%3D03022021%26volume%3D64%26issue%3D4%26spage%3D1763%26epage%3D1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lucas G. Viviani, Erika Piccirillo, Henning Ulrich, <span class="NLM_string-name hlFld-ContribAuthor">Antonia T.-do Amaral</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5′-Nucleotidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (2)
                                     , 621-630. <a href="https://doi.org/10.1021/acs.jcim.9b00884" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00884%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DVirtual%252BScreening%252BApproach%252Bfor%252Bthe%252BIdentification%252Bof%252BHydroxamic%252BAcids%252Bas%252BNovel%252BHuman%252BEcto-5%2525E2%252580%2525B2-Nucleotidase%252BInhibitors%26aulast%3DViviani%26aufirst%3DLucas%2BG.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D30092019%26date%3D26112019%26date%3D12112019%26volume%3D60%26issue%3D2%26spage%3D621%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rency  Mathew</span>, <span class="hlFld-ContribAuthor ">Juliane  Wunderlich</span>, <span class="hlFld-ContribAuthor ">Karine  Thivierge</span>, <span class="hlFld-ContribAuthor ">Krystyna  Cwiklinski</span>, <span class="hlFld-ContribAuthor ">Claire  Dumont</span>, <span class="hlFld-ContribAuthor ">Leann  Tilley</span>, <span class="hlFld-ContribAuthor ">Petra  Rohrbach</span>, <span class="hlFld-ContribAuthor ">John P.  Dalton</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical and cellular characterisation of the Plasmodium falciparum M1 alanyl aminopeptidase (PfM1AAP) and M17 leucyl aminopeptidase (PfM17LAP). </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-82499-4" title="DOI URL">https://doi.org/10.1038/s41598-021-82499-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-82499-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-82499-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DBiochemical%252Band%252Bcellular%252Bcharacterisation%252Bof%252Bthe%252BPlasmodium%252Bfalciparum%252BM1%252Balanyl%252Baminopeptidase%252B%252528PfM1AAP%252529%252Band%252BM17%252Bleucyl%252Baminopeptidase%252B%252528PfM17LAP%252529%26aulast%3DMathew%26aufirst%3DRency%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeepchowdary  Bala</span>, <span class="hlFld-ContribAuthor ">Kalisha vali  Yellamanda</span>, <span class="hlFld-ContribAuthor ">Anilkumar  Kadari</span>, <span class="hlFld-ContribAuthor ">Venkata.S.U.  Ravinuthala</span>, <span class="hlFld-ContribAuthor ">Bhavita  Kattula</span>, <span class="hlFld-ContribAuthor ">Om V.  Singh</span>, <span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Anthony  Addlagatta</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of Helicobacter pylori methionine aminopeptidase by azaindole hydroxamic acid derivatives: Design, synthesis, in vitro biochemical and structural studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>115 </em>, 105185. <a href="https://doi.org/10.1016/j.bioorg.2021.105185" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105185%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSelective%252Binhibition%252Bof%252BHelicobacter%252Bpylori%252Bmethionine%252Baminopeptidase%252Bby%252Bazaindole%252Bhydroxamic%252Bacid%252Bderivatives%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Bbiochemical%252Band%252Bstructural%252Bstudies%26aulast%3DBala%26aufirst%3DSandeepchowdary%26date%3D2021%26volume%3D115%26spage%3D105185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tess R.  Malcolm</span>, <span class="hlFld-ContribAuthor ">Karolina W.  Swiderska</span>, <span class="hlFld-ContribAuthor ">Brooke K.  Hayes</span>, <span class="hlFld-ContribAuthor ">Chaille T.  Webb</span>, <span class="hlFld-ContribAuthor ">Marcin  Drag</span>, <span class="hlFld-ContribAuthor ">Nyssa  Drinkwater</span>, <span class="hlFld-ContribAuthor ">Sheena  McGowan</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the substrate specificity of the
              Plasmodium
              M1 and M17 aminopeptidases. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2021,</strong> <em>478 </em>
                                    (13)
                                     , 2697-2713. <a href="https://doi.org/10.1042/BCJ20210172" title="DOI URL">https://doi.org/10.1042/BCJ20210172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20210172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20210172%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DMapping%252Bthe%252Bsubstrate%252Bspecificity%252Bof%252Bthe%252BPlasmodium%252BM1%252Band%252BM17%252Baminopeptidases%26aulast%3DMalcolm%26aufirst%3DTess%2BR.%26date%3D2021%26date%3D2021%26volume%3D478%26issue%3D13%26spage%3D2697%26epage%3D2713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jisook  Lee</span>, <span class="hlFld-ContribAuthor ">Nyssa  Drinkwater</span>, <span class="hlFld-ContribAuthor ">Sheena  McGowan</span>, <span class="hlFld-ContribAuthor ">Peter  Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">A Structure−Activity Relationship Study of Novel Hydroxamic Acid Inhibitors around the S1 Subsite of Human Aminopeptidase N. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 234-249. <a href="https://doi.org/10.1002/cmdc.202000527" title="DOI URL">https://doi.org/10.1002/cmdc.202000527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000527%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BStudy%252Bof%252BNovel%252BHydroxamic%252BAcid%252BInhibitors%252Baround%252Bthe%252BS1%252BSubsite%252Bof%252BHuman%252BAminopeptidase%252BN%26aulast%3DLee%26aufirst%3DJisook%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D234%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tess R.  Malcolm</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Belousoff</span>, <span class="hlFld-ContribAuthor ">Hariprasad  Venugopal</span>, <span class="hlFld-ContribAuthor ">Natalie A.  Borg</span>, <span class="hlFld-ContribAuthor ">Nyssa  Drinkwater</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Sheena  McGowan</span>. </span><span class="cited-content_cbyCitation_article-title">Active site metals mediate an oligomeric equilibrium in Plasmodium M17 aminopeptidases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100173. <a href="https://doi.org/10.1074/jbc.RA120.016313" title="DOI URL">https://doi.org/10.1074/jbc.RA120.016313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA120.016313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA120.016313%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DActive%252Bsite%252Bmetals%252Bmediate%252Ban%252Boligomeric%252Bequilibrium%252Bin%252BPlasmodium%252BM17%252Baminopeptidases%26aulast%3DMalcolm%26aufirst%3DTess%2BR.%26date%3D2021%26volume%3D296%26spage%3D100173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petar P. S.  Calic</span>, <span class="hlFld-ContribAuthor ">Mahta  Mansouri</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Sheena  McGowan</span>. </span><span class="cited-content_cbyCitation_article-title">Driving antimalarial design through understanding of target mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2020,</strong> <em>48 </em>
                                    (5)
                                     , 2067-2078. <a href="https://doi.org/10.1042/BST20200224" title="DOI URL">https://doi.org/10.1042/BST20200224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20200224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20200224%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DDriving%252Bantimalarial%252Bdesign%252Bthrough%252Bunderstanding%252Bof%252Btarget%252Bmechanism%26aulast%3DCalic%26aufirst%3DPetar%2BP.%2BS.%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D5%26spage%3D2067%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilia M.  Marijanovic</span>, <span class="hlFld-ContribAuthor ">Karolina  Weronika Swiderska</span>, <span class="hlFld-ContribAuthor ">James  Andersen</span>, <span class="hlFld-ContribAuthor ">Jasmin C.  Aschenbrenner</span>, <span class="hlFld-ContribAuthor ">Chaille T.  Webb</span>, <span class="hlFld-ContribAuthor ">Marcin  Drag</span>, <span class="hlFld-ContribAuthor ">Nyssa  Drinkwater</span>, <span class="hlFld-ContribAuthor ">Sheena  McGowan</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray crystal structure and specificity of the Toxoplasma gondii ME49 TgAPN2. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (19)
                                     , 3819-3832. <a href="https://doi.org/10.1042/BCJ20200569" title="DOI URL">https://doi.org/10.1042/BCJ20200569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200569%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DX-ray%252Bcrystal%252Bstructure%252Band%252Bspecificity%252Bof%252Bthe%252BToxoplasma%252Bgondii%252BME49%252BTgAPN2%26aulast%3DMarijanovic%26aufirst%3DEmilia%2BM.%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D19%26spage%3D3819%26epage%3D3832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel  Salomon</span>, <span class="hlFld-ContribAuthor ">Marjorie  Schmitt</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Mouray</span>, <span class="hlFld-ContribAuthor ">Alastair G.  McEwen</span>, <span class="hlFld-ContribAuthor ">Lotfi  Bounaadja</span>, <span class="hlFld-ContribAuthor ">Morgan  Torchy</span>, <span class="hlFld-ContribAuthor ">Pierre  Poussin-Courmontagne</span>, <span class="hlFld-ContribAuthor ">Sarah  Alavi</span>, <span class="hlFld-ContribAuthor ">Céline  Tarnus</span>, <span class="hlFld-ContribAuthor ">Jean  Cavarelli</span>, <span class="hlFld-ContribAuthor ">Isabelle  Florent</span>, <span class="hlFld-ContribAuthor ">Sébastien  Albrecht</span>. </span><span class="cited-content_cbyCitation_article-title">Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>98 </em>, 103750. <a href="https://doi.org/10.1016/j.bioorg.2020.103750" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103750%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAminobenzosuberone%252Bderivatives%252Bas%252BPfA-M1%252Binhibitors%25253A%252BMolecular%252Brecognition%252Band%252Bantiplasmodial%252Bevaluation%26aulast%3DSalomon%26aufirst%3DEmmanuel%26date%3D2020%26volume%3D98%26spage%3D103750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Graham L.  Patrick</span>. </span><span class="cited-content_cbyCitation_article-title">Antimalarial agents acting on hemoglobin degradation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 187-216. <a href="https://doi.org/10.1016/B978-0-08-101210-9.00006-8" title="DOI URL">https://doi.org/10.1016/B978-0-08-101210-9.00006-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101210-9.00006-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101210-9.00006-8%26sid%3Dliteratum%253Aachs%26atitle%3DAntimalarial%252Bagents%252Bacting%252Bon%252Bhemoglobin%252Bdegradation%26aulast%3DPatrick%26aufirst%3DGraham%2BL.%26date%3D2020%26spage%3D187%26epage%3D216%26pub%3DElsevier%26atitle%3DAntimalarial%252BAgents%26date%3D2020%26volume%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manasi  Mishra</span>, <span class="hlFld-ContribAuthor ">Vigyasa  Singh</span>, <span class="hlFld-ContribAuthor ">Shailja  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Insights Into Key Plasmodium Proteases as Therapeutic Drug Targets. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fmicb.2019.00394" title="DOI URL">https://doi.org/10.3389/fmicb.2019.00394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2019.00394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2019.00394%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DStructural%252BInsights%252BInto%252BKey%252BPlasmodium%252BProteases%252Bas%252BTherapeutic%252BDrug%252BTargets%26aulast%3DMishra%26aufirst%3DManasi%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Rodolfo  Lavilla</span>, <span class="hlFld-ContribAuthor ">Francisco Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Ouldouz  Ghashghaei</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent reactions: A mighty journey partner for infectious tropical disease drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 181-217. <a href="https://doi.org/10.1016/bs.armc.2019.05.005" title="DOI URL">https://doi.org/10.1016/bs.armc.2019.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2019.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2019.05.005%26sid%3Dliteratum%253Aachs%26atitle%3DMulticomponent%252Breactions%25253A%252BA%252Bmighty%252Bjourney%252Bpartner%252Bfor%252Binfectious%252Btropical%252Bdisease%252Bdrug%252Bdiscovery%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DDiego%26date%3D2019%26spage%3D181%26epage%3D217%26pub%3DElsevier%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BMalaria%252Band%252BOther%252BTropical%252BDiseases%26date%3D2019%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) cat. concd H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux, 30 h; (b) cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 3,4,5-trifluorophenylboronic acid, degassed 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, degassed THF, reflux, 2 h; (c) method A: acid chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 2 h; method B: acid, HCTU, <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), CH<sub>2</sub>Cl<sub>2</sub>, dimethylformamide (DMF), rt, 2 h; method C: acid, EDC·HCl, 4-dimethylaminopyridine (DMAP), CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (d) NH<sub>2</sub>OH·HCl, 5 M KOH/MeOH, dry MeOH, rt, 16 h.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound inhibition trends for (A) <i>Pf</i>- and <i>Pv</i>-M1 enzymes and (B) <i>Pf</i>- and <i>Pv</i>-M17 aminopeptidases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of selected compounds to <i>Pf</i>-M1 (gray cartoon). (A) Overlay of the binding position of <b>1</b> (yellow sticks) and <b>6h</b> (blue sticks) in the <i>Pf</i>-M1 binding pocket (gray sticks). (B) Structure of <b>6o</b> in complex with <i>Pf</i>-M1 (gray sticks). Molecular interactions between <b>6o</b> and the S1′ subsite are indicated by dashed lines. (C) Solvent-accessible surface of <i>Pf</i>-M1 (gray) with the S1 and S1′ subsites as well as the substrate/product access channel are indicated. Stick representation shows the binding positions of <b>6h</b> (purple), <b>6o</b> (pink), and <b>6p</b> (orange). (D) Structure of <b>6p</b> (orange) in complex with <i>Pf</i>-M1 (gray sticks). Molecular interactions between the <i>N</i>-acyl and ethyl-linked cyclohexane moieties of <b>6o</b> are indicated by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Arrangement of the binuclear metal site of <i>Pf</i>-M17 (gray sticks and spheres) with S1 and S1′ substrate binding sites and catalytic carbonate ion indicated. (A) Crystal structure of <i>Pf</i>-M17 with only the catalytic metal site occupied (Zn<sup>2+</sup>, site 2).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (B) <i>Pf</i>-M17 crystals treated with a Zn<sup>2+</sup> soak solution yield a structure with both the regulatory site 1 and catalytic site 2 occupied by Zn<sup>2+</sup>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (C) Compound <b>1</b> (yellow) coordinates both Zn<sup>2+</sup> ions through the hydroxamic acid moiety.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (D) Compound <b>6k</b> (teal) displaces the catalytic Zn<sup>2+</sup> from site 2 of <i>Pf</i>-M17.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/medium/jm-2018-01310w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of selected compounds to <i>Pf</i>-M17. (A) Solvent-accessible surface of <i>Pf</i>-M17 (gray) with catalytic Zn<sup>2+</sup> (site 2, yellow) and regulatory Zn<sup>2+</sup> (site 1, gray) indicated. Stick representation shows the binding positions of <b>1</b> (yellow) and <b>6k</b> (teal). Zn<sup>2+</sup> occupies site 2 (yellow) when <i>Pf</i>-M17 is in complex with <b>1</b> but not in complex with <b>6k</b>. (B) Structure of <b>6k</b> in complex with <i>Pf</i>-M17 (gray sticks). Molecular interactions between <b>6k</b> (teal) and the site 1 Zn<sup>2+</sup> and S1′ subsite are indicated by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01310/20190116/images/large/jm-2018-01310w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01310&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report</i>; CC BY-NC-SA 3.0 IGO; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva,
Switzerland</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Malaria%2520Report%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjitra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstey, N. M.</span></span> <span> </span><span class="NLM_article-title">Vivax malaria: Neglected and not benign</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.2007.77.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.4269%2Fajtmh.2007.77.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2007&pages=79-87&author=R.+N.+Priceauthor=E.+Tjitraauthor=C.+A.+Guerraauthor=S.+Yeungauthor=N.+J.+Whiteauthor=N.+M.+Anstey&title=Vivax+malaria%3A+Neglected+and+not+benign&doi=10.4269%2Fajtmh.2007.77.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.2007.77.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.2007.77.79%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DTjitra%26aufirst%3DE.%26aulast%3DGuerra%26aufirst%3DC.%2BA.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DAnstey%26aufirst%3DN.%2BM.%26atitle%3DVivax%2520malaria%253A%2520Neglected%2520and%2520not%2520benign%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2007%26volume%3D77%26spage%3D79%26epage%3D87%26doi%3D10.4269%2Fajtmh.2007.77.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdell, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muwanguzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Schalkwyk, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gkrania-Klotsas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiodini, P.</span></span> <span> </span><span class="NLM_article-title">pfk13-Independent treatment failure in four imported cases of <i>Plasmodium falciparum</i> malaria treated with artemether-lumefantrine in the united kingdom</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e02382</span> <span class="refDoi"> DOI: 10.1128/AAC.02382-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1128%2FAAC.02382-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=C.+J.+Sutherlandauthor=P.+L.+Lansdellauthor=M.+Sandersauthor=J.+Muwanguziauthor=D.+A.+van+Schalkwykauthor=H.+Kaurauthor=D.+Nolderauthor=J.+Tuckerauthor=H.+M.+Bennettauthor=T.+D.+Ottoauthor=M.+Berrimanauthor=T.+A.+Patelauthor=R.+Lynnauthor=E.+Gkrania-Klotsasauthor=P.+Chiodini&title=pfk13-Independent+treatment+failure+in+four+imported+cases+of+Plasmodium+falciparum+malaria+treated+with+artemether-lumefantrine+in+the+united+kingdom&doi=10.1128%2FAAC.02382-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FAAC.02382-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02382-16%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DC.%2BJ.%26aulast%3DLansdell%26aufirst%3DP.%2BL.%26aulast%3DSanders%26aufirst%3DM.%26aulast%3DMuwanguzi%26aufirst%3DJ.%26aulast%3Dvan%2BSchalkwyk%26aufirst%3DD.%2BA.%26aulast%3DKaur%26aufirst%3DH.%26aulast%3DNolder%26aufirst%3DD.%26aulast%3DTucker%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DH.%2BM.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DT.%2BA.%26aulast%3DLynn%26aufirst%3DR.%26aulast%3DGkrania-Klotsas%26aufirst%3DE.%26aulast%3DChiodini%26aufirst%3DP.%26atitle%3Dpfk13-Independent%2520treatment%2520failure%2520in%2520four%2520imported%2520cases%2520of%2520Plasmodium%2520falciparum%2520malaria%2520treated%2520with%2520artemether-lumefantrine%2520in%2520the%2520united%2520kingdom%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2FAAC.02382-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sovannaroth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jittamala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chutasmit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchatsoonthorn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runcharoen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Nhien, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Htut, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aye, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokuolu, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaosebikan, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folaranmi, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayxay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanthavong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongvanthong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyamboko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanello, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshefu, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valecha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashraheil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peshu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacInnis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeeyapant, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakulthaew, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intharabut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihokhern, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunasol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrow, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flegg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowe, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepniewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Spread of artemisinin resistance in <i>Plasmodium falciparum</i> malaria</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1314981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1056%2FNEJMoa1314981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25075834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=411-423&author=E.+A.+Ashleyauthor=M.+Dhordaauthor=R.+M.+Fairhurstauthor=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=J.+M.+Andersonauthor=S.+Maoauthor=B.+Samauthor=C.+Sophaauthor=C.+M.+Chuorauthor=C.+Nguonauthor=S.+Sovannarothauthor=S.+Pukrittayakameeauthor=P.+Jittamalaauthor=K.+Chotivanichauthor=K.+Chutasmitauthor=C.+Suchatsoonthornauthor=R.+Runcharoenauthor=T.+T.+Hienauthor=N.+T.+Thuy-Nhienauthor=N.+V.+Thanhauthor=N.+H.+Phuauthor=Y.+Htutauthor=K.+T.+Hanauthor=K.+H.+Ayeauthor=O.+A.+Mokuoluauthor=R.+R.+Olaosebikanauthor=O.+O.+Folaranmiauthor=M.+Mayxayauthor=M.+Khanthavongauthor=B.+Hongvanthongauthor=P.+N.+Newtonauthor=M.+A.+Onyambokoauthor=C.+I.+Fanelloauthor=A.+K.+Tshefuauthor=N.+Mishraauthor=N.+Valechaauthor=A.+P.+Phyoauthor=F.+Nostenauthor=P.+Yiauthor=R.+Tripuraauthor=S.+Borrmannauthor=M.+Bashraheilauthor=J.+Peshuauthor=M.+A.+Faizauthor=A.+Ghoseauthor=M.+A.+Hossainauthor=R.+Samadauthor=M.+R.+Rahmanauthor=M.+M.+Hasanauthor=A.+Islamauthor=O.+Miottoauthor=R.+Amatoauthor=B.+MacInnisauthor=J.+Stalkerauthor=D.+P.+Kwiatkowskiauthor=Z.+Bozdechauthor=A.+Jeeyapantauthor=P.+Y.+Cheahauthor=T.+Sakulthaewauthor=J.+Chalkauthor=B.+Intharabutauthor=K.+Silamutauthor=S.+J.+Leeauthor=B.+Vihokhernauthor=C.+Kunasolauthor=M.+Imwongauthor=J.+Tarningauthor=W.+J.+Taylorauthor=S.+Yeungauthor=C.+J.+Woodrowauthor=J.+A.+Fleggauthor=D.+Dasauthor=J.+Smithauthor=M.+Venkatesanauthor=C.+V.+Ploweauthor=K.+Stepniewskaauthor=P.+J.+Guerinauthor=A.+M.+Dondorpauthor=N.+P.+Dayauthor=N.+J.+White&title=Spread+of+artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa1314981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Spread of artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Ashley, E. A.; Dhorda, M.; Fairhurst, R. M.; Amaratunga, C.; Lim, P.; Suon, S.; Sreng, S.; Anderson, J. M.; Mao, S.; Sam, B.; Sopha, C.; Chuor, C. M.; Nguon, C.; Sovannaroth, S.; Pukrittayakamee, S.; Jittamala, P.; Chotivanich, K.; Chutasmit, K.; Suchatsoonthorn, C.; Runcharoen, R.; Hien, T. T.; Thuy-Nhien, N. T.; Thanh, N. V.; Phu, N. H.; Htut, Y.; Han, K.-T.; Aye, K. H.; Mokuolu, O. A.; Olaosebikan, R. R.; Folaranmi, O. O.; Mayxay, M.; Khanthavong, M.; Hongvanthong, B.; Newton, P. N.; Onyamboko, M. A.; Fanello, C. I.; Tshefu, A. K.; Mishra, N.; Valecha, N.; Phyo, A. P.; Nosten, F.; Yi, P.; Tripura, R.; Borrmann, S.; Bashraheil, M.; Peshu, J.; Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.; Hasan, M. M.; Islam, A.; Miotto, O.; Amato, R.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.; Bozdech, Z.; Jeeyapant, A.; Cheah, P. Y.; Sakulthaew, T.; Chalk, J.; Intharabut, B.; Silamut, K.; Lee, S. J.; Vihokhern, B.; Kunasol, C.; Imwong, M.; Tarning, J.; Taylor, W. J.; Yeung, S.; Woodrow, C. J.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Plowe, C. V.; Stepniewska, K.; Guerin, P. J.; Dondorp, A. M.; Day, N. P.; White, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-423, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria.  Mapping the geog. extent of resistance is essential for planning containment and elimination strategies.  Methods: Between May 2011 and Apr. 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa).  Patients received artesunate, administered orally at a daily dose of either 2 mg per kg of body wt. per day or 4 mg per kg, for 3 days, followed by a std. 3-day course of artemisinin-based combination therapy.  Parasite counts in peripheral-blood samples were measured every 6 h, and the parasite clearance half-lives were detd.  Results: The median parasite clearance half-lives ranged from 1.9 h in the Democratic Republic of Congo to 7.0 h at the Thailand-Cambodia border.  Slowly clearing infections (parasite clearance half-life >5 h), strongly assocd. with single point mutations in the "propeller" region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from Southern Vietnam to central Myanmar.  The incidence of pre-treatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.  In Western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was assocd. with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days.  Conclusions: Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is assocd. with mutations in kelch13.  Prolonged courses of artemisinin- based combination therapies are currently efficacious in areas where std. 3-day treatments are failing. (Funded by the U.K. Department of International Development and others).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aJ4A3O4W8rVg90H21EOLACvtfcHk0lijDtaMCKKnCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF&md5=bb2f2a4d554ba6a1f4c605868be43f6e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1314981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1314981%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DNguon%26aufirst%3DC.%26aulast%3DSovannaroth%26aufirst%3DS.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DChutasmit%26aufirst%3DK.%26aulast%3DSuchatsoonthorn%26aufirst%3DC.%26aulast%3DRuncharoen%26aufirst%3DR.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DThuy-Nhien%26aufirst%3DN.%2BT.%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DPhu%26aufirst%3DN.%2BH.%26aulast%3DHtut%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DK.%2BT.%26aulast%3DAye%26aufirst%3DK.%2BH.%26aulast%3DMokuolu%26aufirst%3DO.%2BA.%26aulast%3DOlaosebikan%26aufirst%3DR.%2BR.%26aulast%3DFolaranmi%26aufirst%3DO.%2BO.%26aulast%3DMayxay%26aufirst%3DM.%26aulast%3DKhanthavong%26aufirst%3DM.%26aulast%3DHongvanthong%26aufirst%3DB.%26aulast%3DNewton%26aufirst%3DP.%2BN.%26aulast%3DOnyamboko%26aufirst%3DM.%2BA.%26aulast%3DFanello%26aufirst%3DC.%2BI.%26aulast%3DTshefu%26aufirst%3DA.%2BK.%26aulast%3DMishra%26aufirst%3DN.%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DTripura%26aufirst%3DR.%26aulast%3DBorrmann%26aufirst%3DS.%26aulast%3DBashraheil%26aufirst%3DM.%26aulast%3DPeshu%26aufirst%3DJ.%26aulast%3DFaiz%26aufirst%3DM.%2BA.%26aulast%3DGhose%26aufirst%3DA.%26aulast%3DHossain%26aufirst%3DM.%2BA.%26aulast%3DSamad%26aufirst%3DR.%26aulast%3DRahman%26aufirst%3DM.%2BR.%26aulast%3DHasan%26aufirst%3DM.%2BM.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DMacInnis%26aufirst%3DB.%26aulast%3DStalker%26aufirst%3DJ.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DJeeyapant%26aufirst%3DA.%26aulast%3DCheah%26aufirst%3DP.%2BY.%26aulast%3DSakulthaew%26aufirst%3DT.%26aulast%3DChalk%26aufirst%3DJ.%26aulast%3DIntharabut%26aufirst%3DB.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DVihokhern%26aufirst%3DB.%26aulast%3DKunasol%26aufirst%3DC.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DW.%2BJ.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWoodrow%26aufirst%3DC.%2BJ.%26aulast%3DFlegg%26aufirst%3DJ.%2BA.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DM.%26aulast%3DPlowe%26aufirst%3DC.%2BV.%26aulast%3DStepniewska%26aufirst%3DK.%26aulast%3DGuerin%26aufirst%3DP.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DSpread%2520of%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D411%26epage%3D423%26doi%3D10.1056%2FNEJMoa1314981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istvan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluzman, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8840</span>– <span class="NLM_lpage">8845</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601876103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.0601876103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=16731623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVChsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=8840-8845&author=J.+Liuauthor=E.+S.+Istvanauthor=I.+Y.+Gluzmanauthor=J.+Grossauthor=D.+E.+Goldberg&title=Plasmodium+falciparum+ensures+its+amino+acid+supply+with+multiple+acquisition+pathways+and+redundant+proteolytic+enzyme+systems&doi=10.1073%2Fpnas.0601876103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems</span></div><div class="casAuthors">Liu, Jun; Istvan, Eva S.; Gluzman, Ilya Y.; Gross, Julia; Goldberg, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8840-8845</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Degrdn. of host Hb by the human malaria parasite Plasmodium falciparum is a massive metabolic process.  What role this degrdn. plays and whether it is essential for parasite survival have not been established, nor have the roles of the various degradative enzymes been clearly defined.  The authors report that P. falciparum can grow in medium contg. a single amino acid (isoleucine, the only amino acid missing from human Hb).  In this medium, growth of Hb-degrading enzyme gene knockout lines (missing falcipain-2 and plasmepsins alone or in combination) is impaired.  Blockade of plasmepsins with the potent inhibitor pepstatin A has a minimal effect on WT parasite growth but kills falcipain-2 knockout parasites at low concns. and is even more potent on falcipain-2, plasmepsin I and IV triple knockout parasites.  It is concluded that: (i) Hb degrdn. is necessary for parasite survival; (ii) Hb degrdn. is sufficient to supply most of the parasite's amino acid requirements; (iii) external amino acid acquisition and Hb digestion are partially redundant nutrient pathways; (iv) Hb degrdn. uses dual protease families with overlapping function; and (v) Hb-degrading plasmepsins are not promising drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlSCICNnyrZLVg90H21EOLACvtfcHk0lhwMb-EIKOtFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVChsrk%253D&md5=d97f115a4b219c4c88f9f781b28b52d5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601876103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601876103%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DIstvan%26aufirst%3DE.%2BS.%26aulast%3DGluzman%26aufirst%3DI.%2BY.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26atitle%3DPlasmodium%2520falciparum%2520ensures%2520its%2520amino%2520acid%2520supply%2520with%2520multiple%2520acquisition%2520pathways%2520and%2520redundant%2520proteolytic%2520enzyme%2520systems%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D8840%26epage%3D8845%26doi%3D10.1073%2Fpnas.0601876103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1042/bj3390363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1042%2Fbj3390363" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1999&pages=363-370&author=P.+Loriaauthor=S.+Millerauthor=M.+Foleyauthor=L.+Tilley&title=Inhibition+of+the+peroxidative+degradation+of+haem+as+the+basis+of+action+of+chloroquine+and+other+quinoline+antimalarials&doi=10.1042%2Fbj3390363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbj3390363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3390363%26sid%3Dliteratum%253Aachs%26aulast%3DLoria%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DFoley%26aufirst%3DM.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520the%2520peroxidative%2520degradation%2520of%2520haem%2520as%2520the%2520basis%2520of%2520action%2520of%2520chloroquine%2520and%2520other%2520quinoline%2520antimalarials%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D339%26spage%3D363%26epage%3D370%26doi%3D10.1042%2Fbj3390363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbut, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velmourougane, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onder, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span> <span> </span><span class="NLM_article-title">Bestatin-based chemical biology strategy reveals distinct roles for malaria M1-and M17-family aminopeptidases</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">E526</span>– <span class="NLM_lpage">E534</span>, <span class="refDoi"> DOI: 10.1073/pnas.1105601108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.1105601108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E526-E534&author=M.+B.+Harbutauthor=G.+Velmourouganeauthor=S.+Dalalauthor=G.+Reissauthor=J.+C.+Whisstockauthor=O.+Onderauthor=D.+Brissonauthor=S.+McGowanauthor=M.+Klembaauthor=D.+C.+Greenbaum&title=Bestatin-based+chemical+biology+strategy+reveals+distinct+roles+for+malaria+M1-and+M17-family+aminopeptidases&doi=10.1073%2Fpnas.1105601108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1105601108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1105601108%26sid%3Dliteratum%253Aachs%26aulast%3DHarbut%26aufirst%3DM.%2BB.%26aulast%3DVelmourougane%26aufirst%3DG.%26aulast%3DDalal%26aufirst%3DS.%26aulast%3DReiss%26aufirst%3DG.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DOnder%26aufirst%3DO.%26aulast%3DBrisson%26aufirst%3DD.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DKlemba%26aufirst%3DM.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26atitle%3DBestatin-based%2520chemical%2520biology%2520strategy%2520reveals%2520distinct%2520roles%2520for%2520malaria%2520M1-and%2520M17-family%2520aminopeptidases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3DE526%26epage%3DE534%26doi%3D10.1073%2Fpnas.1105601108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Working in concert: The metalloaminopeptidases from <i>Plasdmodium falciparum</i></span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1016/j.sbi.2013.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.sbi.2013.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=23948130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Klur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=828-835&author=S.+McGowan&title=Working+in+concert%3A+The+metalloaminopeptidases+from+Plasdmodium+falciparum&doi=10.1016%2Fj.sbi.2013.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Working in concert: the metalloaminopeptidases from Plasmodium falciparum</span></div><div class="casAuthors">McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria remains the world's most prevalent human parasitic disease.  Because of the rapid spread of drug resistance in parasites, there is an urgent need to identify diverse new drug targets.  One group of proteases that are emerging as targets for novel antimalarials are the metalloaminopeptidases.  These enzymes catalyze the removal of the N-terminal amino acids from proteins and peptides.  Given the restricted specificities of each of these enzymes for different N-terminal amino acids, it is thought that they act in concert to facilitate protein turnover.  Here we review recent structure and functional data relating to the development of the Plasmodium falciparum metalloaminopeptidases as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsJoUmCMyXorVg90H21EOLACvtfcHk0lizrus__JSktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Klur%252FM&md5=2730eb149ef16f20d95fdfed21a49fd1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2013.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2013.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DWorking%2520in%2520concert%253A%2520The%2520metalloaminopeptidases%2520from%2520Plasdmodium%2520falciparum%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D23%26spage%3D828%26epage%3D835%26doi%3D10.1016%2Fj.sbi.2013.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemba, M.</span></span> <span> </span><span class="NLM_article-title">Roles for two aminopeptidases in vacuolar hemoglobin catabolism in <i>Plasmodium falciparum</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">35978</span>– <span class="NLM_lpage">35987</span>, <span class="refDoi"> DOI: 10.1074/jbc.M703643200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1074%2Fjbc.M703643200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=17895246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKrsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=35978-35987&author=S.+Dalalauthor=M.+Klemba&title=Roles+for+two+aminopeptidases+in+vacuolar+hemoglobin+catabolism+in+Plasmodium+falciparum&doi=10.1074%2Fjbc.M703643200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum</span></div><div class="casAuthors">Dalal, Seema; Klemba, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">35978-35987</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">During the erythrocytic stage of its life cycle, the human malaria parasite P. falciparum catabolizes large quantities of host-cell Hb in an acidic organelle, the food vacuole.  A current model for the catabolism of globin-derived oligopeptides invokes peptide transport out of the food vacuole followed by hydrolysis to amino acids by cytosolic aminopeptidases.  To test this model, we have examd. the roles of 4 parasite aminopeptidases during the erythrocytic cycle.  Localization of tagged aminopeptidases, coupled with biochem. anal. of enriched food vacuoles, revealed the presence of amino acid-generating pathways in the food vacuole as well as the cytosol.  Based on the localization data and in vitro assays, we propose a specific role for 1 of the plasmodial enzymes, aminopeptidase P, in the catabolism of proline-contg. peptides in both the vacuole and the cytosol.  We establish an apparent requirement for 3 of the 4 aminopeptidases (including the 2 food vacuole enzymes) for efficient parasite proliferation.  To gain insight into the impact of aminopeptidase inhibition on parasite development, we examd. the effect of the presence of amino acids in the culture medium of the parasite on the toxicity of the aminopeptidase inhibitor bestatin.  The ability of bestatin to block parasite replication was only slightly affected when 19 of 20 amino acids were withdrawn from the medium, indicating that exogenous amino acids cannot compensate for the loss of aminopeptidase activity.  Together, these results support the development of aminopeptidase inhibitors as novel chemotherapeutics directed against malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS44RDNvaul7Vg90H21EOLACvtfcHk0lizrus__JSktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKrsbvN&md5=fdd8ca959749a9f2e51d74511ecf41bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M703643200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M703643200%26sid%3Dliteratum%253Aachs%26aulast%3DDalal%26aufirst%3DS.%26aulast%3DKlemba%26aufirst%3DM.%26atitle%3DRoles%2520for%2520two%2520aminopeptidases%2520in%2520vacuolar%2520hemoglobin%2520catabolism%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D35978%26epage%3D35987%26doi%3D10.1074%2Fjbc.M703643200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span> <span> </span><span class="NLM_article-title">Identification of phosphinate dipeptide analog inhibitors directed against the <i>Plasmodium falciparum</i> M17 leucine aminopeptidase as lead antimalarial compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6024</span>– <span class="NLM_lpage">6031</span>, <span class="refDoi"> DOI: 10.1021/jm070733v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070733v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1WmtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6024-6031&author=T.+S.+Skinner-Adamsauthor=J.+Lowtherauthor=F.+Teuscherauthor=C.+M.+Stackauthor=J.+Grembeckaauthor=A.+Muchaauthor=P.+Kafarskiauthor=K.+R.+Trenholmeauthor=J.+P.+Daltonauthor=D.+L.+Gardiner&title=Identification+of+phosphinate+dipeptide+analog+inhibitors+directed+against+the+Plasmodium+falciparum+M17+leucine+aminopeptidase+as+lead+antimalarial+compounds&doi=10.1021%2Fjm070733v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Phosphinate Dipeptide Analog Inhibitors Directed against the Plasmodium falciparum M17 Leucine Aminopeptidase as Lead Antimalarial Compounds</span></div><div class="casAuthors">Skinner-Adams, Tina S.; Lowther, Jonathan; Teuscher, Franka; Stack, Colin M.; Grembecka, Jolanta; Mucha, Artur; Kafarski, Pawel; Trenholme, Katharine R.; Dalton, John P.; Gardiner, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6024-6031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previous studies have pinpointed the M17 leucyl aminopeptidase of Plasmodium falciparum (PfLAP) as a target for the development of new antimalarials.  This metallo-exopeptidase functions in the terminal stages of Hb digestion and is inhibited by bestatin, a natural analog of Phe-Leu.  By screening novel phosphinate dipeptide analogs for inhibitory activity against recombinant PfLAP, the authors have discovered two compds., 4 (hPheP[CH2]Phe) and 5 (hPheP[CH2]Tyr), with inhibitory consts. better than bestatin.  These compds. are fast, tight-binding inhibitors that make improved contacts within the active site of PfLAP.  Both compds. inhibit the growth of P. falciparum in vitro, exhibiting IC50 values against the chloroquine-resistant clone Dd2 of 20-40 and 12-23 μM, resp.  While bestatin exhibited some in vivo activity against Plasmodium chabaudi chabaudi, compd. 4 reduced parasite burden by 92%.  These studies establish the PfLAP as a prime target for the development of antimalarial drugs and provide important new lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryDK8YFccd3rVg90H21EOLACvtfcHk0lg78juYhJW8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1WmtLzL&md5=ceed62d0395c7fc729c6071a26688282</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm070733v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070733v%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DTeuscher%26aufirst%3DF.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520phosphinate%2520dipeptide%2520analog%2520inhibitors%2520directed%2520against%2520the%2520Plasmodium%2520falciparum%2520M17%2520leucine%2520aminopeptidase%2520as%2520lead%2520antimalarial%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6024%26epage%3D6031%26doi%3D10.1021%2Fjm070733v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peatey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krige, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nsangou, D. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thivierge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardinerd, D. L.</span></span> <span> </span><span class="NLM_article-title">The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3244</span>– <span class="NLM_lpage">3249</span>, <span class="refDoi"> DOI: 10.1128/AAC.06245-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1128%2FAAC.06245-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22450967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslWrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3244-3249&author=T.+S.+Skinner-Adamsauthor=C.+L.+Peateyauthor=K.+Andersonauthor=K.+R.+Trenholmeauthor=D.+Krigeauthor=C.+L.+Brownauthor=C.+Stackauthor=D.+M.+M.+Nsangouauthor=R.+T.+Mathewsauthor=K.+Thiviergeauthor=J.+P.+Daltonauthor=D.+L.+Gardinerd&title=The+aminopeptidase+inhibitor+CHR-2863+is+an+orally+bioavailable+inhibitor+of+murine+malaria&doi=10.1128%2FAAC.06245-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria</span></div><div class="casAuthors">Skinner-Adams, Tina S.; Peatey, Christopher L.; Anderson, Karen; Trenholme, Katharine R.; Krige, David; Brown, Christopher L.; Stack, Colin; Nsangou, Desire M. M.; Mathews, Rency T.; Thivierge, Karine; Dalton, John P.; Gardiner, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3244-3249</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Malaria remains a significant risk in many areas of the world, with resistance to the current antimalarial pharmacopeia an ever-increasing problem.  The M1 alanine aminopeptidase (PfM1AAP) and M17 leucine aminopeptidase (PfM17LAP) are believed to play a role in the terminal stages of digestion of host Hb and thereby generate a pool of free amino acids that are essential for parasite growth and development.  Here, we show that an orally bioavailable aminopeptidase inhibitor, CHR-2863, is efficacious against murine malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX3MLziI05o7Vg90H21EOLACvtfcHk0lgDrfdgYoj_TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslWrtbs%253D&md5=2bd3240c1ec39ef630f727573c4f32eb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.06245-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06245-11%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DPeatey%26aufirst%3DC.%2BL.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DKrige%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DC.%2BL.%26aulast%3DStack%26aufirst%3DC.%26aulast%3DNsangou%26aufirst%3DD.%2BM.%2BM.%26aulast%3DMathews%26aufirst%3DR.%2BT.%26aulast%3DThivierge%26aufirst%3DK.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DGardinerd%26aufirst%3DD.%2BL.%26atitle%3DThe%2520aminopeptidase%2520inhibitor%2520CHR-2863%2520is%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520murine%2520malaria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3244%26epage%3D3249%26doi%3D10.1128%2FAAC.06245-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bounaadja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouray, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarnus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florent, I.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">382</span> <span class="refDoi"> DOI: 10.1186/s12936-017-2032-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1186%2Fs12936-017-2032-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=28934959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFegt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&author=L.+Bounaadjaauthor=M.+Schmittauthor=S.+Albrechtauthor=E.+Mourayauthor=C.+Tarnusauthor=I.+Florent&title=Selective+inhibition+of+PfA-M1%2C+over+PfA-M17%2C+by+an+amino-benzosuberone+derivative+blocks+malaria+parasites+development+in+vitro+and+in+vivo&doi=10.1186%2Fs12936-017-2032-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo</span></div><div class="casAuthors">Bounaadja, Lotfi; Schmitt, Marjorie; Albrecht, Sebastien; Mouray, Elisabeth; Tarnus, Celine; Florent, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">382/1-382/13</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background:Plasmodium falciparum M1 family aminopeptidase is currently considered as a promising target for anti-malarial chemotherapy.  Several series of inhibitors developed by various research groups display IC50/Ki values down to nM range on native PfA-M1 or recombinant forms and block the parasite development in culture at [um]M to sub-[um]M concns.  A handful of these inhibitors has been tested on murine models of malaria and has shown anti plasmodial in vivo activity.  However, most of these inhibitors do also target the other neutral malarial aminopeptidase, PfA-M17, often with lower Ki values, which questions the relative involvement and importance of each enzyme in the parasite biol.  Results: An amino-benzosuberone deriv. from a previously published collection of chems. targeting specifically the M1-aminopeptidases has been identified; it is highly potent on PfA-M1 (Ki = 50 nM) and devoid of inhibitory activity on PfA-M17 (no inhibition up to 100 [um]M).  This amino-benzosuberone deriv. (T5) inhibits, in the [um]M range, the in vitro growth of two P. falciparum strains, 3D7 and FcB1, resp. chloroquino-sensitive and resistant.  Evaluated in vivo, on the murine non-lethal model of malaria Plasmodium chabaudi chabaudi, this amino-benzosuberone deriv. was able to reduce the parasite burden by 44 and 40% in a typical 4-day Peters assay at a daily dose of 12 and 24 mg/kg by i.p. route of administration.  Conclusions: The evaluation of a highly selective inhibitor of PfA-M1, over PfA-M17, active on Plasmodium parasites in vitro and in vivo, highlights the relevance of PfA-M1 in the biol. development of the parasite as well as in the list of promising anti-malarial targets to be considered in combination with current or future anti-malarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrPhTiYVZNfLVg90H21EOLACvtfcHk0lgDrfdgYoj_TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFegt7zI&md5=d67b7ef6e4f9cce311d4a3bd3341d66d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs12936-017-2032-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-017-2032-4%26sid%3Dliteratum%253Aachs%26aulast%3DBounaadja%26aufirst%3DL.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DMouray%26aufirst%3DE.%26aulast%3DTarnus%26aufirst%3DC.%26aulast%3DFlorent%26aufirst%3DI.%26atitle%3DSelective%2520inhibition%2520of%2520PfA-M1%252C%2520over%2520PfA-M17%252C%2520by%2520an%2520amino-benzosuberone%2520derivative%2520blocks%2520malaria%2520parasites%2520development%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26doi%3D10.1186%2Fs12936-017-2032-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anvikar, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahi, S.</span></span> <span> </span><span class="NLM_article-title">Screening and in vitro evaluation of potential <i>Plasmodium falciparum</i> leucyl aminopeptidase inhibitors</span>. <i>Curr. Comput.-Aided Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.2174/1573409912666160722111053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.2174%2F1573409912666160722111053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=27449897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=282-293&author=M.+Chaudharyauthor=V.+Singhauthor=A.+R.+Anvikarauthor=S.+Sahi&title=Screening+and+in+vitro+evaluation+of+potential+Plasmodium+falciparum+leucyl+aminopeptidase+inhibitors&doi=10.2174%2F1573409912666160722111053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors</span></div><div class="casAuthors">Chaudhary, Meenakshi; Singh, Vineeta; Anvikar, Anup R.; Sahi, Shakti</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">282-293</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Plasmodium falciparum leucyl aminopeptidase (PfA-M17) regulates the intracellular pool of amino acids required for the growth and development of parasites.  Thus, PfA-M17 is a promising target for anti-malarial drug development.  Method: In the present study, structure-based drug design was used to identify novel PfA-M17 inhibitors, which were subsequently validated by in vitro PfA-M17 and human LAP3 enzyme inhibition assay.  A library of 3,147,882 compds. was screened using receptor-based virtual screening against the active site of PfA-M17, and three levels of accuracy were used: high-throughput virtual screening, gridbased ligand docking with energetics (Glide std. precision) and Glide extra precision.  Results: Seventeen screened compds. were selected and tested in the rPfA-M17 enzyme inhibition assay.  Of these nine compds. were found to be effective inhibitors.  To test the target activity, all nine PfA-M17 inhibitors were tested against rhLAP3, the human homolog of PfA-M17.  One compd. (compd. 2) was found to be moderately effective against PfA-M17 (Ki = 287 M) with limited inhibitory activity against hLAP3 (Ki of 4,464 M).  Subsequently, induced fit docking and pharmacophore modeling were used to further understand more precise ligand-protein interactions in the protein-inhibitor complexes.  Conclusion: Among the 9 effective PfA-M17 inhibitors, 5 compds. were found effective in the P. falciparum schizont maturation inhibition (SMI) assay.  A good correlation (r =0.83) was obsd. between the rPfA-M17 enzyme inhibition concn. and SMI assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLtqAaJGA_YbVg90H21EOLACvtfcHk0lj16TKcDu-raw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVOhu7zK&md5=9b6c76b8498ce291bce8ea3586a646e6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1573409912666160722111053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573409912666160722111053%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DAnvikar%26aufirst%3DA.%2BR.%26aulast%3DSahi%26aufirst%3DS.%26atitle%3DScreening%2520and%2520in%2520vitro%2520evaluation%2520of%2520potential%2520Plasmodium%2520falciparum%2520leucyl%2520aminopeptidase%2520inhibitors%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2016%26volume%3D12%26spage%3D282%26epage%3D293%26doi%3D10.2174%2F1573409912666160722111053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deprez-Poulain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flipo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piveteau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dassonneville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florent, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10909</span>– <span class="NLM_lpage">10917</span>, <span class="refDoi"> DOI: 10.1021/jm301506h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301506h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10909-10917&author=R.+Deprez-Poulainauthor=M.+Flipoauthor=C.+Piveteauauthor=F.+Lerouxauthor=S.+Dassonnevilleauthor=I.+Florentauthor=L.+Maesauthor=P.+Cosauthor=B.+Deprez&title=Structure-activity+relationships+and+blood+distribution+of+antiplasmodial+aminopeptidase-1+inhibitors&doi=10.1021%2Fjm301506h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors</span></div><div class="casAuthors">Deprez-Poulain, Rebecca; Flipo, Marion; Piveteau, Catherine; Leroux, Florence; Dassonneville, Sandrine; Florent, Isabelle; Maes, Louis; Cos, Paul; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10909-10917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria is a severe infectious disease that causes between 655 000 and 1.2 million deaths annually.  To overcome the resistance to current drugs, new biol. targets are needed for drug development.  Aminopeptidase M1 (PfAM1), a zinc metalloprotease, has been proposed as a new drug target to fight malaria.  Herein, we disclosed the structure-activity relationships of a selective family of hydroxamate PfAM1 inhibitors based on the malonic template.  In particular, we performed a fluoro-scanning around hit 1 that enlightened the key positions of the halogen for activity.  The docking of the best inhibitor 2 is consistent with in vitro results.  The stability of 2 was evaluated in microsomes, in plasma, and toward glutathione.  The in vivo distribution study performed with the nanomolar hydroxamate inhibitor BDM14471 revealed that it reaches its site of action.  However, it fails to kill the parasite at concns. relevant to the enzymic inhibitory potency, suggesting that killing the parasite remains a challenge for potent and drug-like catalytic-site binding PfAM1 inhibitors.  In all, this study provides important insights for the design of inhibitors of PfAM1 and the validity of this target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy63Ha4C-69LVg90H21EOLACvtfcHk0lj16TKcDu-raw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL&md5=79f58a63feb789266e494450a5950390</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm301506h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301506h%26sid%3Dliteratum%253Aachs%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DFlorent%26aufirst%3DI.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DStructure-activity%2520relationships%2520and%2520blood%2520distribution%2520of%2520antiplasmodial%2520aminopeptidase-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10909%26epage%3D10917%26doi%3D10.1021%2Fjm301506h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinh, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loganathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent dual inhibitors of <i>Plasmodium falciparum</i> M1 and M17 aminopeptidases through optimization of S1 pocket interactions</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.ejmech.2016.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=26807544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2mur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=43-64&author=N.+Drinkwaterauthor=N.+B.+Vinhauthor=S.+N.+Mistryauthor=R.+S.+Bamertauthor=C.+Ruggeriauthor=J.+P.+Holleranauthor=S.+Loganathanauthor=A.+Paiardiniauthor=S.+A.+Charmanauthor=A.+K.+Powellauthor=V.+M.+Averyauthor=S.+McGowanauthor=P.+J.+Scammells&title=Potent+dual+inhibitors+of+Plasmodium+falciparum+M1+and+M17+aminopeptidases+through+optimization+of+S1+pocket+interactions&doi=10.1016%2Fj.ejmech.2016.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions</span></div><div class="casAuthors">Drinkwater, Nyssa; Vinh, Natalie B.; Mistry, Shailesh N.; Bamert, Rebecca S.; Ruggeri, Chiara; Holleran, John P.; Loganathan, Sasdekumar; Paiardini, Alessandro; Charman, Susan A.; Powell, Andrew K.; Avery, Vicky M.; McGowan, Sheena; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-64</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Malaria remains a global health problem, and though international efforts for treatment and eradication have made some headway, the emergence of drug-resistant parasites threatens this progress.  Antimalarial therapeutics acting via novel mechanisms are urgently required.  Plasmodium falciparum M1 and M17 are neutral aminopeptidases which are essential for parasite growth and development.  Previous work in our group has identified inhibitors capable of dual inhibition of PfA-M1 and PfA-M17, and revealed further regions within the protease S1 pockets that could be exploited in the development of ligands with improved inhibitory activity.  Herein, we report the structure-based design and synthesis of novel hydroxamic acid analogs that are capable of potent inhibition of both PfA-M1 and PfA-M17.  Furthermore, the developed compds. potently inhibit Pf growth in culture, including the multi-drug resistant strain Dd2.  The ongoing development of dual PfA-M1/PfA-M17 inhibitors continues to be an attractive strategy for the design of novel antimalarial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWA9kTGB140LVg90H21EOLACvtfcHk0lhrZDftO8g8ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2mur8%253D&md5=0ca2a60568b2469364c5a75070d67da2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DVinh%26aufirst%3DN.%2BB.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DHolleran%26aufirst%3DJ.%2BP.%26aulast%3DLoganathan%26aufirst%3DS.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPowell%26aufirst%3DA.%2BK.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520dual%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520M1%2520and%2520M17%2520aminopeptidases%2520through%2520optimization%2520of%2520S1%2520pocket%2520interactions%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D110%26spage%3D43%26epage%3D64%26doi%3D10.1016%2Fj.ejmech.2016.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Bacerio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Monte-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charli, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, M. D.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> M1-aminopeptidase: A promising target for the development of antimalarials</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.2174/1389450115666141024115641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.2174%2F1389450115666141024115641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25341419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFaku77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1144-1165&author=J.+Gonzalez-Bacerioauthor=R.+Fandoauthor=A.+del+Monte-Martinezauthor=J.+L.+Charliauthor=M.+D.+Chavez&title=Plasmodium+falciparum+M1-aminopeptidase%3A+A+promising+target+for+the+development+of+antimalarials&doi=10.2174%2F1389450115666141024115641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum M1-Aminopeptidase: A Promising Target for the Development of Antimalarials</span></div><div class="casAuthors">Gonzalez-Bacerio, Jorge; Fando, Rafael; Monte-Martinez, Alberto del; Charli, Jean-Louis; los A. Chavez, Maria de</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1144-1165</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria is a devastating human parasitic disease that receives enhanced attention due to the emergence of resistance to traditional drugs.  Thus, the search for new mol. targets is a major goal.  PfAM1 is an aminopeptidase from Plasmodium falciparum, William H.  Welch 1897, belonging to the M1 family of metalloproteases, which is a promising target of inhibitors to block the intra-erythrocytic stages of the parasite.  Since its identification in 1998, many efforts have been done to validate PfAM1 as an appropriate target of antimalarials.  The present work is a crit. review of the main structural, functional and kinetic characteristics of PfAM1, as well as a summary of the effects of key inhibitors at mol. and cellular levels.  The systematization of exptl. results should contribute to a better understanding of the properties of PfAM1 as a target of antimalarials and promote research projects focused on the development of PfAM1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohGJzUeQgJVLVg90H21EOLACvtfcHk0lhrZDftO8g8ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFaku77P&md5=04b1c966fda73cce0d5c7259a96bdf0a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1389450115666141024115641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666141024115641%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Bacerio%26aufirst%3DJ.%26aulast%3DFando%26aufirst%3DR.%26aulast%3Ddel%2BMonte-Martinez%26aufirst%3DA.%26aulast%3DCharli%26aufirst%3DJ.%2BL.%26aulast%3DChavez%26aufirst%3DM.%2BD.%26atitle%3DPlasmodium%2520falciparum%2520M1-aminopeptidase%253A%2520A%2520promising%2520target%2520for%2520the%2520development%2520of%2520antimalarials%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26spage%3D1144%26epage%3D1165%26doi%3D10.2174%2F1389450115666141024115641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loganathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Two-pronged attack: Dual inhibition of <i>Plasmodium falciparum</i> M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9168</span>– <span class="NLM_lpage">9183</span>, <span class="refDoi"> DOI: 10.1021/jm501323a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501323a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9168-9183&author=S.+N.+Mistryauthor=N.+Drinkwaterauthor=C.+Ruggeriauthor=K.+K.+Sivaramanauthor=S.+Loganathanauthor=S.+Fletcherauthor=M.+Dragauthor=A.+Paiardiniauthor=V.+M.+Averyauthor=P.+J.+Scammellsauthor=S.+McGowan&title=Two-pronged+attack%3A+Dual+inhibition+of+Plasmodium+falciparum+M1+and+M17+metalloaminopeptidases+by+a+novel+series+of+hydroxamic+acid-based+inhibitors&doi=10.1021%2Fjm501323a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Two-Pronged Attack: Dual Inhibition of Plasmodium falciparum M1 and M17 Metalloaminopeptidases by a Novel Series of Hydroxamic Acid-Based Inhibitors</span></div><div class="casAuthors">Mistry, Shailesh N.; Drinkwater, Nyssa; Ruggeri, Chiara; Sivaraman, Komagal Kannan; Loganathan, Sasdekumar; Fletcher, Sabine; Drag, Marcin; Paiardini, Alessandro; Avery, Vicky M.; Scammells, Peter J.; McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9168-9183</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasmodium parasites, the causative agents of malaria, have developed resistance to most of the current antimalarial therapies, including artemisinin combination therapies which are widely described as the last line of defense.  Antimalarial agents with a novel mode of action are urgently required.  Two Plasmodium falciparum aminopeptidases, PfA-M1 and PfA-M17, play crucial roles in the erythrocytic stage of infection and have been validated as potential antimalarial targets.  Using compd.-bound crystal structures of both enzymes, the authors have used a structure-guided approach to develop a novel series of inhibitors capable of potent inhibition of both PfA-M1 and PfA-M17 activity and parasite growth in culture.  Herein the authors describe the design, synthesis, and evaluation of a series of hydroxamic acid-based inhibitors I [R1 = PhCO, 2-FC6H4CO, 3-H2NC6H4CO, etc.; R2 = HO, HONH] and demonstrate the compds. to be exciting new leads for the development of novel antimalarial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTJUvJd2YOGLVg90H21EOLACvtfcHk0livkI_U5VY2jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E&md5=6b6fe308bc3b434d686268e65014d9c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm501323a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501323a%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DLoganathan%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DTwo-pronged%2520attack%253A%2520Dual%2520inhibition%2520of%2520Plasmodium%2520falciparum%2520M1%2520and%2520M17%2520metalloaminopeptidases%2520by%2520a%2520novel%2520series%2520of%2520hydroxamic%2520acid-based%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9168%26epage%3D9183%26doi%3D10.1021%2Fjm501323a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan-Sivaraman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Screening the medicines for malaria venture “malaria box” against the <i>Plasmodium falciparum</i> aminopeptidases, M1, M17 and M18</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>, <span class="NLM_elocation-id">e0115859</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0115859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1371%2Fjournal.pone.0115859" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Paiardiniauthor=R.+S.+Bamertauthor=K.+Kannan-Sivaramanauthor=N.+Drinkwaterauthor=S.+N.+Mistryauthor=P.+J.+Scammellsauthor=S.+McGowan&title=Screening+the+medicines+for+malaria+venture+%E2%80%9Cmalaria+box%E2%80%9D+against+the+Plasmodium+falciparum+aminopeptidases%2C+M1%2C+M17+and+M18&doi=10.1371%2Fjournal.pone.0115859"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0115859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0115859%26sid%3Dliteratum%253Aachs%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DKannan-Sivaraman%26aufirst%3DK.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DScreening%2520the%2520medicines%2520for%2520malaria%2520venture%2520%25E2%2580%259Cmalaria%2520box%25E2%2580%259D%2520against%2520the%2520Plasmodium%2520falciparum%2520aminopeptidases%252C%2520M1%252C%2520M17%2520and%2520M18%26jtitle%3DPLoS%2520One%26date%3D2015%26doi%3D10.1371%2Fjournal.pone.0115859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span> <span> </span><span class="NLM_article-title">Identification and validation of a potent dual inhibitor of the <i>P. falciparum</i> M1 and M17 aminopeptidases using virtual screening</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>, <span class="NLM_elocation-id">e0138957</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0138957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1371%2Fjournal.pone.0138957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Ruggeriauthor=N.+Drinkwaterauthor=K.+K.+Sivaramanauthor=R.+S.+Bamertauthor=S.+McGowanauthor=A.+Paiardini&title=Identification+and+validation+of+a+potent+dual+inhibitor+of+the+P.+falciparum+M1+and+M17+aminopeptidases+using+virtual+screening&doi=10.1371%2Fjournal.pone.0138957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138957%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DPaiardini%26aufirst%3DA.%26atitle%3DIdentification%2520and%2520validation%2520of%2520a%2520potent%2520dual%2520inhibitor%2520of%2520the%2520P.%2520falciparum%2520M1%2520and%2520M17%2520aminopeptidases%2520using%2520virtual%2520screening%26jtitle%3DPLoS%2520One%26date%3D2015%26doi%3D10.1371%2Fjournal.pone.0138957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieńczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from <i>Plasmodium falciparum</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5213</span>– <span class="NLM_lpage">5217</span>, <span class="refDoi"> DOI: 10.1021/jm4005972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVegs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5213-5217&author=K.+K.+Sivaramanauthor=A.+Paiardiniauthor=M.+Sie%C5%84czykauthor=C.+Ruggeriauthor=C.+A.+Oelligauthor=J.+P.+Daltonauthor=P.+J.+Scammellsauthor=M.+Dragauthor=S.+McGowan&title=Synthesis+and+structure-activity+relationships+of+phosphonic+arginine+mimetics+as+inhibitors+of+the+M1+and+M17+aminopeptidases+from+Plasmodium+falciparum&doi=10.1021%2Fjm4005972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Phosphonic Arginine Mimetics as Inhibitors of the M1 and M17 Aminopeptidases from Plasmodium falciparum</span></div><div class="casAuthors">Sivaraman, Komagal Kannan; Paiardini, Alessandro; Sienczyk, Marcin; Ruggeri, Chiara; Oellig, Christine A.; Dalton, John P.; Scammells, Peter J.; Drag, Marcin; McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5213-5217</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The malaria parasite Plasmodium falciparum employs two metallo-aminopeptidases, PfA-M1 and PfA-M17, which are essential for parasite survival.  Compds. that inhibit the activity of either enzyme represent leads for the development of new antimalarial drugs.  Here authors report the synthesis and structure-activity relationships of a small library of phosphonic acid arginine mimetics that probe the S1 pocket of both enzymes and map the necessary interactions that would be important for a dual inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj1_wrwtPtGrVg90H21EOLACvtfcHk0liph4AdEo3sFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVegs7k%253D&md5=f62af0810115619662b8e99a18e47959</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm4005972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005972%26sid%3Dliteratum%253Aachs%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DSie%25C5%2584czyk%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DOellig%26aufirst%3DC.%2BA.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520phosphonic%2520arginine%2520mimetics%2520as%2520inhibitors%2520of%2520the%2520M1%2520and%2520M17%2520aminopeptidases%2520from%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5213%26epage%3D5217%26doi%3D10.1021%2Fjm4005972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> neutral aminopeptidases: New targets for anti-malarials</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2009.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.tibs.2009.08.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=53-61&author=T.+S.+Skinner-Adamsauthor=C.+M.+Stackauthor=K.+R.+Trenholmeauthor=C.+L.+Brownauthor=J.+Grembeckaauthor=J.+Lowtherauthor=A.+Muchaauthor=M.+Dragauthor=P.+Kafarskiauthor=S.+McGowanauthor=J.+C.+Whisstockauthor=D.+L.+Gardinerauthor=J.+P.+Dalton&title=Plasmodium+falciparum+neutral+aminopeptidases%3A+New+targets+for+anti-malarials&doi=10.1016%2Fj.tibs.2009.08.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2009.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2009.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DC.%2BL.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DPlasmodium%2520falciparum%2520neutral%2520aminopeptidases%253A%2520New%2520targets%2520for%2520anti-malarials%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D53%26epage%3D61%26doi%3D10.1016%2Fj.tibs.2009.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thivierge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nsangou, D. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title">Anti-malaria drug development targeting the M1 alanyl and M17 leucyl aminopeptidases</span>. <i>Arkivoc</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0013.424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.3998%2Fark.5550190.0013.424" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=330-346&author=K.+Thiviergeauthor=R.+T.+Mathewauthor=D.+M.+M.+Nsangouauthor=F.+Da+Silvaauthor=S.+Cottonauthor=T.+S.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=C.+L.+Brownauthor=C.+M.+Stackauthor=D.+L.+Gardinerauthor=J.+P.+Dalton&title=Anti-malaria+drug+development+targeting+the+M1+alanyl+and+M17+leucyl+aminopeptidases&doi=10.3998%2Fark.5550190.0013.424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0013.424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0013.424%26sid%3Dliteratum%253Aachs%26aulast%3DThivierge%26aufirst%3DK.%26aulast%3DMathew%26aufirst%3DR.%2BT.%26aulast%3DNsangou%26aufirst%3DD.%2BM.%2BM.%26aulast%3DDa%2BSilva%26aufirst%3DF.%26aulast%3DCotton%26aufirst%3DS.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DBrown%26aufirst%3DC.%2BL.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DAnti-malaria%2520drug%2520development%2520targeting%2520the%2520M1%2520alanyl%2520and%2520M17%2520leucyl%2520aminopeptidases%26jtitle%3DArkivoc%26date%3D2012%26spage%3D330%26epage%3D346%26doi%3D10.3998%2Fark.5550190.0013.424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, <i>Plasmodium falciparum</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e31938</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0031938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1371%2Fjournal.pone.0031938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22359643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=M.+Porebaauthor=S.+McGowanauthor=T.+S.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=D.+L.+Gardinerauthor=J.+C.+Whisstockauthor=J.+Toauthor=G.+S.+Salvesenauthor=J.+P.+Daltonauthor=M.+Drag&title=Fingerprinting+the+substrate+specificity+of+M1+and+M17+aminopeptidases+of+human+malaria%2C+Plasmodium+falciparum&doi=10.1371%2Fjournal.pone.0031938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum</span></div><div class="casAuthors">Poreba, Marcin; McGowan, Sheena; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.; Whisstock, James C.; To, Joyce; Salvesen, Guy S.; Dalton, John P.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e31938</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Plasmodium falciparum, the causative agent of human malaria, expresses two aminopeptidases, PfM1AAP and PfM17LAP, crit. to generating a free amino acid pool used by the intraerythrocytic stage of the parasite for proteins synthesis, growth and development.  These exopeptidases are potential targets for the development of a new class of anti-malaria drugs.  To define the substrate specificity of recombinant forms of these two malaria aminopeptidases we used a new library consisting of 61 fluorogenic substrates derived both from natural and unnatural amino acids.  We obtained a detailed substrate fingerprint for recombinant forms of the enzymes revealing that PfM1AAP exhibits a very broad substrate tolerance, capable of efficiently hydrolyzing neutral and basic amino acids, while PfM17LAP has narrower substrate specificity and preferentially cleaves bulky, hydrophobic amino acids.  The substrate library was also exploited to profile the activity of the native aminopeptidases in sol. cell lysates of P. falciparum malaria.  This data showed that PfM1AAP and PfM17LAP are responsible for majority of the aminopeptidase activity in these exts.  These studies provide specific substrate and mechanistic information important for understanding the function of these aminopeptidases and could be exploited in the design of new inhibitors to specifically target these for anti-malaria treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUDBqzvuxULVg90H21EOLACvtfcHk0liph4AdEo3sFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWjtLs%253D&md5=8af793987903ec128043350c9443a84d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031938%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DTo%26aufirst%3DJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DFingerprinting%2520the%2520substrate%2520specificity%2520of%2520M1%2520and%2520M17%2520aminopeptidases%2520of%2520human%2520malaria%252C%2520Plasmodium%2520falciparum%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0031938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birru, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradoc-Davies, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the <i>Plasmodium falciparum</i> M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">2449</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1073/pnas.0911813107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.0911813107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20133789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1aksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2449-2454&author=S.+McGowanauthor=C.+A.+Oelligauthor=W.+A.+Birruauthor=T.+T.+Caradoc-Daviesauthor=C.+M.+Stackauthor=J.+Lowtherauthor=T.+Skinner-Adamsauthor=A.+Muchaauthor=P.+Kafarskiauthor=J.+Grembeckaauthor=K.+R.+Trenholmeauthor=A.+M.+Buckleauthor=D.+L.+Gardinerauthor=J.+P.+Daltonauthor=J.+C.+Whisstock&title=Structure+of+the+Plasmodium+falciparum+M17+aminopeptidase+and+significance+for+the+design+of+drugs+targeting+the+neutral+exopeptidases&doi=10.1073%2Fpnas.0911813107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases</span></div><div class="casAuthors">McGowan, Sheena; Oellig, Christine A.; Birru, Woldeamanuel A.; Caradoc-Davies, Tom T.; Stack, Colin M.; Lowther, Jonathan; Skinner-Adams, Tina; Mucha, Artur; Kafarski, Pawel; Grembecka, Olanta; Trenholme, Katharine R.; Buckle, Ashley M.; Gardiner, Donald L.; Dalton, John P.; Whisstock, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2449-2454, S2449/1-S2449/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Current therapeutics and prophylactics for malaria are under severe challenge as a result of the rapid emergence of drug-resistant parasites.  The human malaria parasite Plasmodium falciparum expresses two neutral aminopeptidases, PfA-M1 and PfA-M17, which function in regulating the intracellular pool of amino acids required for growth and development inside the red blood cell.  These enzymes are essential for parasite viability and are validated therapeutic targets.  We previously reported the x-ray crystal structure of the monomeric PfA-M1 and proposed a mechanism for substrate entry and free amino acid release from the active site.  Here, we present the x-ray crystal structure of the hexameric leucine aminopeptidase, PfA-M17, alone and in complex with two inhibitors with antimalarial activity.  The six active sites of the PfA-M17 hexamer are arranged in a disk-like fashion so that they are oriented inwards to form a central catalytic cavity; flexible loops that sit at each of the six entrances to the catalytic cavern function to regulate substrate access.  In stark contrast to PfA-M1, PfA-M17 has a narrow and hydrophobic primary specificity pocket which accounts for its highly restricted substrate specificity.  We also explicate the essential roles for the metal-binding centers in these enzymes (two in PfA-M17 and one in PfA-M1) in both substrate and drug binding.  Our detailed understanding of the PfA-M1 and PfA-M17 active sites now permits a rational approach in the development of a unique class of two-target and/or combination antimalarial therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYqQSNGkAH4LVg90H21EOLACvtfcHk0lhIvWazAvSEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1aksrs%253D&md5=e4dde6cdc5f04346b5abefbaa1e92f1f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0911813107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0911813107%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DOellig%26aufirst%3DC.%2BA.%26aulast%3DBirru%26aufirst%3DW.%2BA.%26aulast%3DCaradoc-Davies%26aufirst%3DT.%2BT.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DBuckle%26aufirst%3DA.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26atitle%3DStructure%2520of%2520the%2520Plasmodium%2520falciparum%2520M17%2520aminopeptidase%2520and%2520significance%2520for%2520the%2520design%2520of%2520drugs%2520targeting%2520the%2520neutral%2520exopeptidases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D2449%26epage%3D2454%26doi%3D10.1073%2Fpnas.0911813107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of the essential <i>Plasmodium falciparum</i> M1 neutral aminopeptidase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2537</span>– <span class="NLM_lpage">2542</span>, <span class="refDoi"> DOI: 10.1073/pnas.0807398106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1073%2Fpnas.0807398106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=19196988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislahsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=2537-2542&author=S.+McGowanauthor=C.+J.+Porterauthor=J.+Lowtherauthor=C.+M.+Stackauthor=S.+J.+Goldingauthor=T.+S.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=F.+Teuscherauthor=S.+M.+Donnellyauthor=J.+Grembeckaauthor=A.+Muchaauthor=P.+Kafarskiauthor=R.+DeGoriauthor=A.+M.+Buckleauthor=D.+L.+Gardinerauthor=J.+C.+Whisstockauthor=J.+P.+Dalton&title=Structural+basis+for+the+inhibition+of+the+essential+Plasmodium+falciparum+M1+neutral+aminopeptidase&doi=10.1073%2Fpnas.0807398106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase</span></div><div class="casAuthors">McGowan, Sheena; Porter, Corrine J.; Lowther, Jonathan; Stack, Colin M.; Golding, Sarah J.; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Teuscher, Franka; Donnelly, Sheila M.; Grembecka, Jolanta; Mucha, Artur; Kafarski, Pawel; DeGori, Ross; Buckle, Ashley M.; Gardiner, Donald L.; Whisstock, James C.; Dalton, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2537-2542</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Plasmodium falciparum parasites are responsible for the major global disease malaria, which results in >2 million deaths each year.  With the rise of drug-resistant malarial parasites, novel drug targets and lead compds. are urgently required for the development of new therapeutic strategies.  Here, we address this important problem by targeting the malarial neutral aminopeptidases that are involved in the terminal stages of Hb digestion and essential for the provision of amino acids used for parasite growth and development within the erythrocyte.  We characterize the structure and substrate specificity of one such aminopeptidase, PfA-M1, a validated drug target.  The X-ray crystal structure of PfA-M1 alone and in complex with the generic inhibitor, bestatin, and a phosphinate dipeptide analog with potent in vitro and in vivo antimalarial activity, hPheP[CH2]Phe, reveals features within the protease active site that are crit. to its function as an aminopeptidase and can be exploited for drug development.  These results set the groundwork for the development of antimalarial therapeutics that target the neutral aminopeptidases of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-6_ZNvWMUP7Vg90H21EOLACvtfcHk0lhIvWazAvSEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislahsrY%253D&md5=23bc5efa86832c3fbc10e900f42f3216</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0807398106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0807398106%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DGolding%26aufirst%3DS.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DTeuscher%26aufirst%3DF.%26aulast%3DDonnelly%26aufirst%3DS.%2BM.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DDeGori%26aufirst%3DR.%26aulast%3DBuckle%26aufirst%3DA.%2BM.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520the%2520essential%2520Plasmodium%2520falciparum%2520M1%2520neutral%2520aminopeptidase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D2537%26epage%3D2542%26doi%3D10.1073%2Fpnas.0807398106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lua, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of the <i>Plasmodium falciparum</i> M17 leucyl aminopeptidase - a protease involved in amino acid regulation with potential for antimalarial drug development</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">2069</span>– <span class="NLM_lpage">2080</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609251200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1074%2Fjbc.M609251200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=2069-2080&author=C.+M.+Stackauthor=J.+Lowtherauthor=E.+Cunninghamauthor=S.+Donnellyauthor=D.+L.+Gardinerauthor=K.+R.+Trenholmeauthor=T.+S.+Skinner-Adamsauthor=F.+Teuscherauthor=J.+Grembeckaauthor=A.+Muchaauthor=P.+Kafarskiauthor=L.+Luaauthor=A.+Bellauthor=J.+P.+Dalton&title=Characterization+of+the+Plasmodium+falciparum+M17+leucyl+aminopeptidase+-+a+protease+involved+in+amino+acid+regulation+with+potential+for+antimalarial+drug+development&doi=10.1074%2Fjbc.M609251200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609251200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609251200%26sid%3Dliteratum%253Aachs%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DLowther%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DE.%26aulast%3DDonnelly%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DTeuscher%26aufirst%3DF.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DLua%26aufirst%3DL.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520Plasmodium%2520falciparum%2520M17%2520leucyl%2520aminopeptidase%2520-%2520a%2520protease%2520involved%2520in%2520amino%2520acid%2520regulation%2520with%2520potential%2520for%2520antimalarial%2520drug%2520development%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D2069%26epage%3D2080%26doi%3D10.1074%2Fjbc.M609251200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuzmič, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregar, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janc, J. W.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening of enzyme inhibitors: Simultaneous determination of tight-binding inhibition constants and enzyme concentration</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1006/abio.2000.4685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1006%2Fabio.2000.4685" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2000&pages=45-50&author=P.+Kuzmi%C4%8Dauthor=K.+C.+Elrodauthor=L.+M.+Cregarauthor=S.+Siderisauthor=R.+Raiauthor=J.+W.+Janc&title=High-throughput+screening+of+enzyme+inhibitors%3A+Simultaneous+determination+of+tight-binding+inhibition+constants+and+enzyme+concentration&doi=10.1006%2Fabio.2000.4685"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1006%2Fabio.2000.4685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2000.4685%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmi%25C4%258D%26aufirst%3DP.%26aulast%3DElrod%26aufirst%3DK.%2BC.%26aulast%3DCregar%26aufirst%3DL.%2BM.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DRai%26aufirst%3DR.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26atitle%3DHigh-throughput%2520screening%2520of%2520enzyme%2520inhibitors%253A%2520Simultaneous%2520determination%2520of%2520tight-binding%2520inhibition%2520constants%2520and%2520enzyme%2520concentration%26jtitle%3DAnal.%2520Biochem.%26date%3D2000%26volume%3D286%26spage%3D45%26epage%3D50%26doi%3D10.1006%2Fabio.2000.4685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Determination of accurate K<sub>i</sub> values for tight-binding enzyme inhibitors: An in silico study of experimental error and assay design</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2003.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.ab.2003.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=15033511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFKhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2004&pages=61-67&author=D.+J.+Murphy&title=Determination+of+accurate+Ki+values+for+tight-binding+enzyme+inhibitors%3A+An+in+silico+study+of+experimental+error+and+assay+design&doi=10.1016%2Fj.ab.2003.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design</span></div><div class="casAuthors">Murphy, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-67</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Detn. of accurate KI values for tight-binding enzyme inhibitors is important from both a basic biochem. point of view (understanding the differences in affinity of related mols.) and a medicinal chem. vantage (developing structure-activity relationships (SAR)).  It is advantageous to directly fit the quadratic equation describing tight-binding behavior, known commonly as the Morrison equation, to obtain these KI values.  The results of simulated expts. that examine the effect of assay design and exptl. error on the ability to accurately det. KI values at several [E]0/KI-app ratios are described.  Input ("true") values of the uninhibited velocity, inhibition const., and total enzyme concn. were used to calc. the velocity at various inhibitor concns.  Gaussian error was introduced into the velocities and the simulated reactions were fit to est. v0, KI, and [E]0.  Recommendations for optimizing the inhibitor dilns. within the context of a 96-well-plate format and simple serial diln. steps are made.  These include using three points to det. the enzyme concn. ([I] = 0, 0.5[E]0, and [E]0), using a narrow diln. series with only two or three points to det. the asymptote at high inhibitor concn., and avoidance of fixing [E]0 to a const. value in the fitting if at all possible.  The risks and rewards of fixing [E]0 to a const. value, esp. the effect on SAR, are also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGiaWGV4W5tLVg90H21EOLACvtfcHk0lhU3sc9GiMytg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFKhtrg%253D&md5=f93d7f5648fc310736f4a80c10ef3edd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2003.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2003.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DDetermination%2520of%2520accurate%2520Ki%2520values%2520for%2520tight-binding%2520enzyme%2520inhibitors%253A%2520An%2520in%2520silico%2520study%2520of%2520experimental%2520error%2520and%2520assay%2520design%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D327%26spage%3D61%26epage%3D67%26doi%3D10.1016%2Fj.ab.2003.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velmourougane, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbut, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinhardt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1021/jm101227t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101227t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1655-1666&author=G.+Velmourouganeauthor=M.+B.+Harbutauthor=S.+Dalalauthor=S.+McGowanauthor=C.+A.+Oelligauthor=N.+Meinhardtauthor=J.+C.+Whisstockauthor=M.+Klembaauthor=D.+C.+Greenbaum&title=Synthesis+of+new+%28-%29-bestatin-based+inhibitor+libraries+reveals+a+novel+binding+mode+in+the+S1+pocket+of+the+essential+malaria+M1+metalloaminopeptidase&doi=10.1021%2Fjm101227t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm101227t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101227t%26sid%3Dliteratum%253Aachs%26aulast%3DVelmourougane%26aufirst%3DG.%26aulast%3DHarbut%26aufirst%3DM.%2BB.%26aulast%3DDalal%26aufirst%3DS.%26aulast%3DMcGowan%26aufirst%3DS.%26aulast%3DOellig%26aufirst%3DC.%2BA.%26aulast%3DMeinhardt%26aufirst%3DN.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DKlemba%26aufirst%3DM.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520of%2520new%2520%2528-%2529-bestatin-based%2520inhibitor%2520libraries%2520reveals%2520a%2520novel%2520binding%2520mode%2520in%2520the%2520S1%2520pocket%2520of%2520the%2520essential%2520malaria%2520M1%2520metalloaminopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1655%26epage%3D1666%26doi%3D10.1021%2Fjm101227t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, W.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, B. W.</span></span> <span> </span><span class="NLM_article-title">Metalloaminopeptidases: Common functional themes in disparate structural surroundings</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">4581</span>– <span class="NLM_lpage">4607</span>, <span class="refDoi"> DOI: 10.1021/cr0101757</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0101757" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4581-4607&author=W.%0AT.+Lowtherauthor=B.+W.+Matthews&title=Metalloaminopeptidases%3A+Common+functional+themes+in+disparate+structural+surroundings&doi=10.1021%2Fcr0101757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloaminopeptidases: Common functional themes in disparate structural surroundings</span></div><div class="casAuthors">Lowther, W. Todd; Matthews, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4581-4607</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include leucine aminopeptidase, Aeromonas proteolytica and Streptomyces griseus aminopeptidases, methionine aminopeptidase, aminopeptidase P, and prolidase.  Common structure-function motifs of these metalloaminopeptidases are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ2R9gHtRNlLVg90H21EOLACvtfcHk0lhU3sc9GiMytg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSgu7c%253D&md5=b517a222a63badcbebd0c6d68bebe13f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcr0101757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0101757%26sid%3Dliteratum%253Aachs%26aulast%3DLowther%26aufirst%3DW.%2BT.%26aulast%3DMatthews%26aufirst%3DB.%2BW.%26atitle%3DMetalloaminopeptidases%253A%2520Common%2520functional%2520themes%2520in%2520disparate%2520structural%2520surroundings%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4581%26epage%3D4607%26doi%3D10.1021%2Fcr0101757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maric, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinsin, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenholme, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stack, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowther, J.</span></span> <span> </span><span class="NLM_article-title">The M17 leucine aminopeptidase of the malaria parasite <i>Plasmodium falciparum</i>: Importance of active site metal ions in the binding of substrates and inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5435</span>– <span class="NLM_lpage">5439</span>, <span class="refDoi"> DOI: 10.1021/bi9003638</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9003638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5435-5439&author=S.+Maricauthor=S.+M.+Donnellyauthor=M.+W.+Robinsinauthor=T.+Skinner-Adamsauthor=K.+R.+Trenholmeauthor=D.+L.+Gardinerauthor=J.+P.+Daltonauthor=C.+M.+Stackauthor=J.+Lowther&title=The+M17+leucine+aminopeptidase+of+the+malaria+parasite+Plasmodium+falciparum%3A+Importance+of+active+site+metal+ions+in+the+binding+of+substrates+and+inhibitors&doi=10.1021%2Fbi9003638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The M17 Leucine Aminopeptidase of the Malaria Parasite Plasmodium falciparum: Importance of Active Site Metal Ions in the Binding of Substrates and Inhibitors</span></div><div class="casAuthors">Maric, Selma; Donnelly, Sheila M.; Robinson, Mark W.; Skinner-Adams, Tina; Trenholme, Katharine R.; Gardiner, Donald L.; Dalton, John P.; Stack, Colin M.; Lowther, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5435-5439</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M17 leucine aminopeptidase of the intraerythrocytic stages of the malaria parasite Plasmodium falciparum (PfLAP) plays a role in releasing amino acids from host Hb that are used for parasite protein synthesis, growth, and development.  This enzyme represents a target at which new antimalarials could be designed since metalloaminopeptidase inhibitors prevent the growth of the parasites in vitro and in vivo.  A study on the metal ion binding characteristics of recombinant P. falciparum M17 leucine aminopeptidase (rPfLAP) shows that the active site of this exopeptidase contains two metal-binding sites, a readily exchangeable site (site 1) and a tight binding site (site 2).  The enzyme retains activity when the metal ion is removed from site 1, while removal of metal ions from both sites results in an inactive apoenzyme that cannot be reactivated by the addn. of divalent metal cations.  The metal ion at site 1 is readily exchangeable with several divalent metal ions and displays a preference in the order of preference Zn2+ > Mn2+ > Co2+ > Mg2+.  While it is likely that native PfLAP contains a Zn2+ in site 2, the metal ion located in site 1 may be dependent on the type and concn. of metal ions in the cytosolic compartment of the parasite.  Importantly, the type of metal ion present at site 1 influences not only the catalytic efficiency of the enzyme for peptide substrates but also the mode of binding by bestatin, a metal-chelating inhibitor of M17 aminopeptidases with antimalarial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3w8yqPIYgT7Vg90H21EOLACvtfcHk0lgFHHnkeGpEQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsLo%253D&md5=a440cc1c00ce86fb3130444536cf3cf6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi9003638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9003638%26sid%3Dliteratum%253Aachs%26aulast%3DMaric%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DS.%2BM.%26aulast%3DRobinsin%26aufirst%3DM.%2BW.%26aulast%3DSkinner-Adams%26aufirst%3DT.%26aulast%3DTrenholme%26aufirst%3DK.%2BR.%26aulast%3DGardiner%26aufirst%3DD.%2BL.%26aulast%3DDalton%26aufirst%3DJ.%2BP.%26aulast%3DStack%26aufirst%3DC.%2BM.%26aulast%3DLowther%26aufirst%3DJ.%26atitle%3DThe%2520M17%2520leucine%2520aminopeptidase%2520of%2520the%2520malaria%2520parasite%2520Plasmodium%2520falciparum%253A%2520Importance%2520of%2520active%2520site%2520metal%2520ions%2520in%2520the%2520binding%2520of%2520substrates%2520and%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D5435%26epage%3D5439%26doi%3D10.1021%2Fbi9003638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">From crystal to compound: Structure-based antimalarial drug discovery</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1042/BJ20140240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1042%2FBJ20140240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2014&pages=349-369&author=N.+Drinkwaterauthor=S.+McGowan&title=From+crystal+to+compound%3A+Structure-based+antimalarial+drug+discovery&doi=10.1042%2FBJ20140240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1042%2FBJ20140240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20140240%26sid%3Dliteratum%253Aachs%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DFrom%2520crystal%2520to%2520compound%253A%2520Structure-based%2520antimalarial%2520drug%2520discovery%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D461%26spage%3D349%26epage%3D369%26doi%3D10.1042%2FBJ20140240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kyrieleis, O. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goettig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefersauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandstetter, H.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the tricorn interacting factor F3 from thermoplasma acidophilum, a zinc aminopeptidase in three different conformations</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.jmb.2005.03.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2005&pages=787-800&author=O.+J.+P.+Kyrieleisauthor=P.+Goettigauthor=R.+Kiefersauerauthor=R.+Huberauthor=H.+Brandstetter&title=Crystal+structures+of+the+tricorn+interacting+factor+F3+from+thermoplasma+acidophilum%2C+a+zinc+aminopeptidase+in+three+different+conformations&doi=10.1016%2Fj.jmb.2005.03.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DKyrieleis%26aufirst%3DO.%2BJ.%2BP.%26aulast%3DGoettig%26aufirst%3DP.%26aulast%3DKiefersauer%26aufirst%3DR.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DCrystal%2520structures%2520of%2520the%2520tricorn%2520interacting%2520factor%2520F3%2520from%2520thermoplasma%2520acidophilum%252C%2520a%2520zinc%2520aminopeptidase%2520in%2520three%2520different%2520conformations%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D349%26spage%3D787%26epage%3D800%26doi%3D10.1016%2Fj.jmb.2005.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratikos, E.</span></span> <span> </span><span class="NLM_article-title">The role of conformational dynamics in antigen trimming by intracellular aminopeptidases</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">946</span> <span class="refDoi"> DOI: 10.3389/fimmu.2017.00946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.3389%2Ffimmu.2017.00946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=28824657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWntLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=A.+Papakyriakouauthor=E.+Stratikos&title=The+role+of+conformational+dynamics+in+antigen+trimming+by+intracellular+aminopeptidases&doi=10.3389%2Ffimmu.2017.00946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The role of conformational dynamics in antigen trimming by intracellular aminopeptidases</span></div><div class="casAuthors">Papakyriakou, Athanasios; Stratikos, Efstratios</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">946/1-946/7</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Antigenic peptides presented by the major histocompatibility complex class I (MHC-I) mols. for recognition by cytotoxic T-lymphocytes are processed by members of the oxytocinase sub-family of M1 aminopeptidases ERAP1, ERAP2, and IRAP.  These three homologous zinc metallopeptidases trim N-terminally extended precursor antigenic peptides down to the correct length for loading onto the MHC-I but can also destroy some antigenic peptides by over-trimming, therefore, influencing the antigenic peptide repertoire and immunodominance hierarchy.  Polymorphic variation has been found to affect their trimming function and predispose to human disease in complex and poorly understood patterns.  Structural and biochem. anal. have pointed toward a complicated trimming mechanism that involves a major conformational transition during each catalytic cycle.  Here, we provide an overview of current knowledge on the structure and mechanism of action of those enzymes with a focus on the proposed key role of conformational dynamics in their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIey33g_W7hrVg90H21EOLACvtfcHk0lgFHHnkeGpEQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWntLbE&md5=64704c46e5ee1e4c6733521ed9afeb49</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00946%26sid%3Dliteratum%253Aachs%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DStratikos%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520conformational%2520dynamics%2520in%2520antigen%2520trimming%2520by%2520intracellular%2520aminopeptidases%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26doi%3D10.3389%2Ffimmu.2017.00946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span> <span> </span><span class="NLM_article-title">Towards third generation matrix metalloproteinase inhibitors for cancer therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6603043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1038%2Fsj.bjc.6603043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=16538215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=941-946&author=C.+M.+Overallauthor=O.+Kleifeld&title=Towards+third+generation+matrix+metalloproteinase+inhibitors+for+cancer+therapy&doi=10.1038%2Fsj.bjc.6603043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Towards third generation matrix metalloproteinase inhibitors for cancer therapy</span></div><div class="casAuthors">Overall, C. M.; Kleifeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The failure of matrix metalloproteinase (MMP) inhibitor drug clin. trials in cancer was partly due to the inadvertent inhibition of MMP antitargets that counterbalanced the benefits of MMP target inhibition.  We explore how MMP inhibitor drugs might be developed to achieve potent selectivity for validated MMP targets yet therapeutically spare MMP antitargets that are crit. in host protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWaFApPMIKRLVg90H21EOLACvtfcHk0lhu-H7esdh9kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D&md5=5e672a6e9495ec2e283856edc6e61a60</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603043%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTowards%2520third%2520generation%2520matrix%2520metalloproteinase%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D941%26epage%3D946%26doi%3D10.1038%2Fsj.bjc.6603043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span> <span> </span><span class="NLM_article-title">Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1038/nrc1821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&author=C.+M.+Overallauthor=O.+Kleifeld&title=Validating+matrix+metalloproteinases+as+drug+targets+and+anti-targets+for+cancer+therapy&doi=10.1038%2Fnrc1821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lhu-H7esdh9kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DValidating%2520matrix%2520metalloproteinases%2520as%2520drug%2520targets%2520and%2520anti-targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D227%26epage%3D239%26doi%3D10.1038%2Fnrc1821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span> <span> </span><span class="NLM_article-title">Strategies for MMP inhibition in cancer: Innovations for the post-trial era</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrc884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1038%2Fnrc884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=12209155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslamsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=657-672&author=C.+M.+Overallauthor=C.+Lopez-Otin&title=Strategies+for+MMP+inhibition+in+cancer%3A+Innovations+for+the+post-trial+era&doi=10.1038%2Fnrc884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for MMP inhibition in cancer: innovations for the post-trial era</span></div><div class="casAuthors">Overall, Christopher Mark; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">657-672</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For more than two decades, the view that tumor-assocd. matrix metalloproteinases (MMPs) were required for peritumor tissue degrdn. and metastasis dominated the drive to develop MMP inhibitors as anticancer therapeutics.  Until recently, clin. trials with MMP inhibitors have yielded disappointing results, highlighting the need for better insight into the mechanisms by which this growing family of multifunctional enzymes contribute to tumor growth.  It is now recognized that MMP activity is tightly regulated at several levels, providing new avenues for blocking these enzymes.  What are the different approaches that can be used to target MMPs, and which of these might lead to new therapeutic strategies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorJX_WvW8wvLVg90H21EOLACvtfcHk0lhu-H7esdh9kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslamsro%253D&md5=1d37c018f346969782f80585027ef989</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrc884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc884%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DLopez-Otin%26aufirst%3DC.%26atitle%3DStrategies%2520for%2520MMP%2520inhibition%2520in%2520cancer%253A%2520Innovations%2520for%2520the%2520post-trial%2520era%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D657%26epage%3D672%26doi%3D10.1038%2Fnrc884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitzerd, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbrugge, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossenkoppele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Positioning of aminopeptidase inhibitors in next generation cancer therapy</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.1007/s00726-013-1648-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1007%2Fs00726-013-1648-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=24385243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=793-808&author=S.+M.+Hitzerdauthor=S.+E.+Verbruggeauthor=G.+Ossenkoppeleauthor=G.+Jansenauthor=G.+J.+Peters&title=Positioning+of+aminopeptidase+inhibitors+in+next+generation+cancer+therapy&doi=10.1007%2Fs00726-013-1648-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Positioning of aminopeptidase inhibitors in next generation cancer therapy</span></div><div class="casAuthors">Hitzerd, Sarina M.; Verbrugge, Sue Ellen; Ossenkoppele, Gert; Jansen, Gerrit; Peters, Godefridus J.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">793-808</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">A review.  Aminopeptidases represent a class of (zinc) metalloenzymes that catalyze the cleavage of amino acids nearby the N-terminus of polypeptides, resulting in hydrolysis of peptide bonds.  Aminopeptidases operate downstream of the ubiquitin-proteasome pathway and are implicated in the final step of intracellular protein degrdn. either by trimming proteasome-generated peptides for antigen presentation or full hydrolysis into free amino acids for recycling in renewed protein synthesis.  This review focuses on the function and subcellular location of five key aminopeptidases (aminopeptidase N, leucine aminopeptidase, puromycin-sensitive aminopeptidase, leukotriene A4 hydrolase and endoplasmic reticulum aminopeptidase 1/2) and their assocn. with different diseases, in particular cancer and their current position as target for therapeutic intervention by aminopeptidase inhibitors.  Historically, bestatin was the first prototypical aminopeptidase inhibitor that entered the clinic 35 years ago and is still used for the treatment of lung cancer.  More recently, new generation aminopeptidase inhibitors became available, including the aminopeptidase inhibitor prodrug tosedostat, which is currently tested in phase II clin. trials for acute myeloid leukemia.  Beyond bestatin and tosedostat, medicinal chem. has emerged with addnl. series of potential aminopeptidases inhibitors which are still in an early phase of (pre)clin. investigations.  The expanded knowledge of the unique mechanism of action of aminopeptidases has revived interest in aminopeptidase inhibitors for drug combination regimens in anti-cancer treatment.  In this context, this review will discuss relevant features and mechanisms of action of aminopeptidases and will also elaborate on factors contributing to aminopeptidase inhibitor efficacy and/or loss of efficacy due to drug resistance-related phenomena.  Together, a growing body of data point to aminopeptidase inhibitors as attractive tools for combination chemotherapy, hence their implementation may be a step forward in a new era of personalized treatment of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABQrQu0W5GrVg90H21EOLACvtfcHk0lhu-H7esdh9kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVOltQ%253D%253D&md5=c17cc3a379f6a21b0126d672f3680dc6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00726-013-1648-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-013-1648-0%26sid%3Dliteratum%253Aachs%26aulast%3DHitzerd%26aufirst%3DS.%2BM.%26aulast%3DVerbrugge%26aufirst%3DS.%2BE.%26aulast%3DOssenkoppele%26aufirst%3DG.%26aulast%3DJansen%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DPositioning%2520of%2520aminopeptidase%2520inhibitors%2520in%2520next%2520generation%2520cancer%2520therapy%26jtitle%3DAmino%2520Acids%26date%3D2014%26volume%3D46%26spage%3D793%26epage%3D808%26doi%3D10.1007%2Fs00726-013-1648-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. X.</span></span> <span> </span><span class="NLM_article-title">Resistance-resistant antibiotics</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2Fj.tips.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25458541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=664-674&author=E.+Oldfieldauthor=X.+X.+Feng&title=Resistance-resistant+antibiotics&doi=10.1016%2Fj.tips.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance-resistant antibiotics</span></div><div class="casAuthors">Oldfield, Eric; Feng, Xinxin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">664-674</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New antibiotics are needed because drug resistance is increasing while the introduction of new antibiotics is decreasing.  We discuss here six possible approaches to develop 'resistance-resistant' antibiotics.  First, multitarget inhibitors in which a single compd. inhibits more than one target may be easier to develop than conventional combination therapies with two new drugs.  Second, inhibiting multiple targets in the same metabolic pathway is expected to be an effective strategy owing to synergy.  Third, discovering multiple-target inhibitors should be possible by using sequential virtual screening.  Fourth, repurposing existing drugs can lead to combinations of multitarget therapeutics.  Fifth, targets need not be proteins.  Sixth, inhibiting virulence factor formation and boosting innate immunity may also lead to decreased susceptibility to resistance.  Although it is not possible to eliminate resistance, the approaches reviewed here offer several possibilities for reducing the effects of mutations and, in some cases, suggest that sensitivity to existing antibiotics may be restored in otherwise drug-resistant organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFcN1H0q81rVg90H21EOLACvtfcHk0lioUTNk5Nxubw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP&md5=1fd8f53ba0e90abbc83a6616db24568a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DX.%2BX.%26atitle%3DResistance-resistant%2520antibiotics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D664%26epage%3D674%26doi%3D10.1016%2Fj.tips.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verlinden, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span> <span> </span><span class="NLM_article-title">Resisting resistance: Is there a solution for malaria?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1517/17460441.2016.1154037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1517%2F17460441.2016.1154037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=395-406&author=B.+K.+Verlindenauthor=A.+Louwauthor=L.+M.+Birkholtz&title=Resisting+resistance%3A+Is+there+a+solution+for+malaria%3F&doi=10.1517%2F17460441.2016.1154037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1517%2F17460441.2016.1154037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2016.1154037%26sid%3Dliteratum%253Aachs%26aulast%3DVerlinden%26aufirst%3DB.%2BK.%26aulast%3DLouw%26aufirst%3DA.%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26atitle%3DResisting%2520resistance%253A%2520Is%2520there%2520a%2520solution%2520for%2520malaria%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D395%26epage%3D406%26doi%3D10.1517%2F17460441.2016.1154037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, J. M.</span></span> <span> </span><span class="NLM_article-title">The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">36804</span>– <span class="NLM_lpage">36813</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.398842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1074%2Fjbc.M112.398842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22932899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOqsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=36804-36813&author=A.+H.+M.+Wongauthor=D.+X.+Zhouauthor=J.+M.+Rini&title=The+X-ray+crystal+structure+of+human+aminopeptidase+N+reveals+a+novel+dimer+and+the+basis+for+peptide+processing&doi=10.1074%2Fjbc.M112.398842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The X-ray Crystal Structure of Human Aminopeptidase N Reveals a Novel Dimer and the Basis for Peptide Processing</span></div><div class="casAuthors">Wong, Alan H. M.; Zhou, Dongxia; Rini, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">36804-36813</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human aminopeptidase N (hAPN/hCD13) is a dimeric membrane protein and a member of the M1 family of zinc metallopeptidases.  Within the rennin-angiotensin system, its enzymic activity is responsible for processing peptide hormones angiotensin III and IV.  In addn., hAPN is also involved in cell adhesion, endocytosis, and signal transduction and it is an important target for cancer therapy.  Reported here are the high resoln. x-ray crystal structures of the dimeric ectodomain of hAPN and its complexes with angiotensin IV and the peptidomimetic inhibitors, amastatin and bestatin.  Each monomer of the dimer is found in what has been termed the closed form in other M1 enzymes and each monomer is characterized by an internal cavity surrounding the catalytic site as well as a unique substrate/inhibitor-dependent loop ordering, which in the case of the bestatin complex suggests a new route to inhibitor design.  The hAPN structure provides the first example of a dimeric M1 family member and the obsd. structural features, in conjunction with a model for the open form, provide novel insights into the mechanism of peptide processing and signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1AkeQE7nfNLVg90H21EOLACvtfcHk0lioUTNk5Nxubw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOqsrnF&md5=7b4950107a47e98f51b22d02695b8363</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.398842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.398842%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DA.%2BH.%2BM.%26aulast%3DZhou%26aufirst%3DD.%2BX.%26aulast%3DRini%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520X-ray%2520crystal%2520structure%2520of%2520human%2520aminopeptidase%2520N%2520reveals%2520a%2520novel%2520dimer%2520and%2520the%2520basis%2520for%2520peptide%2520processing%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D36804%26epage%3D36813%26doi%3D10.1074%2Fjbc.M112.398842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, P. J.</span></span> <span> </span><span class="NLM_article-title">The use of Dixon plots to study enzyme inhibition</span>. <i>Biochim. Biophys. Acta, Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/0005-2744(72)90074-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1016%2F0005-2744%2872%2990074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=4631005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADyaE3sXjvFyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1972&pages=251-253&author=P.+J.+Butterworth&title=The+use+of+Dixon+plots+to+study+enzyme+inhibition&doi=10.1016%2F0005-2744%2872%2990074-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Dixon plots to study enzyme inhibition</span></div><div class="casAuthors">Butterworth, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-3</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">The use of the Dixon method of plotting enzyme inhibition data is considered for cases where the interaction between the inhibitor and enzyme is more complex than for classical competitive and noncompetitive inhibition.  It is concluded that the use of Dixon plots in conjunction with Lineweaver-Burk plots can be a valuable aid in the identification of inhibition behavior.  The inhibition patterns considered include mixed, hyperbolic-competitive, and 2 forms of uncompetitive inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCE_-4fgfoZrVg90H21EOLACvtfcHk0lioUTNk5Nxubw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXjvFyrtQ%253D%253D&md5=221e08a1552a324cd9a562574aa33afe</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2872%2990074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252872%252990074-5%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520use%2520of%2520Dixon%2520plots%2520to%2520study%2520enzyme%2520inhibition%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Enzymol.%26date%3D1972%26volume%3D289%26spage%3D251%26epage%3D253%26doi%3D10.1016%2F0005-2744%2872%2990074-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drinkwater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiardini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, S.</span></span> <span> </span><span class="NLM_article-title">X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1002/prot.24771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1002%2Fprot.24771" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2015&pages=789-795&author=N.+Drinkwaterauthor=R.+S.+Bamertauthor=K.+K.+Sivaramanauthor=A.+Paiardiniauthor=S.+McGowan&title=X-ray+crystal+structures+of+an+orally+available+aminopeptidase+inhibitor%2C+Tosedostat%2C+bound+to+anti-malarial+drug+targets+PfA-M1+and+PfA-M17&doi=10.1002%2Fprot.24771"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fprot.24771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24771%26sid%3Dliteratum%253Aachs%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DX-ray%2520crystal%2520structures%2520of%2520an%2520orally%2520available%2520aminopeptidase%2520inhibitor%252C%2520Tosedostat%252C%2520bound%2520to%2520anti-malarial%2520drug%2520targets%2520PfA-M1%2520and%2520PfA-M17%26jtitle%3DProteins%26date%3D2015%26volume%3D83%26spage%3D789%26epage%3D795%26doi%3D10.1002%2Fprot.24771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowieson, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clift, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrop, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panjikar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riboldi-Tunnicliffe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradoc-Davies, T.</span></span> <span> </span><span class="NLM_article-title">MX1: A bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at The Australian Synchrotron</span>. <i>J. Synchrotron Radiat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1107/S1600577514021717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS1600577514021717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=25537608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFeitLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=187-190&author=N.+P.+Cowiesonauthor=D.+Aragaoauthor=M.+Cliftauthor=D.+J.+Ericssonauthor=C.+Geeauthor=S.+J.+Harropauthor=N.+Mudieauthor=S.+Panjikarauthor=J.+R.+Priceauthor=A.+Riboldi-Tunnicliffeauthor=R.+Williamsonauthor=T.+Caradoc-Davies&title=MX1%3A+A+bending-magnet+crystallography+beamline+serving+both+chemical+and+macromolecular+crystallography+communities+at+The+Australian+Synchrotron&doi=10.1107%2FS1600577514021717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">MX1: a bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at the Australian Synchrotron</span></div><div class="casAuthors">Cowieson, Nathan Philip; Aragao, David; Clift, Mark; Ericsson, Daniel J.; Gee, Christine; Harrop, Stephen J.; Mudie, Nathan; Panjikar, Santosh; Price, Jason R.; Riboldi-Tunnicliffe, Alan; Williamson, Rachel; Caradoc-Davies, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-190</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">1600-5775</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MX1 is a bending-magnet crystallog. beamline at the 3 GeV Australian Synchrotron.  The beamline delivers hard X-rays in the energy range from 8 to 18 keV to a focal spot at the sample position of 120 μm FWHM.  The beamline end station and ancillary equipment facilitate local and remote access for both chem. and biol. macromol. crystallog.  Here, the design of the beamline and end station are discussed.  The beamline has enjoyed a full user program for the last seven years and scientific highlights from the user program are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonncGct23S27Vg90H21EOLACvtfcHk0lj1bVkCWvpCYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFeitLrO&md5=2f00508e17ab0c8584519b30c3f0505b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS1600577514021717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600577514021717%26sid%3Dliteratum%253Aachs%26aulast%3DCowieson%26aufirst%3DN.%2BP.%26aulast%3DAragao%26aufirst%3DD.%26aulast%3DClift%26aufirst%3DM.%26aulast%3DEricsson%26aufirst%3DD.%2BJ.%26aulast%3DGee%26aufirst%3DC.%26aulast%3DHarrop%26aufirst%3DS.%2BJ.%26aulast%3DMudie%26aufirst%3DN.%26aulast%3DPanjikar%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DJ.%2BR.%26aulast%3DRiboldi-Tunnicliffe%26aufirst%3DA.%26aulast%3DWilliamson%26aufirst%3DR.%26aulast%3DCaradoc-Davies%26aufirst%3DT.%26atitle%3DMX1%253A%2520A%2520bending-magnet%2520crystallography%2520beamline%2520serving%2520both%2520chemical%2520and%2520macromolecular%2520crystallography%2520communities%2520at%2520The%2520Australian%2520Synchrotron%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2015%26volume%3D22%26spage%3D187%26epage%3D190%26doi%3D10.1107%2FS1600577514021717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battye, T. G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontogiannis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span> <span> </span><span class="NLM_article-title">iMosflm: A new graphical interface for diffraction-image processing with mosflm</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1107/S0907444910048675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444910048675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=21460445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=271-281&author=T.+G.+G.+Battyeauthor=L.+Kontogiannisauthor=O.+Johnsonauthor=H.+R.+Powellauthor=A.+G.+W.+Leslie&title=iMosflm%3A+A+new+graphical+interface+for+diffraction-image+processing+with+mosflm&doi=10.1107%2FS0907444910048675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM</span></div><div class="casAuthors">Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen; Powell, Harold R.; Leslie, Andrew G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">IMOSFLM is a graphical user interface to the diffraction data-integration program MOSFLM.  It is designed to simplify data processing by dividing the process into a series of steps, which are normally carried out sequentially.  Each step has its own display pane, allowing control over parameters that influence that step and providing graphical feedback to the user.  Suitable values for integration parameters are set automatically, but addnl. menus provide a detailed level of control for experienced users.  The image display and the interfaces to the different tasks (indexing, strategy calcn., cell refinement, integration and history) are described.  The most important parameters for each step and the best way of assessing success or failure are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeZl2UOMg3_bVg90H21EOLACvtfcHk0lj1bVkCWvpCYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D&md5=852651253f8d9c9a81e0513b6633c705</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444910048675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910048675%26sid%3Dliteratum%253Aachs%26aulast%3DBattye%26aufirst%3DT.%2BG.%2BG.%26aulast%3DKontogiannis%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DiMosflm%253A%2520A%2520new%2520graphical%2520interface%2520for%2520diffraction-image%2520processing%2520with%2520mosflm%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D271%26epage%3D281%26doi%3D10.1107%2FS0907444910048675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgijourVoun8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lgijourVoun8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lgijourVoun8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgVefti8lf_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">Phenix: A comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=Phenix%3A+A+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgVefti8lf_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPhenix%253A%2520A%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: Model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgVefti8lf_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgVefti8lf_RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span> <span> </span><span class="NLM_article-title">Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.2012.11-0302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=10.4269%2Fajtmh.2012.11-0302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=22232455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1ymu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=84-92&author=S.+Duffyauthor=V.+M.+Avery&title=Development+and+optimization+of+a+novel+384-well+anti-malarial+imaging+assay+validated+for+high-throughput+screening&doi=10.4269%2Fajtmh.2012.11-0302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening</span></div><div class="casAuthors">Duffy, Sandra; Avery, Vicky M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Tropical Medicine and Hygiene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-92</span>CODEN:
                <span class="NLM_cas:coden">AJTHAB</span>;
        ISSN:<span class="NLM_cas:issn">0002-9637</span>.
    
            (<span class="NLM_cas:orgname">American Society of Tropical Medicine and Hygiene</span>)
        </div><div class="casAbstract">With the increasing occurrence of drug resistance in the malaria parasite, Plasmodium falciparum, there is a great need for new and novel anti-malarial drugs.  We have developed a 384-well, high-throughput imaging assay for the detection of new anti-malarial compds., which was initially validated by screening a marine natural product library, and subsequently used to screen more than 3 million data points from a variety of compd. sources.  Founded on another fluorescence-based P. falciparum growth inhibition assay, the DNA-intercalating dye 4',6-diamidino-2-phenylindole, was used to monitor changes in parasite no.  Fluorescent images were acquired on the PerkinElmer Opera High Throughput confocal imaging system and analyzed with a spot detection algorithm using the Acapella data processing software.  Further optimization of this assay sought to increase throughput, assay stability, and compatibility with our high-throughput screening equipment platforms.  The assay typically yielded Z'-factor values of 0.5-0.6, with signal-to-noise ratios of 12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9mpHAvJlL67Vg90H21EOLACvtfcHk0ljfHF2i-s2AVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1ymu7k%253D&md5=60ae874f46758c03566acfdc948e1188</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.2012.11-0302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.2012.11-0302%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DDevelopment%2520and%2520optimization%2520of%2520a%2520novel%2520384-well%2520anti-malarial%2520imaging%2520assay%2520validated%2520for%2520high-throughput%2520screening%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2012%26volume%3D86%26spage%3D84%26epage%3D92%26doi%3D10.4269%2Fajtmh.2012.11-0302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EBG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EBG','PDB','3EBG'); return false;">PDB: 3EBG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KQZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KQZ','PDB','3KQZ'); return false;">PDB: 3KQZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA1','PDB','6EA1'); return false;">PDB: 6EA1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA2','PDB','6EA2'); return false;">PDB: 6EA2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAA','PDB','6EAA'); return false;">PDB: 6EAA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAB','PDB','6EAB'); return false;">PDB: 6EAB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE3','PDB','6EE3'); return false;">PDB: 6EE3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE4','PDB','6EE4'); return false;">PDB: 6EE4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE6','PDB','6EE6'); return false;">PDB: 6EE6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EED" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EED','PDB','6EED'); return false;">PDB: 6EED</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE2','PDB','6EE2'); return false;">PDB: 6EE2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EEE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EEE','PDB','6EEE'); return false;">PDB: 6EEE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01310">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24260"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01310">10.1021/acs.jmedchem.8b01310</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Proposed mechanism of hemoglobin digestion and action of hydroxamate inhibitors in <i>Plasmodium</i> (Supp Figure 1); compound design schematic from substrate analogue to compound 1 (Supp Figure 2); binding mode of compound 1 to <i>Pf</i>-M1 and <i>Pf</i>-M17 (Supp Figure 3); binding of <b>6k</b> is reversible, but possesses a very low off-rate (Supp Figure 4); <i>Pf</i>-M1—<b>6d</b>–<b>a</b>, <b>6h</b>, <b>6i</b>, and <b>6j</b> data collection and refinement statistics (Supp Table 1); <i>Pf</i>-M1—<b>6k</b>, <b>6m</b>, <b>6o</b>, and <b>6p</b> data collection and refinement statistics (Supp Table 2); <i>Pf</i>-M17—<b>6i</b>, and <b>6k</b> data collection and refinement statistics (Supp Table 3); activity of <b>6l</b> against a panel of matrix metalloproteinases (Supp Table 4) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular-formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_001.csv">jm8b01310_si_001.csv (1.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01310/suppl_file/jm8b01310_si_002.pdf">jm8b01310_si_002.pdf (1.39 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><i>Pf</i>-Mg1—<b>6d</b>–<b>a</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA1">6EA1</a>; <i>Pf</i>-M1—<b>6h</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EA2">6EA2</a>; <i>Pf</i>-M1—<b>6i</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAA">6EAA</a>; <i>Pf</i>-M1—<b>6j</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EAB">6EAB</a>; <i>Pf</i>-M1—<b>6k</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE3">6EE3</a>; <i>Pf</i>-M1—<b>6m</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE4">6EE4</a>; <i>Pf</i>-M1—<b>6o</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE6">6EE6</a>; <i>Pf</i>-M1—<b>6p</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EED">6EED</a>; <i>Pf</i>-M17—<b>6i</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EE2">6EE2</a>; <i>Pf</i>-M17—<b>6k</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EEE">6EEE</a></p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01310&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01310" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01310" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a2d5f299a3da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
